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1 Abstract 
Herpes simplex virus type 1 (HSV1) infects keratinocytes and epithelial cells of the oral and perioral 
region. Amplified virus enters neurons innervating that area and is transported retrogradely to the 
neuronal nuclei located in the cranial ganglia, where it can establish a latent infection. After 
reactivation, progeny virus is transported anterogradely to the synapse. After release from the synapse 
it can reinfect the epithelium and cause recurrent disease. Thus, during several stages of its life cycle, 
the neurotropic alphaherpesvirus HSV1 depends on intracellular long distance transport. 
After fusion of the viral envelope and a cellular membrane, incoming capsids are transported along 
microtubules (MTs) to the MT-organizing center (MTOC) and further to the nucleus. At the nuclear 
pore they release their genome into the nucleoplasm, where viral replication, transcription and capsid 
assembly take place. 
During my Ph.D. thesis I was involved in a project which confirmed with quantitative assays that 
MTs are required for efficient nuclear targeting of HSV1. Incoming HSV1 capsids colocalized with 
the minus-end directed MT motor cytoplasmic dynein and its cofactor dynactin. Interfering with 
dynein function by overexpressing the dynactin subunit dynamitin reduced nuclear targeting of HSV1, 
and as a consequence expression of immediate-early viral genes, while virus binding and virus 
internalization were not affected, and only slight alterations of the MT network were observed. Thus, 
dynein and its cofactor dynactin mediate nuclear targeting of HSV1. In some cells overexpressing 
dynamitin HSV1 particles accumulated in the cell periphery, and this peripheral accumulation required 
MTs, suggesting that it was mediated by a plus-end directed MT motor of the kinesin family. 
The small capsid protein VP26 can interact with the 14 kDa dynein light chains Tctex-1 and rp3. 
Therefore, we analyzed the cell entry of HSV1-∆VP26, which lacks VP26, and HSV1-GFPVP26, 
which contains GFPVP26 instead of VP26. Both required MTs and functional dynactin for efficient 
nuclear targeting in Vero and PtK2 cells, and consequently for efficient expression of immediate-early 
viral genes. Since Vero cells are infected after fusion at the plasma membrane, we conclude that 
cytosolic capsids lacking the potential dynein receptor VP26 can use MTs, dynein and dynactin for 
efficient nuclear targeting. Moreover, capsids from HSV1-wildtype, HSV1-∆VP26 and HSV1-
GFPVP26 bound to dynein and dynactin in vitro with similar efficiency. Compared to nuclear capsids 
with almost no tegument and capsids with complete tegument, capsids which had partially lost their 
outer tegument bound to dynein and dynactin more efficiently and showed the strongest motility along 
MTs in vitro, suggesting that inner tegument proteins might engage with molecular motors.  
In summary, cytosolic HSV1 capsids use MTs, cytoplasmic dynein and dynactin for efficient 
nuclear targeting. Our data suggest that besides VP26, HSV1 must encode at least one other receptor 
for dynein or dynactin and that inner tegument proteins are likely candidates.                                     
 
Key words: herpes simplex virus, cytoplasmic dynein, dynactin 
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2 Zusammenfassung 
Herpes-Simplex-Virus Typ 1 (HSV1) infiziert Keratinocyten und Epithelzellen im Mundbereich. 
Nach Vermehrung in diesen Zellen infiziert HSV1 Neuronen, die diesen Bereich innervieren, und 
wandert retrograd zu den neuronalen Zellkernen in den Kranialganglien. Dort kann es eine latente 
Infektion etablieren, nach deren Reaktivierung neu synthetisierte Viruspartikel anterograd zur Synapse 
transportiert werden. Dort freigesetzte HSV1-Viren infizieren erneut das Epithel mit ähnlichen 
Symptomen wie bei der Primärinfektion. Somit ist das neurotrope Alphaherpesvirus HSV1 zu 
unterschiedlichen Stadien seines Replikationszyklus auf einen intrazellulären Langstreckentransport 
angewiesen. 
Nach Fusion der Virushülle mit einer zellulären Membran werden eintretende Kapside entlang von 
Mikrotubuli (MT) zum MT-organisierenden Zentrum (MTOC) und weiter zum Zellkern transportiert. 
An der Kernpore entlassen die Kapside ihr Genom in das Nukleoplasma, in dem virale Replikation, 
Transkription und Kapsidzusammenbau stattfinden. 
Während meiner Doktorarbeit war ich daran beteiligt, mit quantitativen Messungen zu bestätigen, 
dass MT für den effizienten Transport von HSV1 zum Zellkern erforderlich sind (Mabit et al., 2002). 
Eintretende HSV1-Kapside kolokalisierten mit dem minus-gerichteten MT-Motor Dynein und dessen 
Kofaktor Dynactin. Eine Störung der Dynein-Funktion durch Überexpression der Dynactin-
Untereinheit Dynamitin reduzierte den Transport von HSV1 zum Zellkern und infolgedessen die frühe 
virale Genexpression, wohingegen Virusbindung und -internalisierung nicht beeinträchtigt und nur 
geringe Veränderungen am MT-Netwerk zu beobachten waren. Dynein und sein Kofaktor Dynactin 
transportierten somit HSV1-Kapside zum Zellkern. In einigen Dynamitin überexprimierenden Zellen 
akkumulierten HSV1-Partikel in der Zellperipherie. Für diese periphere Akkumulierung waren MT 
erforderlich, was möglicherweise bedeutet, dass sie von einem plus-gerichteten MT-Motor aus der 
Kinesin-Familie vermittelt wurde. 
Das kleine Kapsidprotein VP26 kann mit den 14 kDa leichten Ketten von Dynein, Tctex-1 und rp3, 
interagieren. Daher untersuchten wir den Zelleintritt von HSV1-∆VP26 und HSV1-GFPVP26, in 
denen VP26 deletiert bzw. durch GFPVP26 ersetzt ist. Beide benötigten MT und funktionelles 
Dynactin für einen effizienten Transport zum Zellkern von Vero- und PtK2-Zellen und infolgedessen 
für eine effiziente Expression früher viraler Gene. Da Vero-Zellen durch Fusion an der 
Plasmamembran infiziert werden, verwendeten vermutlich auch cytosolische Kapside, denen der 
potentielle Dynein-Rezeptor VP26 fehlte, MT, Dynein und Dynactin, um effizient zum Zellkern zu 
gelangen. Zudem banden Kapside von HSV1-Wildtyp, HSV1-∆VP26 und HSV1-GFPVP26 Dynein 
und Dynactin in vitro mit ähnlicher Effizienz. Verglichen mit nukleären, beinahe tegumentfreien 
Kapsiden und Kapsiden mit innerem und äußerem Tegument, banden Kapside, deren äußere 
Tegumentschicht teilweise entfernt war, Dynein und Dynactin effizienter und zeigten in vitro mehr 
Bewegung entlang von MT. Daher vermuten wir, dass Proteine aus der inneren Tegumentschicht mit 
molekularen Motoren interagieren. 
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Insgesamt zeigen unsere Daten, dass HSV1 MT, Dynein und Dynactin benutzt, um effizient zum 
Zellkern zu gelangen. Neben VP26 hat HSV1 vermutlich mindestens einen weiteren Rezeptor für 
Dynein oder Dynactin, und innere Tegumentproteine stellen gute Kandidaten hierfür dar. 
 
Schlagwörter: Herpes-Simplex-Virus, cytoplasmatisches Dynein, Dynactin 
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3 Introduction 
 
3.1 Intracellular trafficking of viral particles 
Incoming viral particles travel from the cell surface to sites of viral transcription and replication. 
In contrast, during assembly and egress, subviral particles move from these sites to sites of assembly, 
and virions are transported to the plasma membrane for egress. Although diffusion is efficient for 
translocation over short distances, it does not provide a means for directed long distance transport 
(Sodeik, 2000; Döhner and Sodeik, 2004). The presence of many organelles and the cytoskeleton, 
particularly the actin filaments, and molecular crowding caused by high protein concentrations restrict 
free diffusion of molecules larger than 500 kDa (Luby-Phelps, 2000; Verkman, 2002; Dauty and 
Verkman, 2005). Therefore, viruses and host organelles require active mechanisms for directed 
transport. Especially neurotropic viruses such as herpes simplex virus type 1 (HSV1) require efficient 
active axonal transport during pathogenesis. It has been calculated that an HSV1 capsid with a 
diameter of 125 nm would need 231 years for a diffusional translocation of one cm in axonal 
cytoplasm, and since diffusion depends on particle size, an enveloped HSV1 virion inside a transport 
vesicle is expected to be even less mobile (Sodeik, 2000; Döhner et al., 2005). Therefore, viruses 
exploit the host cell’s transport machinery for intracellular transport. They use two alternative 
strategies, either cytoplasmic membrane traffic, namely endocytosis for cell entry and exocytosis for 
egress, or viral components interact directly with the cytoskeletal transport machinery. 
  
3.2 The cytoskeleton and motor proteins 
The cytoskeleton is a three-dimensional network of protein filaments that defines cell shape as 
well as internal cell organization. It consists of three principal types of filaments: microtubules (MTs), 
actin filaments, and intermediate filaments. These filaments are regulated by many kinases and 
phosphatases as well as tubulin- or actin-binding proteins. Moreover, these filaments operate together, 
and several proteins provide direct links between them (Rodriguez et al., 2003; Jefferson et al., 2004; 
Kodama et al., 2004). Three classes of motor proteins transport various cargoes along MTs and actin 
filaments. Myosins carry their cargoes along actin filaments, while dyneins and kinesins catalyze 
transport along MTs. 
 
3.2.1 Intermediate filaments 
Rope-like intermediate filaments span the entire cytosol and provide mechanical strength against 
shear forces (Strelkov et al., 2003; Coulombe and Wong, 2004; Styers et al., 2005). Intermediate 
filaments do not seem to play any role in intracellular transport, because they have no polarity, and no 
motor proteins have been identified that use them as tracks. 
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3.2.2 Actin filaments 
Actin filaments, also known as microfilaments or F-actin, are flexible structures with a diameter of 
7-9 nm. They are built by head-to-tail assembly of globular actin monomers (G-actin). Actin filaments 
have an intrinsic polarity with fast growing barbed or plus-ends and slow growing pointed or minus-
ends (Welch and Mullins, 2002). Actin filaments are organized into a variety of linear bundles, two-
dimensional networks or three-dimensional gels. Besides actin filaments dispersed throughout the 
entire cell, all cells contain a cortical network of actin filaments underneath the plasma membrane, and 
possibly also around intracellular membrane compartments (Medalia et al., 2002). 
In addition to its structural role, actin is a key player in various cell motility processes which are 
either based on actin polymerization or on the action of ATP-dependent motors of the myosin family 
(Welch and Mullins, 2002; Kieke and Titus, 2003; Krendel and Mooseker, 2005). Actin filaments play 
a role during the life cycles of several viruses (Cudmore et al., 1997; Sodeik, 2000; Ploubidou and 
Way, 2001; Smith and Enquist, 2002; Döhner and Sodeik, 2004; Smith et al., 2004). The best 
understood example is vaccinia virus that utilizes actin polymerization for efficient cell-to-cell spread 
(Smith et al., 2003). 
Besides its various functions within the cytoplasm, actin was identified in several nuclear 
complexes implicating it in diverse nuclear activities including transcription, splicing, mRNA export 
and chromatin remodelling (Bettinger et al., 2004; Pederson and Aebi, 2005). Additionally, nuclear 
actin might have a structural function as part of a nucleoskeleton and the nuclear lamina. Several 
actin-binding proteins including myosin I are present in the nucleus, and nuclear myosin I is involved 
in transcription. Moreover, studies on energy-dependent movement of ND10 domains (nuclear 
domain 10) suggest that nuclear actin-myosin complexes mediate the dynamics of nuclear processes 
(Muratani et al., 2002). 
 
3.2.3 Myosins catalyze transport along actin filaments 
Myosins are composed of one or two heavy chains, and one to six light chains (Kieke and Titus, 
2003; Krendel and Mooseker, 2005). The heavy chain consists of a relatively conserved N-terminal 
motor domain which binds actin filaments and hydrolyzes ATP, a converter domain which generates 
the force required for movement, a neck domain which binds the light chains, and a divergent C-
terminal globular tail implicated in cargo binding. Based on sequence homology, 20 myosin classes 
have been designated. 
Myosin II is called conventional myosin, all other types of myosin are referred to as 
unconventional. Myosins move unidirectionally along actin filaments, either towards the plus-end or 
the minus-end. The arrangement of actin filaments in the cell periphery is generally with the plus-ends 
towards the plasma membrane. Therefore, plus-end directed myosins, like myosin I or V, are expected 
to carry their cargo to the cell periphery. In contrast, minus-end directed myosins, such as myosin VI 
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and possibly myosin IXb, may have complementary roles (Kieke and Titus, 2003; Krendel and 
Mooseker, 2005). 
 
3.2.4 Microtubules are the highways for long distance transport 
MTs are long hollow cylindrical filaments with a diameter of 25 nm. They are built of equally 
oriented heterodimers of α-and β-tubulin and MT-associated proteins (Nogales, 2000). This head-to-
tail assembly gives MTs an intrinsic polarity. The MT minus end depolymerizes if not stabilized by 
other proteins, and its polymerization rate is three times lower than at the plus-end. Thus, MTs grow 
primarily at the plus-end, but they can also depolymerize from the plus-end. This dynamic instability 
leads to alternating phases of growth and shrinkage and enables temporal and spatial flexibility in MT 
organization (Mitchison and Kirschner, 1984). Typically, the minus-ends are attached to a MT-
organizing center (MTOC) which nucleates MT assembly. MTs can detach from an MTOC, and the 
resulting noncentrosomal MTs either depolymerize, or are stabilized by minus-end binding proteins 
(Dammermann et al., 2003). Plus-end binding proteins stabilize the plus-ends, and enable interactions 
with the actin cortex, organelles or kinetochores. Different cell types contain different MT arrays 
(Fig. 1). 
MTs are the highways for long distance transport. Their ATP hydrolyzing motor proteins are 
dyneins and kinesins. Because a particular motor moves only in one direction, the cell specific MT 
organization determines the destination a specific motor can reach. MTs mediate the intracellular 
transport of many viral structures, either within vesicles or by a direct interaction of MT motors and 
viral proteins. Many viruses replicating in the nucleus including HSV1 (Sodeik et al., 1997), human 
cytomegalovirus (HCMV; Ogawa-Goto et al., 2003), human immunodeficiency virus (HIV; 
McDonald et al., 2002), adenovirus (Ad; Suomalainen et al., 1999; Leopold et al., 2000), parvoviruses 
(Seisenberger et al., 2001; Suikkanen et al., 2003), simian virus 40 (Pelkmans et al., 2001), influenza 
virus (Lakadamyali et al., 2003) and hepatitis B virus (Funk et al., 2004) use MTs for efficient nuclear 
targeting during cell entry. Even incoming cores of vaccinia virus (VV), which replicates in 
cytoplasmic viral factories, are transported along MTs (Carter et al., 2003). During assembly and 
egress, viruses also need MTs for trafficking inside exocytic vesicles or for cytosolic transport of 
subviral particles to the budding compartment. HIV, VV and African Swine Fever Virus are examples 
of viruses which use MTs during assembly and egress (Ploubidou et al., 2000; Sanderson et al., 2000; 
Geada et al., 2001; Heath et al., 2001; Hollinshead et al., 2001; Mouland et al., 2001; Rietdorf et al., 
2001; Ward and Moss, 2001a; Ward and Moss, 2001b; Jouvenet et al., 2004; Ward, 2005). The 
neurotropic alphaherpesviruses HSV1 and the porcine pseudorabies virus (PRV) absolutely require 
MTs for anterograde axonal transport during egress (Miranda-Saksena et al., 2000; Tomishima et al., 
2001). 
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Figure 1: Organization of microtubules (MTs) in different cell types. (a) MTs (red) of unpolarized 
fibroblasts or epithelial cells radiate from the MT-organizing center (MTOC) to the cell periphery, where their 
plus-ends (+) are located. The MTOC nucleates MT minus-ends (-) and is often close to the nucleus (N) 
(Dammermann et al., 2003). (b) In polarized columnar epithelial cells, MTs form an apico-basal array with their 
plus-ends near the basal surface and the minus-ends pointing to the apical membrane. Moreover, there is an 
apical and a basal MT web composed of short filaments. Only few MTs are associated with the MTOC under the 
cell apex (Dammermann et al., 2003; Müsch, 2004). (c) In the soma of neurons, MTs are radially arranged with 
their minus-ends attached to the MTOC. Axons and dendrites contain noncentrosomal MTs. Axons have MTs of 
uniform polarity, with their plus-ends pointing towards the synapse. In the proximal region of dendrites, the 
polarity of MTs is mixed, whereas at the distal end, the polarity is the same as in the axon (Baas et al., 1988; 
Hirokawa and Takemura, 2005). This figure was taken from Döhner et al., 2005 and has been modified. 
 
3.2.5 Cytoplasmic dynein and its cofactor dynactin 
Most minus-end directed MT transport is powered by cytoplasmic dynein (Fig. 2), a 20 S protein 
complex consisting of two dynein heavy chains (DHCs; 520 kDa), two dynein intermediate chains 
(DICs; 74 kDa), several dynein light intermediate chains (DLICs; 53-57 kDa) and a series of dynein 
light chains (DLCs) of the LC8, Tctex/rp3 and LC7/roadblock families (Vale, 2003; Vallee et al., 
2004). The C-terminus of DHC comprises both the globular head that hydrolyzes ATP and a 10-15 nm 
stalk that terminates in a MT-binding domain. The N-terminus mediates DHC dimerization and 
binding to DLIC and to DIC, which in turn also binds to DLCs. DIC, DLIC and DLC are implicated in 
cargo binding and regulation of motor activity. There are two DHC, two DIC, two DLIC, two LC7 and 
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three LC8 genes, and further diversity is generated by different isoforms of DIC and DLC. Dynein 
holoenzymes with different subunit compositions can recognize diverse cargos (Susalka et al., 2000; 
Tynan et al., 2000; Tai et al., 2001; King et al., 2002). 
 
 
Figure 2: The minus-end directed MT motor cytoplasmic dynein is a 20 S multiprotein complex. The 
dynein globular head is shown in mixed purple, blue shading to illustrate the distinct domains that comprise the 
motor head. The stalks extending from the rings bind to MTs with their globular tips. Tightly associated motor 
subunits (light intermediate, intermediate and light chains) are shown in green. Domains described in the text are 
labeled. Surface features are rendered based upon atomic resolution structures when available and appear as 
smooth images for domains of unknown structure. This picture was taken from Vale, 2003. 
 
DHC belongs to the AAA family of ATPases, where AAA stands for ATPase associated with 
various cellular activities (Oiwa and Sakakibara, 2005). Electron microscopy revealed that DHC has a 
complex morphology, in which six sequentially linked AAA modules together with a seventh domain 
are arranged in a ring. A principal site of ATP hydrolysis has been mapped to the first AAA module, 
while three additional AAA modules possibly act in a regulatory manner by binding either ADP or 
ATP (Oiwa and Sakakibara, 2005). Single molecule measurements have shown that cytoplasmic 
dynein makes steps of 8-32 nm length depending on the load (Mallik et al., 2004). 
Cytoplasmic dynein is assisted by dynactin (Fig. 3), another large protein complex of 20 S 
(Schroer, 2004). Dynactin enhances the processivity of dynein catalyzed transport, and is involved in 
cargo binding (Roghi and Allan, 1999; King and Schroer, 2000). It consists of a filament of the actin-
related protein 1 (Arp1) and a flexible sidearm projecting from this filament. The Arp1 filament is 
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capped at its plus-end by the actin capping protein CapZ, and at its minus-end by a heterotetrameric 
complex of Arp11, p62, p25 and p27. The projecting sidearm consists of two molecules of p150Glued, 
four copies of dynamitin and the homodimer p24/p22. The latter two form a shoulder-like structure 
that connects the p150Glued sidearm to the Arp1 filament (Schroer, 2004). If dynamitin is present in 
large excess, the 20 S dynactin complex separates in two non-functional subcomplexes (Echeverri et 
al., 1996; Eckley et al., 1999). This inhibits most if not all transport mediated by cytoplasmic dynein 
(Echeverri et al., 1996; Burkhardt et al., 1997; Valetti et al., 1999). 
 
 
 
Figure 3: Schematic illustrating the location and approximate structural features of dynactin. The overall 
structure of dynactin was inferred from electron microscopy (Schafer et al., 1994; Hodgkinson et al., 2005). 
Dynactin consists of a 10 nm × 40 nm rod made mainly of Arp1 (in red) which is capped at its plus-end by the 
actin capping protein CapZ (in green) and at its minus-end by the pointed-end complex consisting of Arp11 (in 
yellow), p25, p27 (both in brown) and p62 (in orange). A flexible sidearm of p150Glued (light blue) with a length 
of 25-50 nm projects from this Arp1 filament (Schroer, 2004). Dynein and other motors are thought to bind to 
dynactin along or near the base of this p150Glued sidearm. Each globular head of p150Glued has a MT-binding site, 
whereas the Arp1 filament has been implicated in cargo binding. The flexible sidearm and the Arp1 filament are 
linked by p24/22 (dark blue) and dynamitin (turquoise). This picture was taken from Schroer, 2004. 
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Cytoplasmic dynein and dynactin drive a variety of fundamental cellular processes, including 
nuclear envelope breakdown, mitotic spindle organization, chromosome separation during mitosis, the 
positioning of many intracellular organelles, and fast retrograde axonal transport (Vallee et al., 2004). 
Furthermore, several viruses including Ad, HSV1, Kaposi’s sarcoma-associated herpesvirus, VV, 
African swine fever virus, influenza virus, canine parvovirus and several retroviruses use dynein 
mediated transport during several stages of their life cycle (Sodeik et al., 1997; Suomalainen et al., 
1999; Leopold et al., 2000; Ploubidou et al., 2000; Sanderson et al., 2000; Alonso et al., 2001; Heath 
et al., 2001; Döhner et al., 2002; McDonald et al., 2002; Lakadamyali et al., 2003; Petit et al., 2003; 
Sfakianos and Hunter, 2003; Sfakianos et al., 2003; Suikkanen et al., 2003; Naranatt et al., 2005). 
 
3.2.6 The kinesin superfamily 
Kinesins are members of a superfamily containing 45 human proteins. They contain a MT-binding 
motor domain of 320 amino acids that is folded similarly to myosins and G proteins. The kinesins 
have been classified into three major groups according to the position of the motor domain at the N-
terminus, in the middle, or at the C-terminus, hence the names N-kinesins, M-kinesins and C-kinesins, 
respectively (Hirokawa and Takemura, 2005). There are 39 N-kinesins, three M-kinesins and three C-
kinesins. Based on sequence homology, kinesins are further subdivided into 14 families (Lawrence et 
al., 2004). N-kinesins move their cargo towards the MT plus-ends, whereas C-kinesins catalyze 
transport towards the minus-ends. M-kinesins most likely do not work as motors but depolymerize 
MTs (Ovechkina and Wordeman, 2003). 
Conventional kinesin (Fig. 4) has two heavy chains (KHCs, kinesin-1, 120 kDa) and two light 
chains (KLCs; 64 kDa). Each KHC consists of an N-terminal motor head, a neck linker, a long coiled 
coil dimerization region and a globular tail domain. The N-terminus of KLC interacts with the C-
terminus of KHC, and a tetratricopeptide motif in the C-terminus of KLC and the KHC tail mediate 
cargo binding. Three KHC and three KLC genes may give rise to differently assembled motors. 
Kinesin-1 can interact with cytoplasmic dynein via KLC and DIC (Ligon et al., 2004). It makes 8 nm 
steps and walks by moving its two heads in a hand-over-hand mechanism (Yildiz and Selvin, 2005). 
Kinesin-1 carries axonal vesicles, mitochondria, lysosomes, endocytic vesicles, tubulin oligomers, 
intermediate filament proteins and mRNA complexes, and participates in the subcellular localization 
of the ER and the Golgi apparatus (Hirokawa and Takemura, 2005). It is also be involved in cytosolic 
viral transport (Rietdorf et al., 2001; Jouvenet et al., 2004; Ward and Moss, 2004).  
Heterotrimeric kinesin-2 (Fig. 4) comprises two motor subunits, KIF3A and either KIF3B or 
KIF3C (85-95 kDa), and a non-motor subunit called kinesin-associated protein (KAP; 115 kDa). 
Kinesin-2 participates in a variety of transport processes, including intraciliary, intraflagellar and 
axonal transport (Hirokawa and Takemura, 2005), membrane transport between the ER and the Golgi 
complex (Le Bot et al., 1998), and outward movement of melanosomes (Tuma et al., 1998). 
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Furthermore, kinesin-2 contributes to the proper localization of late endosomes and lysosomes 
(Bananis et al., 2004; Brown et al., 2005). KAP interacts with the dynactin subunit p150Glued, and 
excess dynamitin reduces kinesin-2 mediated transport of melanosomes to the cell periphery (Deacon 
et al., 2003). 
 
 
 
 
Figure 4: A selection of plus-end directed N-type kinesins: kinesin-1, kinesin-2 and kinesin-3. The catalytic 
motor domains are displayed in blue, mechanical amplifiers in light blue, and tail domains implicated in cargo 
attachment are shown in purple. Kinesin-2 contains two distinct motor subunits, which is reflected in the two 
different colour shadings. Tightly associated motor subunits (light chains, KAP) are shown in green. Domains 
described in the text are labeled. Kinesin-3 can exist as a monomer and dimer, as indicated by the equilibrium. 
Surface features are rendered based upon atomic resolution structures when available and appear as smooth 
images for domains of unknown structure. This picture was taken from Vale, 2003. 
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Members of the kinesin-3 family are monomeric in solution, but dimerize on membranes, and 
thereby become processive (Tomishige et al., 2002; Al-Bassam et al., 2003). Via a pleckstrin-
homology domain, they attach to membranes (Klopfenstein et al., 2002; Klopfenstein and Vale, 2004). 
They transport mitochondria and convey transport vesicles to the nerve terminals of motor neurons 
(Nangaku et al., 1994; Okada et al., 1995). 
Kinesin-14 proteins carry their motor domain at the C-terminus, and catalyze minus-end directed 
transport. They have been implicated in the organization of bipolar spindles, retrograde transport in 
neurons, Golgi apparatus positioning and motility of early endosomes (Nielsen et al., 1999; Bananis et 
al., 2003; Ovechkina and Wordeman, 2003). Other kinesins, not further discussed here, are involved in 
membrane traffic, mitosis and cytokinesis (Hirokawa and Takemura, 2005; Zhu et al., 2005). 
 
3.3 Herpesviridae 
The herpesviridae are a large family of enveloped double-stranded DNA viruses (Roizman and 
Pellet, 2001; Cleator and Klapper, 2004). Members of this family encode a large array of enzymes 
involved in nucleic acid metabolism and DNA synthesis. Viral replication and capsid assembly occur 
in the nucleus and the production of infectious progeny virus is invariably accompanied by the lysis of 
the infected cells. Following infection of their natural host, herpesviruses establish a lifelong latent 
infection (Roizman and Pellet, 2001; Cleator and Klapper, 2004). 
 Members of the herpesviridae have been identified in a wide range of vertebrates, and 
interestingly one invertebrate, the Pacific oyster (Minson et al., 2000). The vertebrate herpesviruses 
fall into two major phylogenetic groups. Those in the first group have mammalian or avian hosts, and 
are classified into the subfamilies alpha-, beta- and gammaherpesvirinae, and each subfamily is in turn 
divided into a series of genera (McGeoch et al., 2000). Reptilian herpesviruses probably also belong to 
the alphaherpesvirinae. Viruses in the second group infect amphibians and bony fish (Davison et al., 
1999). 
There are presently nine members of the Herpesviridae known to infect man (Table 1). The 
official names, human herpesviruses (HHV) 1-8, are rarely used, with the exception of human 
herpesviruses 6A, 6B, 7 and 8. The other herpesviruses are generally described using their common 
names. Herpes simplex virus type 1 (HSV1) is officially named human herpesvirus 1 and belongs to 
the genus simplexvirus of the subfamily alphaherpesvirinae. The members of the subfamily 
alphaherpesvirinae show a variable host range, short reproductive cycle, rapid spread in culture, 
efficient lysis of infected cells, and capacity to establish latent infections, primarily but not 
exclusively, in sensory ganglia (Roizman and Knipe, 2001; Cleator and Klapper, 2004). 
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Official name and 
abbreviation Subfamily Genus 
Common name and 
abbreviation 
Human herpesvirus 1 
(HHV-1) Alphaherpesvirinae Simplexvirus 
Herpes simplex virus type 1 
(HSV1) 
Human herpesvirus 2 
(HHV-2) Alphaherpesvirinae Simplexvirus 
Herpes simplex virus type 2 
(HSV2) 
Human herpesvirus 3 
(HHV-3) Alphaherpesvirinae Varicellovirus Varicella zoster virus (VZV) 
Human herpesvirus 4 
(HHV-4) Gammaherpesvirinae Lymphocryptovirus Epstein-Barr virus (EBV) 
Human herpesvirus 5 
(HHV-5) Betaherpesvirinae Cytomegalovirus 
Human cytomegalovirus 
(HCMV) 
Human herpesvirus 6A 
(HHV-6A) Betaherpesvirinae Roseolovirus HHV-6A 
Human herpesvirus 6B 
(HHV-6B) Betaherpesvirinae Roseolovirus HHV-6B 
Human herpesvirus 7 
(HHV-7) Betaherpesvirinae not determined HHV-7 
Human herpesvirus 8 
(HHV-8) Gammaherpesvirinae Rhadinovirus 
Kaposi’s sarcoma-associated 
herpesvirus (KSHV) 
 
Table 1. Classification of the human herpesviruses. This table was taken from Cleator and Klapper, 2004. 
 
3.4 Herpes simplex virus type 1 
In most immunocompetent humans, a primary infection with HSV1 is unremarkable. HSV1 
mainly infects keratinocytes and epithelial cells of the oral and perioral region (Fig. 5). Amplified 
virus then enters sensory or autonomic neurons innervating that area, and is transported retrogradely to 
the neuronal nuclei located in the cranial ganglia (Enquist et al., 1998; Vrabec and Alford, 2004). In 
neurons, HSV1 either initiates an acute infection resulting in the production of progeny virions, or the 
viral DNA circularizes and establishes a latent infection. During latency, the episomal viral genome is 
largely inactive, and viral replication appears to be repressed by the host’s immune system (Bloom, 
2004; Khanna et al., 2004). Upon stress, latent viral genomes can be reactivated, a lytic infection 
begins, and progeny virus is anterogradely transported via the axon to the nerve terminal. After release 
at the presynapse, HSV1 reinfects the epithelium resulting in secretion of infectious virus and, in some 
cases, lesion formation (Jerome and Ashley, 2003). This generally mild course of infection is in sharp 
contrast to HSV1 associated diseases like disseminated infection or life-threatening HSV1 encephalitis 
in neonates and immunocompromised patients, and ocular HSV1 infections that can lead to scarring, 
opacification of the cornea and ultimately blindness. 
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Figure 5: HSV1 latency and reactivation: HSV1 initially infects keratinocytes and epithelial cells of the oral 
and perioral area (left). Amplified virus then enters neurons innervating that region and is transported 
retrogradely to cranial ganglia, for example the trigeminal ganglion (left), where a latent infection is established 
(middle). Upon stress, the latent virus becomes reactivated and progeny virus is transported anterogradely from 
the trigeminal ganglion to the synapse (right). After release from the synapse it reinfects the epithelium 
eventually causing cold sores and blisters (right). This figure was taken from Janeway et al., 2001 and has been 
modified. 
 
The infectious HSV1 virion consists of four structural components: (1) the viral DNA, (2) an 
icosahedral capsid, (3) the tegument, and (4) the envelope (Roizman and Knipe, 2001). The double-
stranded DNA of 152 kbp encodes about 80 proteins (Rajcani et al., 2004), half of which are structural 
proteins. HSV1 proteins are named according to their genes that are either located on the unique long 
(UL1, UL2 etc.) or the unique short (US1, US2 etc.) genome region, in descending order by apparent 
molecular weight (VP1-3, VP5 etc.) or by their function (e.g. vhs – virus host shut off protein). 
The icosahedral capsid has a diameter of 125 nm and is organized into 12 pentagonal vertices and 
20 triangular faces. It consists of 162 capsomers that are linked by 320 triplexes composed of two 
copies of VP23 and one copy of VP19C (Zhou et al., 2000). Each capsomer has a chimney-like 
protrusion and is traversed by an axial channel (Zhou et al., 1999). There are three types of capsomers: 
hexons that form the capsid faces and edges, pentons that are located at 11 of the 12 vertices, and the 
portal found at one of the 12 vertices (Newcomb et al., 2001; Trus et al., 2004). The major capsid 
protein VP5 forms hexamers or pentamers which form the 150 hexons and the 11 pentons, 
respectively. The tips of the hexons, but not the pentons, are decorated with six copies of the 12 kDa 
capsid protein VP26 (Wingfield et al., 1997). The portal is a dodecamer of the portal protein UL6. It 
 
primary infection 
 
latency
 
 reactivation 
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has approximately the same size as a penton and is cylindrical, with an axial channel through which 
the DNA passes as it is packaged (Newcomb et al., 2001; Trus et al., 2004). After DNA packaging 
UL25 is believed to seal the portal (Ogasawara et al., 2001; Sheaffer et al., 2001). 
The tegument, the hallmark of all herpesviruses, is a protein layer between the capsid and the viral 
envelope. The HSV1 envelope contains about twelve viral membrane proteins that are involved in 
binding to and entry into host cells, envelopment during virus assembly, cell-to-cell spread and 
modulation of the host immune response (Roizman and Knipe, 2001; Mettenleiter, 2002; Mettenleiter, 
2003; Mettenleiter, 2004; Spear, 2004). 
 
 
 
Fig. 6: Cryoelectronmicroscopy tomogram of an HSV1 virion. The host derived envelope with the viral 
membrane proteins (red), the tegument (light green), and the icosahedral capsid (dark green) are illustrated. The 
capsid is built by 162 capsomers: 150 VP5 hexons at the edges and surfaces and 11 VP5 pentons at 11 of the 12 
vertices. At one vertex, the VP5 penton is supposed to be replaced by the UL6 portal complex. The capsomers 
are connected at the bottom by triplexes of VP19C and VP23. The tegument has an asymmetric distribution: at 
the bottom of the depicted virion, the capsid closely approaches the envelope, whereas at the top it is separated 
by about 35 nm of tegument. In HSV1, the tegument contains about 20 different proteins. This image was kindly 
provided by Dr. Kay Grünewald, Max-Planck Institute of Biochemistry, Martinsried, Germany (Grünewald et 
al., 2003). 
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Cryoelectronmicroscopy and image reconstruction revealed the three-dimensional structure of the 
HSV1 virion in a near-native state (Zhou et al., 1999; Zhou et al., 2000; Grünewald et al., 2003; 
Fig. 6). The diameter of the approximately 5 nm thick envelope ranges from 170-200 nm, averaging 
186 nm. An array of spikes with a length of 10 to 25 nm protrudes from each virion, making the full 
diameter, on average, ~ 225 nm. Inside the envelope, the capsid occupies an eccentric position. On the 
proximal pole it is close to the envelope, whereas on the distal pole, capsid and envelope are separated 
by 30 to 35 nm of tegument (Grünewald et al., 2003). Most of the tegument is not icosahedrally 
ordered, but a small portion appears as filamentous structures around the pentons. The interaction 
between the capsid and the tegument seems to be confined to the pentons and the directly 
neighbouring hexons (Zhou et al., 1999; Grünewald et al., 2003). 
 
3.4.1 HSV1 entry into cells 
Any viral life cycle can be roughly divided into the following phases: (1) adsorption to the cell, (2) 
penetration of the plasma or endosomal membrane, (3) genome uncoating and release from a viral 
nucleoprotein complex or capsid, (4) early viral protein synthesis, (5) genome replication, (6) late viral 
protein synthesis, (7) virus assembly/maturation, and finally (8) viral release or egress. I define here 
phases (1)–(3), up to the stage at which the viral genome has been uncoated for transcription and 
replication, collectively as “viral cell entry” (Whittaker et al., 2000; Döhner and Sodeik, 2004; Smith 
and Helenius, 2004). 
To enter cells HSV1 binds via the viral glycoproteins gB and gC to its primary receptors heparan 
sulfate or other glycosaminoglycan chains of cell surface proteoglycans (Fig. 7; Spear et al., 2000; 
Roizman and Knipe, 2001; Spear and Longnecker, 2003; Spear, 2004). The interaction between gB 
and/or gC with glycosaminoglycans significantly enhances the efficiency of HSV1 infection, but is 
neither absolutely required, nor sufficient for viral entry. For successful entry into cells, the viral 
glycoprotein gD has to interact with one of several secondary receptors. This interaction triggers 
fusion of the viral envelope with a cellular membrane, either the plasma membrane or an endosomal 
membrane, and results in release of the viral nucleocapsid and tegument into the cytoplasm. Fusion of 
the viral envelope with a cellular membrane requires the viral glycoproteins gB and the heterodimer of 
gH and gL in addition to gD and the gD receptor. 
The so far known secondary receptors fall into three classes. They include HVEM (herpes virus 
entry mediator), a member of the tumor necrosis factor receptor family, nectin-1, a member of the 
immunoglobulin superfamily, and specific sites in heparan sulfate generated by certain 3-O-
sulfotransferases (Spear, 2004). Moreover, expression of the type II cell surface membrane protein B5 
that is broadly expressed in human tissues, renders replication competent but entry deficient porcine 
cells susceptible for HSV1 infection (Perez et al., 2005; Perez-Romero and Fuller, 2005). Recently, 
the RGD motif in the gH ectodomain was shown to bind to αvβ3 integrins (Parry et al., 2005). 
Although blocking this interaction does not abrogate HSV1 infection, it might be involved in signaling 
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during virus entry (Qie et al., 1999; Zachos et al., 1999; Cheshenko et al., 2003; Cheshenko et al., 
2005). 
 
 
 
Figure 7: MT mediated transport during HSV1 cell entry. Herpes simplex virus type 1 (HSV1) binds via 
viral glycoproteins to the plasma membrane of host cells (1). It enters many cells by fusion of its envelope with 
the plasma membrane (2), thereby releasing the capsid (dark green) and tegument (green) into the cytosol (3). 
The capsid with some tegument is transported along microtubules (MTs, red, 4) to the MT-organizing center 
(MTOC; 5) that is close to the nucleus in many cell types. This transport is catalyzed by the minus-end directed 
MT motor cytoplasmic dynein (dark blue) and its cofactor dynactin (light blue). From the MTOC the capsid 
moves further to the nuclear envelope (6). Importin β is required for capsid binding to the nuclear pore. At the 
nuclear pore, the viral genome is released into the nucleoplasm (7) where viral replication and transcription take 
place. Some cell types are productively infected by endocytosis (8). Endosomes containing HSV1 are 
presumably also transported along MT (9). Release from endosomes (10) might already take place in the cell 
periphery or in the perinuclear area. To initiate an infection, capsids released from endosomes also inject their 
genome into the nucleoplasm (7). 
 
HSV1 enters many cell types by fusion of the viral envelope with the plasma membrane (Fig. 7). 
Examples are Vero, BHK, Hep2, COS and 143tk- cells, several neuroblastoma cell lines like SK-N-
SH, IMR32 and SH-SY5Y, human CNS progenitor cells and human dorsal root ganglion neurons 
(Koyama and Uchida, 1987; Lycke et al., 1988; Wittels and Spear, 1991; Sodeik et al., 1997; Nicola et 
al., 2003; Gianni et al., 2004; Nicola and Straus, 2004; Nicola et al., 2005). However, some cell types 
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are productively infected after entry by endocytosis. Examples for this entry mechanism are CHO-
nectin1, CHO-HVEM, and HeLa cells, or keratinocytes such as HaCaT, SCC13, and NHEK cells 
(Nicola et al., 2003; Gianni et al., 2004; Nicola and Straus, 2004; Nicola et al., 2005). Evidence for 
entry by endocytosis is based on electron microscopy or pharmacological inhibitors of the endocytic 
pathway (Nicola et al., 2003; Nicola and Straus, 2004), or on drugs interfering with endosomal 
acidification (Gianni et al., 2004; Nicola et al., 2005). Since the HSV1 envelope can fuse with the 
plasma membrane at neutral pH, a lack of sensitivity to changes in the endosomal pH does not exclude 
an infection via endocytic organelles (Milne et al., 2005). 
An interesting question is how the choice is made between entry by fusion of the viral envelope 
with the plasma membrane and entry by endocytosis. In principle, this might be host or virally 
determined. It has been suggested that a dense cortical cytoskeleton might prevent productive infection 
after fusion of the viral envelope and the plasma membrane (Marsh and Bron, 1997). In contrast, 
virions inside endosomes might circumvent this cortical actin barrier, and after release from the 
endosome into the cytosol the viral particle can initiate a productive infection (Marsh and Bron, 1997; 
Sodeik, 2000; Döhner and Sodeik, 2004; Smith and Helenius, 2004; Milne et al., 2005). 
 
3.4.2 HSV1 cytosolic transport during entry 
After fusion of the viral envelope with the plasma membrane, the capsid and the tegument are 
released into the cytosol. Part of the tegument remains at the plasma membrane (Sodeik et al., 1997). 
After traversing the actin cortex beneath the plasma membrane, the capsid with residual tegument is 
transported along MTs to the MTOC that is close to the nucleus in many cell types (Fig. 7; 
Kristensson et al., 1986; Lycke et al., 1988; Topp et al., 1994; Hammonds et al., 1996; Topp et al., 
1996; Sodeik et al., 1997; Mabit et al., 2002; Marozin et al., 2004). This transport is catalyzed be the 
minus-end directed MT-motor cytoplasmic dynein and its cofactor dynactin (Kristensson et al., 1986; 
Sodeik et al., 1997; Döhner et al., 2002). It is currently unknown how capsids are further translocated 
from the MTOC to the nuclear envelope (Sodeik, 2002; Döhner et al., 2005). While capsids initially 
accumulate at the nuclear site facing the MTOC, they later spread over the entire nuclear envelope 
indicating additional transport mechanisms (Sodeik et al., 1997; Döhner et al., 2002; Everett et al., 
2004). In injured axons, minus-end directed transport is coupled to nuclear import (Hanz et al., 2003). 
Cytoplasmic dynein can interact with the nuclear import receptor importin α and recruit a nuclear 
import cargo that is bound to importin β. A similar mechanism might be involved in transport of 
HSV1 capsids from the MTOC to the nuclear envelope. Alternatively, viral particles might utilize 
plus-end directed MT motors to proceed (Döhner et al., 2002; Sodeik, 2002). 
After arrival at the nucleus, capsids are oriented with a penton toward the nuclear pore, and they 
are often attached to the cytoplasmic fibrils of the nuclear pore complex (NPC; Granzow et al., 1997; 
Sodeik et al., 1997; Ojala et al., 2000). Importin β is required for capsid binding to the nuclear pores.  
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The interaction with the nuclear pore destabilizes the capsid and triggers viral genome uncoating 
(Batterson and Roizman, 1983; Ojala et al., 2000). The viral DNA is released into the nucleoplasm, 
where viral replication and transcription take place. VP16 of the incoming tegument together with host 
transcription factors transactivates the expression of five immediate-early HSV1 genes (Roizman and 
Knipe, 2001; Wysocka and Herr, 2003). The immediate-early gene products cooperate with host 
transcription factors to regulate the expression of HSV1 early genes. The HSV1 early gene products 
are involved in nucleotide metabolism and DNA replication. More than 35 HSV1 gene products 
expressed with late kinetics form structural components of the virion (Roizman and Knipe, 2001). 
 
3.4.3 Potential role of microtubules during assembly and egress of HSV1 
Potential functions of MTs during HSV1 assembly and egress are less well understood. If MTs are 
depolymerized during assemby, virus yields are reduced, but HSV1 infection is not completely 
blocked in cultured epithelial cells (Avitabile et al., 1995; Kotsakis et al., 2001). In contrast, MTs are 
essential for axonal transport of viral particles and virus release at the axon terminal in cultured 
neurons (Miranda-Saksena et al., 2000; Tomishima et al., 2001). 
HSV1 replication and capsid assembly take place within the nucleus. Therefore, capsid proteins 
and proteins required for DNA packaging have to be imported into the nucleus. The viral genome is 
then packaged into preassembled procapsids via the UL6 portal (Newcomb et al., 2001; White et al., 
2003; Trus et al., 2004). After DNA packaging, the UL6 portal is supposed to be sealed by UL25 
(Ogasawara et al., 2001; Sheaffer et al., 2001). 
Within infected nuclei, HSV1 capsids are actively transported away from sites of capsid assembly. 
This movement is sensitive to the unspecific myosin inhibitor 2,3-butanedione monoxime and to actin 
depolymerization with latrunculin A, but insensitive to actin depolymerization with cytochalasin D 
(Forest et al., 2005). Insensitivity to cytochalasin D is consistent with the idea that nuclear actin is 
structurally distinct from cytoplasmic F-actin (Bettinger et al., 2004). The authors speculate that this 
intranuclear movement might either be catalyzed by a viral protein e.g. the capsid-associated DNA-
packaging motor or by a cellular intranuclear transport system, such as that proposed to transport some 
ND10 domains (Muratani et al., 2002). 
By budding at the inner nuclear membrane the DNA-containing capsids acquire the protein kinase 
US3, the primary tegument protein UL31 and the primary viral membrane protein UL34, and reach the 
periplasmic space, the lumen between the inner and outer nuclear membrane that is continuous with 
the ER lumen (Fig. 8). The primary envelope of these periplasmic virions then fuses with the outer 
nuclear membrane or the ER membrane, and the resulting capsids reach the cytosol (Enquist et al., 
1998; Mettenleiter, 2002; Mettenleiter, 2004). These cytosolic capsids are then transported to the site 
of secondary envelopment, which is most likely related to the trans-Golgi network (TGN) or possibly 
to endosomes (Brunetti et al., 1998; Alconada et al., 1999; Granzow et al., 2001; Harley et al., 2001; 
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McMillan and Johnson, 2001; Wisner and Johnson, 2004; Turcotte et al., 2005). Infectious virions are 
then released from infected cells either by cell lysis, or more likely by fusion of virion containing 
membrane vesicles with the plasma membrane (Roizman and Knipe, 2001; Mettenleiter, 2002; 
Mettenleiter, 2004). 
Late during HSV1 infection, the radial MT organization is lost, at least in some epithelial cell 
types (Avitabile et al., 1995). Instead, the MTs are fragmented, particularly in the cell periphery, form 
bundles which surround the nucleus, and an apparent MTOC is lost, but may regenerate later 
(Avitabile et al., 1995; Elliott and O'Hare, 1998; Ward et al., 1998; Kotsakis et al., 2001). This 
reorganization of the MT network late in infection has hampered the analyzis of the contribution of 
MTs and MT motors during assembly and egress. The predicted functions of MTs, dynein and kinesin, 
which are hypothesized below, would only facilitate assembly and egress, if they occurred prior to the 
reorganization of the MT network. 
MTs could mediate transport of cytosolic capsids to the secondary budding compartment, and 
secretory vesicles containing virions might be carried along MTs to the plasma membrane. If budding 
occurred at the TGN or at endosomes, which are often concentrated around the MTOC, capsids might 
recruit dynein and its cofactor dynactin or a minus-end directed kinesin for this transport. In contrast, 
plus-end directed kinesins might carry virion-containing vesicles to the plasma membrane. 
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Figure 8: Potential functions of microtubules during neuronal HSV1 assembly and egress. After nuclear 
DNA-packaging, capsids (dark green) acquire a primary tegument (light green) and a primary envelope by 
budding at the inner nuclear membrane (1) leading to the formation of periplasmic virions. Such periplasmic 
virions fuse with the outer nuclear membrane to release capsids into the cytosol (2). Cytosolic capsids are 
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transported, presumably along MTs (MT, red), to another membrane compartment for secondary envelopment 
(3A) or by axonal transport to the synapse (3B). Cytosolic capsids may already bind some tegument (green). 
Viral glycoproteins (gP) are transported from the endoplasmic reticulum (ER) to the cis-Golgi network (CGN; 
4), and further through the Golgi apparatus to the trans-Golgi network (TGN), or even to the plasma membrane. 
Some gPs contain endocytosis signals in their cytosolic tail and may be targeted to endocytic organelles. The 
cytosolic tails of some viral gPs interact with some tegument proteins (green). 
 Secondary envelopment may occur at the TGN (5A), at TGN-derived vesicles (5B), at endosomes localized 
in the soma (5C), or in the axon terminal (5D). TGN and endosomes are often clustered around the MT-
organizing center (MTOC). After secondary envelopment, secretory vesicles containing virions can be 
transported, presumably along MTs, to the plasma membrane of the soma (6A) where the viral membrane fuses 
with the plasma membrane (7A), and releases mature virions into the medium. Most likely, viral assembly 
intermediates are also transported along axonal MTs: capsids with or without tegument (3B), vesicles with viral 
gPs and tegument proteins on the outside, or vesicles with virions (6B). Virions may be released by exocytosis 
(7B), or final budding might occur at the synapse resulting in virus secretion (7B). Vesicles may also fuse with 
the plasma membrane (5E), and insert gPs and attached tegument into the presynaptic plasma membrane. 
Partially tegumented capsids might then bud there resulting in virion release into the medium. 
 
 
In neurons, cytosolic capsids might bud at compartments related either to the TGN or to 
endosomes in the soma as described above, and might then be transported inside secretory vesicles to 
the plasma membrane of the soma (Miranda-Saksena et al., 2002) or to the presynapse. Alternatively, 
cytosolic capsids might enter axons and might move along MTs to the nerve terminals. Several studies 
found that capsids and envelope proteins were conveyed separately in the axon, suggesting that final 
virion assembly takes place in the presynapse (Penfold et al., 1994; Holland et al., 1999; Miranda-
Saksena et al., 2000; Tomishima and Enquist, 2001; Diefenbach et al., 2002). In axons of retinal 
ganglion cells, HSV1 antigens and DNA were found in unenveloped particles of 110 nm diameter 
consistent with transport of unenveloped capsids (LaVail et al., 2005). Additionally, membrane-bound 
particles of 150-180 nm diameter containing HSV1 antigens were reported. 
However, recent experiments in PRV, the porcine alphaherpesvirus, revealed that the viral 
glycoprotein gE is required for axonal entry of capsids, as well as at least one tegument protein (Ch'ng 
and Enquist, 2005a). Moreover, brefeldin A treatment blocked entry of capsid, tegument and viral 
membrane proteins into axons, whereas in untreated cells capsids enclosed within vesicles entered 
axons (Ch'ng and Enquist, 2005b; del Rio et al., 2005). These studies indicate that viral capsids may 
be transported in association with tegument and possibly viral membrane proteins within vesicles 
rather than as unenveloped capsids. 
 
3.4.4 Potential receptors for dynein, dynactin and kinesins on the HSV1 virion 
In contrast to many cellular structures transported along MTs, the protein composition of HSV1 is 
known and can be specifically altered by directed mutagenesis. Therefore, the potential significance of 
interactions of HSV1 proteins with molecular motors identified in vitro by yeast two-hybrid assays, 
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glutathione-S-transferase(GST)-pulldowns, coimmunoprecipitation, pepscan techniques or other 
assays can be validated by analyzing viral strains deleted for potential interaction partners. 
Moreover, HSV1 particles are conveyed predominantly to the MT minus-ends during entry, while 
during egress, at least in neurons, they preferentially move to the MT plus-ends. The viral cargo might 
be structurally similar during both stages of the viral life cycle, and the change in transport direction 
might be achieved by some regulatory mechanisms. Upon entry, HSV1 induces signaling events (Qie 
et al., 1999; Zachos et al., 1999; Cheshenko et al., 2003; Cheshenko et al., 2005), and it is possible that 
this signaling plays a role in regulating the direction of transport as has been shown for Ad 
(Suomalainen et al., 2001). The viral protein kinases UL13 and US3, which are components of the 
tegument, may also modify viral or cellular proteins, and thereby influence the transport direction. 
Alternatively, the viral structure transported during entry – possibly a capsid surrounded only by 
inner tegument proteins – might differ from the viral cargo during egress – for example a viral capsid 
surrounded by more tegument proteins or even a capsid enclosed in a membrane (Ch'ng and Enquist, 
2005b; del Rio et al., 2005; Granzow et al., 2005; Luxton et al., 2005).  
In principle, all tegument and those capsid and capsid-associated proteins located on the capsid 
surface could be involved in cytosolic MT transport. Moreover, viral membrane proteins or 
nonstructural viral proteins might also interact with the host cytoskeleton, and mediate MT transport 
of virion containing vesicles, or of capsids associated with the cytosolic surface of a vesicle. 
 
3.4.4.1 Potential motor receptors among the viral membrane proteins 
Cytosolic domains of viral membrane proteins might recruit MT motors to secretory vesicles 
either enclosing complete virions, or containing viral membrane proteins embedded in the vesicle’s 
membrane, and thus contribute to the viral life cycle. The cytosolic tail of the HSV1 integral 
membrane protein UL34 can interact with the DIC subunit of cytoplasmic dynein in GST-pulldown 
assays (Ye et al., 2000). UL34 is targeted to the inner nuclear membrane, and during budding at the 
inner nuclear membrane it is incorporated into the primary envelope of periplasmic virions (Fig. 9; 
Klupp et al., 2000; Reynolds et al., 2002). Cytoplasmic membranes, cytoplasmic virions and 
extracellular virions do not contain UL34. Thus, UL34 is less likely to function in cytoplasmic MT 
transport of HSV1 particles. 
The HSV protein UL56 is a C-terminal-anchored, type II membrane protein. In yeast-two hybrid 
and GST-pulldown assays HSV2-UL56 interacts with KIF1A, a member of the kinesin-3 family. 
While the precise role of UL56 during virus infection remains to be elucidated, UL56 might function 
in plus-end directed MT transport of secretory vesicles containing viral membrane proteins or even 
complete virions (Koshizuka et al., 2005). However, PRV which also undergoes anterograde transport 
during egress does not code for a UL56 homolog (Smith et al., 2001; Klupp et al., 2004). 
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3.4.4.2 Potential motor receptors among the tegument proteins 
Viral tegument proteins are exposed to the cytosol and may recruit MT motors for capsid transport 
either after fusion of the viral envelope with a cellular membrane during entry or prior to secondary 
budding during egress,. Moreover, tegument proteins may bind simultaneously to MT motors and to 
the cytosolic domains of viral membrane proteins, and thereby mediate MT transport of vesicles 
containing viral components. 
Based on studies of PRV and HSV1, the major tegument proteins VP11/12 [UL46], VP13/14 
[UL47], and VP22 [UL49] were recently classified as outer tegument proteins (Mettenleiter, 2004; 
Vittone et al., 2005; Wolfstein et al., 2006). VP16 [UL48] can interact with VP11/12, VP13/14, VP22 
and the inner tegument protein VP1-3 [UL36] suggesting that VP16 may provide a connecting link 
between outer and inner tegument (Elliott et al., 1995; Hafezi et al., 2005; Mouzakitis et al., 2005; 
Vittone et al., 2005). HSV1-VP22 colocalizes with MT when expressed in the absence of other HSV1 
proteins and induces MT stabilization and hyperacetylation (Elliott and O'Hare, 1997; Elliott and 
O'Hare, 1998; Martin et al., 2002). Moreover, VP22 can interact with the heavy chain of nonmuscle 
myosin II (van Leeuwen et al., 2002). After penetration, VP13/14, VP16, VP22, and the myristoylated 
protein UL11 are lost from incoming PRV capsids (Granzow et al., 2005; Luxton et al., 2005), 
whereas during egress in neurons VP13/14, VP16 and VP22 are either transported in association with 
or independent of capsids (Luxton et al., 2005). Thus, VP13/14, VP16, VP22 and UL11 are less likely 
to mediate the interaction between incoming capsids and MT motors. 
VP1-3 [UL36], UL37, and US3 are postulated to constitute the inner tegument shell 
(Mettenleiter, 2004; Vittone et al., 2005; Wolfstein et al., 2006). Coimmunoprecipitation and yeast 
two-hybrid assays revealed that VP1-3 can bind to the major capsid protein VP5, to UL37 and to 
VP16 that might connect the inner and the outer tegument shell (McNabb and Courtney, 1992a; 
Vittone et al., 2005). Although they are probably exposed on the surface of incoming capsids 
(Granzow et al., 2005; Luxton et al., 2005), none of these proteins have so far been reported to interact 
with MTs or MT motors. However, in blot overlay assays the HCMV VP1-3 homolog UL48 interacts 
with ES130/p180 which contains a region homologous to kinectin which was originally identified as a 
candidate receptor for kinesin-1 on the ER (Ogawa-Goto et al., 2002). During assembly in the absence 
of VP1-3 or UL37, unenveloped capsids accumulate in the cytosol indicating that VP1-3 or UL37 
either mediate transport to the compartment of secondary envelopment, or are required for the 
attachment of further tegument proteins which are needed for transport or secondary envelopment 
(Desai, 2000; Desai et al., 2001). Moreover, a temperature-sensitive mutation mapped to VP1-3 results 
in accumulation of incoming DNA-containing capsids at the nuclear pore implicating VP1-3 in DNA 
release at the nuclear pore (Batterson et al., 1983; Ojala et al., 2000). The N-terminal 500 residues of 
VP1-3 function as deubiquitinating enzyme after cleavage from full-length VP1-3 (Kattenhorn et al., 
2005). 
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Tegument proteins with established enzymatic activities are the protein kinases UL13 and US3, 
the ribonucleotide reductase subunits UL39 and UL40, and the RNase UL41, involved in shutt off of 
host protein synthesis (Smiley, 2004). Further tegument proteins are US10, US11, UL14 and UL11, 
the latter being membrane-associated after posttranslational myristoylation. In contrast to the others, 
the tegument proteins US10 and US11 are not conserved across the neurotropic alphaherpesvirsuses 
(Davison and McGeoch, 1986; Klupp et al., 2004). Of these proteins, only the product of the late gene 
US11 was reported to interact with MT motors. 
US11 binds to kinesin-1, the heavy chain of conventional kinesin, in affinity chromatography and 
GST-pull down assays (Diefenbach et al., 2002). During egress, axonal HSV1 capsids colocalize with 
kinesin-1, and the predicted cargo-binding domain of kinesin-1 binds the major capsid protein VP5, 
and the tegument proteins VP16, VP22 and US11 from an infected cell lysate (Diefenbach et al., 
2002). With VP16 and VP22 also binding to US11, the latter is perceived as the direct binding partner 
of kinesin-1. US11 also interacts with PAT1 (protein interacting with amyloid precursor protein tail 1) 
in a region with sequence similarity to the cargo binding domain of kinesin light chains (Benboudjema 
et al., 2003). PAT1 is a nucleocytoplasmic host protein that binds to the cytosolic tail of amyloid 
precursor protein and to MTs in a nucleotide dependent manner, but it is unclear whether it can really 
function as an accessory subunit of a kinesin motor (Zheng et al., 1998). US11 genes are only found in 
the highly related alphaherpesviruses HSV1, HSV2, and simian B virus, but not in PRV or varicella 
zoster virus, which are also transported anterogradely during their life cycles (Davison and McGeoch, 
1986; Smith et al., 2001; Ohsawa et al., 2002; Klupp et al., 2004). This raises the question which 
proteins of the latter viruses interact with kinesins in the absence of US11. During virus infection, 
protein kinase R can phosphorylate the eukaryotic initiation factor 2α, thereby blocking translation. 
US11 cooperates with the early viral gene product γ134.5 to overcome this antiviral response of the 
host and to ensure that viral protein synthesis continues (Mohr, 2004). 
  
3.4.4.3 Potential motor receptors among the capsid and capsid-associated proteins 
Of the bona fide capsid proteins, VP5, VP19C, VP23, VP24 and V26, VP5 and VP26 are located 
on the capsid surface, and therefore potentially accessible for direct or indirect interactions with MTs 
and/or MT motors. Other minor capsid-associated proteins involved in DNA cleavage and packaging 
are the portal protein UL6 as well as UL15, UL16, UL17 and the proposed capsid plug UL25. Of 
those, there is experimental data suggesting MT interactions for VP26 and for UL25.  
VP26 is a basic, multiply phosphorylated protein with a molecular weight of 12 kDa (McNabb 
and Courtney, 1992b). It is located on the tips of the VP5 hexons, but not on the pentons (Booy et al., 
1994; Trus et al., 1995; Zhou et al., 1995; Wingfield et al., 1997). VP26 is not essential for virus 
replication, but its deletion decreases virus yields twofold in cultured cells, as well as in a mouse 
infection model (Desai et al., 1998). HSV1-VP26 interacts with the 14 kDa dynein light chains 
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Tctex-1 and rp3 in yeast two-hybrid and GST-pulldown assays (Douglas et al., 2004). Moreover, after 
microinjection into cells, in vitro assembled capsids lacking VP26 show reduced nuclear targeting 
when compared to capsids containing VP26. However, after corneal infection of mice, HSV1-∆VP26 
is transported to the trigeminal ganglia, indicating that even in the absence of VP26, HSV1 is able to 
undergo retrograde transport (Desai et al., 1998).  
UL25 is an essential capsid-associated protein supposed to seal the capsid after DNA packaging in 
the nucleus (Ogasawara et al., 2001; Sheaffer et al., 2001). The UL25 protein of PRV was reported to 
colocalize with MTs after transient transfection (Kaelin et al., 2000). Based on this observation a 
potential function in MT-mediated transport was proposed. 
 
 
Figure 9: Interactions between HSV1 or PRV gene products during virus assembly. Solid lines or direct 
contacts between the rectangles representing the designated gene products indicate physical interactions. Arrows 
point to functional interactions. Dotted lines and question marks denote suggested, but not firmly established 
interactions or involvements of proteins. Between glycoproteins only direct contacts resulting in complex 
formation are depicted (Roizman and Knipe, 2001; Mettenleiter, 2002; Mettenleiter, 2003; Mettenleiter, 2004; 
Spear, 2004). The picture was taken from Mettenleiter, 2002 and modified by A. Wolfstein, Institute of 
Virology. 
 
3.5 Life cell imaging of alphaherpesvirinae 
Light and electron microscopy of fixed cells has provided elementary information on the function 
of MTs and MT motors during the life cycle of many viruses. However, with recombinant fluorescent 
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proteins and sensitive digital cameras it is now possible to analyze the dynamics of motile virus 
particles in living cells. 
Nuclear targeting has been demonstrated in vivo with green fluorescent protein (GFP)-VP26-
tagged PRV in neurons (Smith et al., 2004), GFP-Vpr-tagged HIV (McDonald et al., 2002), GFP-
UL32-tagged HCMV (Sampaio et al., 2005), fluorescent dyes directly coupled to Ad, simian virus 40 
or adeno-associated virus (Suomalainen et al., 1999; Leopold et al., 2000; Seisenberger et al., 2001) or 
intercalated in the membrane of influenza virus (Lakadamyali et al., 2003). Transport during egress 
has been shown in vivo using GFPVP26-tagged PRV in neurons (Smith et al., 2001), and VV 
containing GFP fused to the membrane proteins F13L or B5R (Geada et al., 2001; Hollinshead et al., 
2001; Rietdorf et al., 2001; Ward and Moss, 2001a; Ward and Moss, 2001b). 
To analyze the transport of HSV1 virions and subviral particles, fluorescent proteins have been 
attached to several structural proteins: VP22 (Elliott and O'Hare, 1999), VP16 (Bearer et al., 2000; La 
Boissiere et al., 2004), VP13/14 (Donnelly and Elliott, 2001), and VP11/12 (Willard, 2002). 
Moreover, the small capsid protein VP26 was tagged with GFP or monomeric red fluorescent protein 
(mRFP) and reintroduced into HSV1 (Desai and Person, 1998; Nagel, Fathollahy, Strive, Borst, 
Messerle, and Sodeik; manuscript in preparation), PRV (Smith et al., 2001; del Rio et al., 2005) and 
bovine herpesvirus (Wild et al., 2005). HSV1-GFPVP26 is very well suited for in vivo experiments, 
since VP26 is not essential for virus replication in cultured cells (Desai et al., 1998) and the 
incorporation of GFPVP26 does not significantly disturb virus assembly (Desai and Person, 1998). 
Furthermore, VP26 stays on the capsid until it reaches the nucleus (our unpublished observations), 
while several tegument proteins are lost from incoming capsids (Sodeik et al., 1997; Morrison et al., 
1998; Granzow et al., 2005; Luxton et al., 2005).  
After injection into squid axons VP16GFP containing detergent stripped HSV1 particles moved 
exclusively in the retrograde direction with a mean velocity of 2.2 µm/s (Bearer et al., 2000). In 
contrast, during entry into axons PRV particles underwent bidirectional and saltatory movement to the 
cell body (Smith et al., 2004). Retrograde and anterograde runs during entry had average velocities of 
1.2 µm/s and 0.6 µm/s, respectively. Bidirectional transport was also observed during egress of PRV, 
but in this situation transport to the axon terminals predominated (Smith et al., 2001). During egress, 
retrograde and anterograde runs had average velocities of 1.3 µm/s and 2 µm/s, respectively. These 
data indicate that the net transport to the cell body during entry and to the axon terminal during exit is 
probably regulated by modulation of the plus-end directed motor (Smith et al., 2004). 
 
Introduction  30 
 
    
3.6 Aim of the study 
During entry, HSV1 capsids are transported along MTs to the MTOC which lies close to the 
nucleus in many cell types (Kristensson et al., 1986; Lycke et al., 1988; Hammonds et al., 1996; Topp 
et al., 1996; Sodeik et al., 1997; Mabit et al., 2002; Marozin et al., 2004). Electron microscopy studies 
revealed that incoming capsids colocalize with cytoplasmic dynein implicating dynein in minus-end 
directed transport of HSV1 capsids (Sodeik et al., 1997). 
Moreover, during my diploma thesis I showed that nuclear targeting of HSV1 capsids and viral 
immediate-early gene expression were reduced in transfected cells expressing high levels of 
dynamitin, a subunit of the dynein cofactor dynactin. One task during this Ph.D. thesis was to confirm 
and more importantly to quantify the effect of dynamitin overexpression on nuclear targeting and viral 
immediate early gene expression. Furthermore, it was investigated whether reduced nuclear targeting 
was due to an effect of excess dynamitin on virus binding, on virus internalization, on the MT 
cytoskeleton, or on cytosolic capsid transport. Since dynamitin overexpression affects the endocytic 
and the secretory pathway (Burkhardt et al., 1997; Presley et al., 1997; Valetti et al., 1999), it may 
alter cell surface expression of HSV1 receptors, and consequently virus binding and/or internalization. 
Dynactin is involved in MT anchoring at the MTOC, and excess dynamitin affects the MT 
organization in several cell types to different extent (Burkhardt et al., 1997; Quintyne et al., 1999; 
Quintyne and Schroer, 2002). Therefore, I compared the MT organization of untransfected PtK2 cells 
and PtK2 cells overexpressing dynamitin. Another idea was to further analyze the colocalization of 
incoming capsids with antibodies to several dynein and dynactin subunits. 
In addition to the cellular requirements for HSV1 transport, our group wants to identify viral 
factors required for efficient nuclear targeting. Therefore, we characterized the nuclear targeting of 
several viral mutants lacking potential viral motor receptors. To compare different viral strains in their 
entry behavior, the particle composition of different viral inocula had to be characterized 
quantitatively. Therefore, another aim of this Ph.D. thesis was to optimize the preparation of purified 
virus to be used for entry experiments, to compare several methods for quantification of virus 
preparations, and to develop rational criteria for evaluating the quality of virus preparations. 
 To analyze the intracellular transport of HSV1 in living cells and in in vitro motility assays, we 
wanted to use digital time lapse microscopy and HSV1-GFPVP26, in which the small capsid protein 
VP26 was replaced by GFPVP26 (Desai and Person, 1998). A potential dynein receptor among the 
HSV1 proteins is VP26 that interacts with the 14 kDa dynein light chains Tctex-1 and rp3 in yeast two 
hybrid and GST-pulldown assays (Douglas et al., 2004). Therefore, I characterized the cell entry of 
HSV1-GFPVP26 (Desai and Person, 1998) and HSV1-∆VP26 (Desai et al., 1998), which is deleted 
for the putative dynein receptor VP26. I analyzed viral immediate-early gene expression and capsid 
transport of HSV1-GFPVP26 and HSV1-∆VP26 in the presence and absence of MTs, and the capsid 
transport after overexpression of dynamitin-GFP. 
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4 Discussion 
 
4.1 MTs are required for efficient nuclear targeting of Ad and HSV1 
HSV1 enters many cell types by fusion at the plasma membrane, thereby releasing the capsid and 
the tegument into the cytosol (Koyama and Uchida, 1987; Lycke et al., 1988; Wittels and Spear, 1991; 
Sodeik et al., 1997; Nicola et al., 2003; Gianni et al., 2004; Nicola and Straus, 2004; Nicola et al., 
2005). Part of the HSV1 and PRV tegument remains at the cytosolic side of the plasma membrane 
(Sodeik et al., 1997; Granzow et al., 2005; Luxton et al., 2005), while the capsid with residual 
tegument is transported along MTs to the MTOC (Sodeik et al., 1997). During entry, incoming HSV1 
capsids colocalize with MTs (Lycke et al., 1988; Sodeik et al., 1997), and MT-depolymerizing drugs 
reduce nuclear targeting, viral gene expression and virus yields (Kristensson et al., 1986; Topp et al., 
1994; Hammonds et al., 1996; Topp et al., 1996; Sodeik et al., 1997). 
Spedies C Ad2 and 5 are taken up by clathrin-mediated endocytosis (Meier et al., 2002). After 
release from early endosomes, nuclear targeting of species C Ad also requires MTs, cytoplasmic 
dynein and dynactin (Greber et al., 1993; Suomalainen et al., 1999; Leopold et al., 2000). Ad2 moves 
in both directions, towards and away from the nucleus, but transport towards the nucleus predominates 
(Suomalainen et al., 1999). After depolymerization of MTs, motility of Ad2 and Ad5 is severely 
reduced (Suomalainen et al., 1999; Leopold et al., 2000). 
In contrast to these observations, Glotzer and colleagues reported that depolymerization of MTs 
neither affected adenoviral gene expression, nor motility of adenoviruses, which were labeled with a 
GFP-tetracycline repressor fusion protein bound to operator sequences introduced into their genome 
(Glotzer et al., 2001). Furthermore, the authors claimed that depolymerization of MTs during infection 
prevented adenoviral accumulation around the MTOC, but did not abolish perinuclear localization of 
adenoviral particles. Since this study challenged the role of MTs during virus entry, the group of Prof. 
Urs Greber (University of Zürich, Switzerland) and our group reassessed the function of MTs during 
adenovirus and HSV1 infection (Mabit et al., 2002). In these studies HSV1 served as a positive 
control, since it had been well established that agents interfering with MT function reduce HSV1 gene 
expression. 
The colleagues from Zürich analyzed Ad5 mediated transgene expression quantitatively with Ad5 
expressing β-galactosidase or luciferase under the control of a CMV-promoter, which is constitutively 
active in eukaryotic cells (Mabit et al., 2002; Fig. 1). Efficient adenoviral gene expression after 
infection at 10 to 10,000 particles per cell required MTs, and the assays were linear in this range. The 
effect of the MT-depolymerizing drug nocodazole was reversible, it did not reduce cell viability, and 
when added at 3 h p.i., a time point when most Ad5 particles had already reached the nuclear 
envelope, nocodazole only marginally inihibited Ad-mediated transgene expression. Additionally, 
quantitative confocal fluorescence microscopy (Nakano and Greber, 2000) confirmed that MTs were 
required for efficient nuclear targeting of Texas-Red labeled Ad2 (Mabit et al., 2002; Fig. 2). 
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We analyzed HSV1-mediated transgene expression quantitatively using an HSV1 strain 
expressing β-galactosidase under the control of the HSV1 immediate-early promoter ICP4 (Warner et 
al., 1998). The amount of β-galactosidase expressed after HSV1 infection depended on the multiplicity 
of infection, and increased from 3 to 7 h of infection (Mabit et al., 2002; Fig. 3). Nocodazole reduced 
HSV1-mediated transgene expression in a concentration dependent manner, reaching maximal 
inhibition of about 90% at 25 µM in cells infected for 4 h with 10 plaque forming units per cell. 
Quantitative confocal fluorescence microscopy (Nakano and Greber, 2000) revealed that 
depolymerization of MTs strongly reduced nuclear targeting of HSV1 at 2 and 3 h of infection (Mabit 
et al., 2002; Fig. 4). Consistent with earlier studies (Kristensson et al., 1986; Sodeik et al., 1997), the 
MT-stabilizing drug taxol had no significant effect on nuclear accumulation of HSV1 suggesting that 
dynamic MTs and MT treadmilling were not required for efficient transport of HSV1. Nuclear 
targeting of Ad is even enhanced when MTs are stabilized (Giannakakou et al., 2002). 
However, the inhibition of nuclear targeting and virus mediated gene expression was not complete 
in epithelial cells. Viral particles which enter from the plasma membrane proximal to the nuclear 
envelope are separated from the nucleus by only a few micrometers, and may cover this distance in the 
absence of an intact MT network (discussed in Sodeik et al., 1997). Ad particles are able to travel a 
few µm in the absence of MTs (Suomalainen et al., 1999; Glotzer et al., 2001). Thus, particles entering 
from the apical plasma membrane proximal to or above the nucleus will most likely not require MTs 
to reach the nucleus. In addition, actin-based transport or transport along short, randomly oriented MT 
filaments resistant to nocodazole might have accounted for the residual nuclear targeting activity and 
virus mediated gene expression in the absence of an intact MT network (discussed in Mabit et al., 
2002). 
Our results clearly demonstrated that MTs were required for efficient nuclear targeting of both, Ad 
and HSV1, and consequently for efficient Ad and HSV1 mediated transgene expression (Mabit et al., 
2002). In this respect our findings contradict the results obtained by Glotzer and colleagues (2001), but 
confirm earlier studies on Ad (Suomalainen et al., 1999; Leopold et al., 2000) and HSV1 (Kristensson 
et al., 1986; Topp et al., 1994; Hammonds et al., 1996; Topp et al., 1996; Sodeik et al., 1997) showing 
a role for MT-mediated transport during cell entry. While we measured within the linear range of the 
β-galactosidase and luciferase assays (Mabit et al., 2002), Glotzer et al. (2001) did not report any 
studies on analyzing the linearity of their read-out. 
In living cells, Ad2 and Ad5 motility over longer distances requires MTs (Suomalainen et al., 
1999; Leopold et al., 2000; Suomalainen et al., 2001). MTs are also required for long range transport 
of HSV1 in living cells (Willard, 2002; Döhner, Büttner, Wolfstein, Prank, Ewers, and Sodeik; 
manuscript in preparation). In contrast to these results, Glotzer and coworkers (2001) did not observe 
fast minus-end directed transport of Ad particles. Instead they reported that Ad particles moved along 
similar paths and with similar velocities in the presense and absence of MTs. These conflicting results 
may be explained by different experimental set-ups. Compared to other studies (Suomalainen et al., 
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1999; Leopold et al., 2000; Suomalainen et al., 2001; Döhner, Büttner, Wolfstein, Prank, Ewers, and 
Sodeik; manuscript in preparation), Glotzer et al. (2001) measured in vivo motility at room 
temperature, maintained the cells in phosphate buffered saline without nutrients during the 
experiments, recorded at lower temporal resolution, used a shorter wavelength of higher energy for 
excitation and longer exposure times, recorded from the middle of the cells, and analyzed a smaller 
data set (discussed in Mabit et al., 2002). At room temperature, the activity of molecular motors may 
be reduced compared to 37°C, and in the absence of nutrients the cells may be depleted of ATP. At 
low temporal resolution, fast movements are not detected, because unambiguous tracking is no longer 
possible. Furthermore, the shorter wavelength and extended exposure times may have lead to higher 
phototoxic damage resulting in lower motility. Tracking in the middle of the cells, where cells are 
elevated compared to the flat cell periphery, may have resulted in an apparent disappearance of 
moving particles due to translocation out of the focus plane.  
In summary, the quantitative assays used in our study (Mabit et al., 2002), confirmed that MTs 
were required for efficient nuclear targeting of Ad and HSV1, and as a consequence for efficient 
expression of viral genes or virus mediated expression of transgenes.  
 
4.2 Function of dynein and dynactin in HSV1 capsid transport 
In epithelial cells and neurons, incoming HSV1 is transported along MTs to the MTOC 
(Kristensson et al., 1986; Lycke et al., 1988; Topp et al., 1994; Hammonds et al., 1996; Topp et al., 
1996; Sodeik et al., 1997). This minus-end directed transport could be catalyzed by cytoplasmic 
dynein or by minus-end directed C-type kinesins. Although most C-type kinesins function during 
mitosis (Ovechkina and Wordeman, 2003), some are involved in cytoplasmic transport during 
interphase (Hanlon et al., 1997; Saito et al., 1997; Nielsen et al., 1999; Bananis et al., 2000; Noda et 
al., 2001; Xu et al., 2002; Bananis et al., 2003; Bananis et al., 2004; Brown et al., 2005). 
EHNA (erythro-9-3-[2-hydroxynonyl]adenine), an inhibitor of axonemal and cytoplasmic dynein, 
blocks HSV1 infection in neuronal cells, suggesting a role for cytoplasmic dynein during retrograde 
axonal transport of HSV1 capsids (Kristensson et al., 1986). However, EHNA also affects adenosine 
deaminase, cGMP stimulated phosphodiesterase, and the actin cytoskeleton (Penningroth, 1986; Mery 
et al., 1995). In some cases, electron-dense material attached to the vertices of incoming HSV1 capsids 
has the dimensions and the shape of cytoplasmic dynein (Sodeik et al., 1997). Moreover, quantitative 
immunelectron microscopy with antibodies to the DHC revealed that incoming cytosolic HSV1 
capsids colocalize with cytoplasmic dynein (Sodeik et al., 1997).  
During this Ph.D. thesis, I analyzed the colocalization of incoming capsids with further dynein and 
dynactin subunits using immunofluorescence microscopy (Döhner et al., 2002; Fig. 1). Approximately 
15 to 20% of incoming capsids were labeled with antibodies to dynein (15% for DIC) or dynactin 
(20% for p150Glued). This incomplete colocalization might have been due to steric hindrance, and thus 
limited epitope access in a putative ternary complex of capsid, dynein, and dynactin. Moreover, it is 
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possible that only a subset of viral capsids bound to dynein and/or dynactin at any given time point. 
Consistently, in a time interval of about 5 min, only a fraction of about 10% of HSV1 particles 
underwent substantial movement in living cells (Döhner, Büttner, Wolfstein, Prank, Ewers, and 
Sodeik; manuscript in preparation). Because most dynein and dynactin subunits only exist in 20 S 
complexes and not as soluble proteins, these data showed that both protein complexes, namely dynein 
and dynactin, were at least transiently present on incoming capsids. 
To test whether functional dynein and dynactin were required during HSV1 entry, I transfected 
cells with dynamitin. Overexpression of dynamitin disrupts the dynactin complex and inhibits dynein 
and kinesin-2 mediated transport (Echeverri et al., 1996; Burkhardt et al., 1997; Eckley et al., 1999; 
Valetti et al., 1999; Deacon et al., 2003). Overexpression of dynamitin-GFP reduced transgene 
expression after infection with HSV1 expressing β-galactosidase (Warner et al., 1998; Mabit et al., 
2002) by 25% compared to overexpression of GFP alone (Döhner et al., 2002; Fig. 2). Single cell 
analysis by immunofluorescence microscopy confirmed that expression of the immediate-early HSV1 
gene ICP4 was significantly reduced in cells overexpressing dynamitin (Döhner et al., 2002; Fig. 3). 
Dynactin is involved in anchoring MTs at the MTOC (Quintyne et al., 1999; Quintyne and 
Schroer, 2002), and overexpression of dynamitin affects the organization of the MT-network in 
fibroblastic cells (Burkhardt et al., 1997; Quintyne et al., 1999). After overexpression of dynamitin in 
PtK2 cells, MTs still emanated from the perinuclear region, but compared to control cells, there were 
less cells with a single, well-defined MTOC (Döhner et al., 2002; Fig. 4). Cells in which MTs 
emanated from a broad zone in the perinuclear area were also observed among untransfected cells, and 
nuclear targeting in these cells was as efficient as in cells with a well-defined MTOC. The 
organization of the actin cytoskeleton was not affected by dynamitin overexpression (not shown; 
Burkhardt et al., 1997). Therefore, the reduced immediate-early viral gene expression after 
overexpression of dynamitin was most likely not due to alterations in the cytoskeleton. 
Since dynamitin overexpression affects the secretory and the endocytic pathway (Burkhardt et al., 
1997; Presley et al., 1997; Valetti et al., 1999; Schroer, 2004) reduced immediate-early viral gene 
expression could have been due to impaired virus binding or internalization caused by altered 
expression of viral receptors on the cell surface. However, immunfluorescence microscopy (Döhner et 
al., 2002; Fig. 5), radioactive virus binding and virus internalization assays (Döhner et al., 2002; Fig. 
6) showed that HSV1 binding and internalization were not reduced after overexpression of dynamitin. 
Thus, reduced immediate-early gene expression after dynamitin overexpression was not due to less 
efficient virus internalization. While virus internalization was not impaired, dynamitin overexpression 
reduced nuclear targeting of HSV1 by about 50%, and in cells expressing high levels of dynamitin 
even by 85% (Döhner et al., 2002; Fig. 7 and 8).  
In summary, these data show that overexpressing dynamitin reduced nuclear targeting of HSV1, 
and as a consequence immediate-early viral gene expression. Reduced nuclear targeting and 
immediate-early viral gene expression by high amounts of dynamitin were not due to impaired virus 
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binding, virus internalization, or changes in the MT network, but rather caused by decreased cytosolic 
HSV1 capsid transport along MTs. The other target of dynamitin overexpression, kinesin-2, is a plus-
end directed MT motor, and is therefore most likely not responsible for minus-end directed MT 
transport of HSV1. Therefore, our data suggest that incoming HSV1 capsids were propelled along 
MTs by dynein, and that dynein and dynactin were required for efficient HSV1 capsid transport to the 
nucleus. 
 
4.3 Bidirectional HSV1 transport along MTs 
While incoming capsids are distributed randomly over the entire cytoplasm at early time points 
(Sodeik et al., 1997), capsids in dynamitin overexpressing cells were often concentrated in peripheral 
parts of the cells at 3 h post infection (Döhner et al., 2002; Fig. 7 and 9). This peripheral accumulation 
depended on MTs, suggesting that a plus-end directed MT motor of the kinesin family might transport 
capsids to the cell periphery when dynein function was inhibited.  
Peripheral accumulation of dynein cargo after overexpression of dynamitin or microinjection of 
function-blocking dynein antibodies is also observed with endosomes (Burkhardt et al., 1997; Valetti 
et al., 1999), adenoviral capsids (Suomalainen et al., 1999)  and HIV reverse transcription complexes 
(McDonald et al., 2002). Thus, these structures can be transported by minus- and plus-end directed 
motors, and after inhibition of dynein, kinesins may take over and catalyze transport to the MT plus-
ends. 
Consistently, GFP-tagged PRV is transported bidirectionally during entry and egress in neurons 
(Smith et al., 2001; Smith et al., 2004) with a bias towards the cell body during entry. In contrast, 
transport to the synapse predominates during egress. Bidirectional transport of HSV1-GFPVP11/12 
containing particles along MTs was also observed during assembly in Vero cells (Willard, 2002). 
Early during infection of PtK2 cells, GFP-tagged HSV1 particles also moved towards and away from 
the nucleus (Döhner, Büttner, Wolfstein, Prank, Ewers and Sodeik; manuscript in preparation). 
Transport to the nucleus was more frequent, faster and proceeded over longer distances, finally 
resulting in accumulation of viral particles at the nuclear envelope. In contrast, detergent-extracted 
VP16-GFP tagged HSV1 particles moved exclusively in the retrograde direction after microinjection 
into squid axoplasm (Bearer et al., 2000). These conflicting results might reflect a different 
composition of mammalian versus invertebrate cytoplasm. Alternatively, detergent-treated HSV1 
particles might differ in their composition from HSV1 particles which are present in cells after entry or 
after assembly. 
As has been suggested for other cargo, plus-end directed HSV1 motility during entry could 
prevent being trapped in “traffic jams” on MTs. Alternatively plus-end directed motors could catalyze 
the translocation from the MTOC further to the nucleus. HSV1 capsids initially accumulate at the site 
of the nuclear envelope facing the MTOC (Döhner et al., 2002; Fig. 4; Everett et al., 2004) and later 
distribute over the entire nuclear envelope (Sodeik et al., 1997; Döhner et al., 2002). Similar 
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observations were reported for human foamy virus, a retrovirus, and Ad2 (Petit et al., 2003; Strunze et 
al., 2005). Kinesins could then mediate the transport from the MTOC further to the nuclear envelope. 
Interestingly, dynein and kinesin-1 can interact with members of the importin family (Mavlyutov et 
al., 2002; Hanz et al., 2003), and kinesin-1 interacts with RanBP2 which is located on cytoplasmic 
NPC fibrils (Cai et al., 2001). Importins transport cargo with nuclear localization signals through the 
NPC into the nucleus, whereas exportins convey cargo with nuclear export signals into the cytoplasm. 
The transport direction is regulated by the small GTPase Ran, and RanBP2 helps to dissassemble 
transport complexes after passage through the NPC (Pemberton and Paschal, 2005). Several cytosolic 
proteins bearing nuclear localization signals bind dynein and importin β, and are transported towards 
the nucleus along MTs (Mesika et al., 2005; Salman et al., 2005). These interactions might couple 
cytoplasmic transport and nucleocytoplasmic shuttling. 
Kinesin-1 can interact with HSV1-US11, and axonal HSV1 capsids colocalize with kinesin-1 
during egress (Diefenbach et al., 2002). Therefore, Jessica Janus and Simone Schmidt from our lab 
(Institute of Virology, Hannover Medical School) analyzed the subcellular localization of HSV1-
∆US11 which is deleted for the potential kinesin-1 receptor US11 (Schmidt, 2003; Janus, 2005; Janus, 
Döhner, Schmidt, Nagel, Roller, and Sodeik; manuscript in preparation). HSV1-∆US11 required MTs 
and functional dynactin for efficient nuclear targeting. Like HSV1-wt, HSV1-∆US11 often 
accumulated in the periphery of dynamitin overexpressing cells, and this peripheral accumulation also 
required MTs. This shows that during cell entry, US11 was required neither for MT-dependent nuclear 
targeting in untransfected cells, nor for peripheral HSV1 accumulation after dynamitin overexpression. 
The interaction between US11 and kinesin-1 might rather be involved during assembly and egress 
(Diefenbach et al., 2002). However, only the highly related alphaherpesviruses HSV1, HSV2, and 
simian B virus, but not PRV or varicella zoster virus have genes coding for US11, nevertheless all 
these alphaherpesviruses are transported anterogradely during their life cycle (Davison and McGeoch, 
1986; Smith et al., 2001; Ohsawa et al., 2002; Klupp et al., 2004). Therefore, other viral proteins 
besides US11 must provide receptors for plus-end directed kinesins. 
Different motors could catalyze plus-end directed transport during different stages of the viral life 
cycle. Other cellular cargoes also switch between different MT motors: early endosomes use kinesin-1 
for plus- and C-type kinesins for minus-end directed transport, while late endosomes use kinesin-2 for 
plus- and dynein for minus-end directed transport (Burkhardt et al., 1997; Nielsen et al., 1999; Valetti 
et al., 1999; Bananis et al., 2000; Bananis et al., 2003; Bananis et al., 2004; Brown et al., 2005). 
Jessica Janus showed that incoming viral particles colocalized with kinesin-2, but not with 
kinesin-1 (Janus, 2005; Janus, Döhner, Schmidt, Nagel, Roller, and Sodeik; manuscript in preparation) 
suggesting that kinesin-2 might be involved in plus-end directed HSV1 transport during cell entry. In 
addition to dynein mediated transport, dynamitin overexpression inhibits kinesin-2 mediated transport 
of melanosomes (Deacon et al., 2003) and possibly other cargoes. Therefore, kinesin-2 is a less likely 
candidate to mediate the peripheral accumulation of HSV1 in dynamitin overexpressing cells. 
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To analyze transport after dynamitin overexpression in more detail, Jessica Janus infected living 
cells overexpressing dynamitin-mRFP with GFP-tagged HSV1. Preliminary experiments showed that 
after overexpression of dynamitin, no long range transport to the cell center or the cell periphery was 
observed (Janus, 2005; Janus, Döhner, Schmidt, Nagel, Roller, and Sodeik; manuscript in 
preparation). No HSV1 movement after dynamitin overexpression was consistent with dynein 
mediating minus-end, and kinesin-2 catalyzing plus-end directed transport during cell entry. However, 
it does not explain the peripheral accumulation of HSV1 often observed after dynamitin 
overexpression (Döhner et al., 2002; Schmidt, 2003; Janus, 2005). Similarly, endosomes accumulate 
in the cell periphery after dynamitin overexpression, but long distance transport of endosomes is also 
reduced, and bidirectional motility of lipid droplets is almost completely abolished under these 
conditions (Valetti et al., 1999). Valetti and colleagues speculated that the immediate effect of 
dynamitin overexpression might have been to initially inhibit dynein-based movement selectively, 
resulting in the dominance of plus end-directed movement for a short time (Burkhardt et al., 1997; 
Valetti et al., 1999). However, since they observed no plus-end directed particle movements in 
dynamitin overexpressing cells, they suggested that, at steady state, kinesin based motility is also 
inhibited. MT-dependent peripheral accumulation or retention of late endosomes and lysosomes might 
be explained by a latent MT plus-end binding activity (e.g., CLIP-170; Burkhardt et al., 1997; Valetti 
et al., 1999). A similar hypothesis might reconcile the apparently conflicting results that we obtained 
with HSV1. Further experiments are needed to test these hypotheses, to identify the motor(s) for plus-
end directed motility during entry, and to characterize the composition of the peripheral HSV1 
particles, and whether they represent cytosolic capsids, endocytosed virions, or cytosolic capsids taken 
up into autophagosomes (c.f. Outlook). 
 
4.4 High quality virus preparations are required to analyze cell entry of HSV1  
The small capsid protein VP26 can interact with the 14 kDa dynein light chains Tctex-1 and rp3 
(Douglas et al., 2004). Microinjected recombinant viral capsids containing VP26 were reported to 
“congregate near the nuclear rim, while capsids lacking VP26 did not” (Douglas et al., 2004). 
Therefore, we analyzed the nuclear targeting of incoming HSV1-∆VP26 capsids, which are deleted for 
VP26, and of HSV1-GFPVP26 capsids, which express GFPVP26 instead of VP26 (Desai et al., 1998; 
Desai and Person, 1998).  
To be able to compare the entry of HSV1-wt (wildtype) with mutants, which may differ in the 
efficiency of virus assembly, and in the particle to plaque forming units (PFU) ratio, we analyzed 
several of our wildtype and mutant virus preparations by plaque assays, polymerase chain reaction 
(PCR), Coomassie stained polyacrylamid gels, immunoblots, electron and immunofluorescence 
microscopy. Different preparations of the same strain varied significantly with regard to their particle 
to PFU ratio (Döhner, Schmidt, Radtke, and Sodeik; manuscript in preparation, Table 1, c.f. 
Appendix). Virus preparations with a higher viral genome to PFU ratio also contained more viral 
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protein per PFU and showed a higher number of viral particles in electron microscopy. Since such 
preparations were also targeted to the nucleus less efficiently, they were considered to be of lower 
quality than preparations with a lower DNA, lower protein, and lower particle to PFU ratio (Döhner, 
Schmidt, Radtke, and Sodeik; manuscript in preparation, Table 1, Fig. 2 and 3). Based on these 
criteria, my best HSV1-∆VP26 preparations were of lower quality than my best wildtype preparations. 
This was most likely due to the less efficient virus assembly of the mutants (Desai et al., 1998; Desai 
and Person, 1998; Desai et al., 2003). Nevertheless, HSV1-∆VP26 of good preparations was 
efficiently transported to the nucleus (Döhner, Schmidt, Radtke, and Sodeik; manuscript in 
preparation, Fig. 3e). If I had compared a high quality preparation of HSV1-wt (Fig. 3a and c) with an 
HSV1-∆VP26 preparation of lower quality (Fig. 3f), I might have concluded, that VP26 was required 
for efficient nuclear targeting. However, as discussed below, HSV1-∆VP26 used MTs as HSV1-wt 
during cell entry. Therefore, it was crucial to use high quality virus preparation and to carefully 
characterize the inocula, especially when the entry of HSV1 mutants was to be analyzed. 
 
4.5 The formation of hexon-specific VP5 epitopes requires VP26 
VP26 is localized on VP5 hexons, but not on pentons, even if present in 8-fold molar excess 
(Booy et al., 1994; Zhou et al., 1994; Trus et al., 1995; Zhou et al., 1995; Wingfield et al., 1997). In 
contrast to HSV1-wt strains F and KOS, viral particles of HSV1-∆VP26 and HSV1-GFPVP26 did not 
display VP5 epitopes 5C10 and 8F5, which are specific to mature hexons, while they were efficiently 
recognized by other anti-VP5 and anti-capsid antibodies (Döhner, Schmidt, Radtke, and Sodeik; 
manuscript in preparation, Fig. 4). This suggests that the formation of the mature hexon-specific 5C10 
and 8F5 epitopes required VP26 during virus assembly, and it neither occured in the absence of VP26, 
nor in the presence of GFPVP26. Alternatively, HSV1-∆VP26 and HSV1-GFPVP26 might contain 
mutations in VP5. 
The formation of mature hexon-specific epitopes requires ATP (Dasgupta and Wilson, 1999), as 
does the assembly of VP26 onto the hexons of angularized capsids (Chi and Wilson, 2000). 
Nevertheless, it was unclear whether VP26 binding caused or was a consequence of mature hexon-
specific epitope formation. My data now suggest that VP26 binding caused mature hexon-specific 
epitope formation, possibly by inducing conformational changes in VP5. 
 
4.6 HSV1-∆VP26 and HSV1-GFPVP26 require dynein/dynactin for efficient nuclear targeting  
VP26 has been shown to interact with the 14 kDa DLCs Tctex-1 and rp3 in yeast two-hybrid and 
GST-pulldown assays (Douglas et al., 2004). Some Tctex-1 binding partners like DIC, parathyroid 
hormone receptor and CD155α contain a bipartite Tctex-1 binding motif, consisting of a proximal 
(K/R)(K/R)XX(K/R) and a distal VS(K/H)(T/S)X(V/T)(T/S)(N/Q)V motif (Sugai et al., 2003). 
However, in the latter motif, gaps of varying length need to be inserted and parts are missing in some 
Tctex-1 binding proteins. In contrast, some binding partners contain either only the proximal binding 
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motif (for example Doc2α and Doc2β and CD5; Mok et al., 2001), or the distal motif (rhodopsin; Tai 
et al., 1999). 
The binding motifs for the VP26-rp3 and VP26-Tctex-1 interactions have so far not been mapped. 
However, VP26 contains neither the proximal, nor the distal Tctex-1 binding motif, and thus must 
bind via a motif to Tctex-1 which differs from the Tctex-1 binding motif of DIC. Therefore, Tctex-1 
might simultaneously bind to HSV1 via VP26 and to the dynein complex via DIC, and the interaction 
between VP26 and Tctex-1 could contribute to dynein mediated MT transport of incoming HSV1 
capsids. Thus, we tested the roles of MTs and dynein during entry of HSV1-∆VP26 and HSV1-
GFPVP26.  
After infection with HSV1-∆VP26 or HSV1-GFPVP26 efficient expression of the immediate-early 
HSV1 gene ICP0 required MTs (Döhner, Schmidt, Radtke, and Sodeik; manuscript in preparation, 
Fig. 5). Moreover, HSV1-∆VP26 and HSV1-GFPVP26 capsids accumulated at the nuclear envelope 
of PtK2 and Vero cells in a MT-dependent manner (Döhner, Schmidt, Radtke, and Sodeik; manuscript 
in preparation, Fig. 6 and 7). Compared to infection with HSV1-wt, the nuclear targeting of HSV1-
∆VP26 was slightly less efficient. This was most likely due to a higher proportion of defective 
particles in the virus preparations of the mutants. 
To distinguish between cytosolic capsids and virions inside endosomes, I performed double-labeling 
experiments with anti-capsid antibodies and antibodies to the viral membrane protein gD. I assumed 
that virions inside endosomes will contain capsid as well as viral membrane antigens, while cytosolic 
capsids should not be labeled with gD-antibodies. After infection of PtK2 cells with HSV1-wt, most of 
the capsid signal had already separated from the gD signal as early as 30 min post infection (Döhner, 
Schmidt, Radtke, and Sodeik; manuscript in preparation; Fig. 6d). At this time point, most capsids 
were still distributed over the entire cytoplasm, suggesting that in PtK2 cells HSV1-wt traveled most of 
its way to the nucleus as a cytosolic capsid and not within endosomes. 
However, at later time points, the gD signal was strongly diminished (Fig. 6e), and it was therefore 
no longer possible to determine whether capsid signals that did not colocalize with gD represented free 
cytosolic capsids or virions inside endosomes whose gD had been denatured or degraded by 
endosomal or lysosomal enzymes. After 30 min of infection with HSV1-∆VP26, many capsid signals 
had also separated from the gD signal, but the fraction of particles containing both epitopes was higher 
if compared to wildtype infection (compare Fig. 6d and 6j). This might be due to more defective 
particles in the virus preparations which either bound, but did not enter cells, or were taken up by 
endocytosis. 
While the entry mechanism into PtK2 cells has not been elucidated, Vero cells are known to be 
productively infected after fusion at the plasma membrane (Sodeik et al., 1997; Nicola et al., 2003; 
Nicola and Straus, 2004). Since HSV1-∆VP26 and HSV1-GFPVP26 required MTs for efficient 
nuclear targeting also in Vero cells (Fig. 7, g-l), most likely free cytosolic HSV1-∆VP26 and HSV1-
GFPVP26 capsids interacted with MTs via MT motor proteins. Even after endocytic uptake, capsids 
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are released from endosomes as early as 30 min p.i. (Nicola and Straus, 2004). At this early time point, 
the capsid signal was still distributed over the entire cytoplasm (Fig. 6 and 7), suggesting that even if 
the mutants had entered these cells by endocytosis, cytosolic capsids released from endosomes rather 
than virions inside endosomes were transported along MTs to the nucleus. 
Moreover, HSV1-GFPVP26 capsids isolated from extracellular virions after detergent lysis moved 
along MTs in an in vitro motility assay which also contained Cy3 labeled MTs and membrane-free 
Xenopus cytosol (Wolfstein et al., 2006; movies S1-S5, Fig. 1 and 3, and Supplementary Fig. S2). In 
vitro motility of HSV1-GFPVP26 capsids required ATP and cytosolic factors (Wolfstein et al., 2006; 
Fig. 2 and Supplementary table S1), further supporting the hypothesis that HSV1-GFPVP26 capsids 
can interact directly with the cytosolic transport machinery in the absence of any membranes. 
Taken together these data suggest that cytosolic capsids of HSV1-∆VP26 and HSV1-GFPVP26 
can be transported along MTs to the MTOC.  
Dynein in cooperation with dynactin catalyzes most minus-end directed transport. However, some 
C-type kinesins can also convey cargo to the MT minus-ends during interphase (Hanlon et al., 1997; 
Saito et al., 1997; Nielsen et al., 1999; Bananis et al., 2000; Noda et al., 2001; Xu et al., 2002; Bananis 
et al., 2003; Bananis et al., 2004), and could therefore theoretically transport HSV1 to the nucleus in 
the absence of the potential dynein receptor VP26. To this end, I analyzed the subcellular localization 
of HSV1-∆VP26 and HSV1-GFPVP26 in PtK2 and Vero cells overexpressing dynamitin. In both cell 
lines, nuclear targeting was reduced by dynamitin overexpression (Döhner, Schmidt, Radtke, and 
Sodeik; manuscript in preparation; Fig. 8). Consistently, addition of recombinant dynamitin reduced 
the number of motile HSV1-GFPVP26 capsids in the in vitro motility assay (Wolfstein et al., 2006; 
Fig. 2 and Supplementary Table S1). Since kinesin-2, the other target of dynamitin overexpression, is 
a plus-end directed MT motor, it cannot convey HSV1 capsids to the MTOC in Vero and PtK2 cells. 
To my knowledge, effects of dynamitin overexpression on minus-end directed kinesins were not 
reported. Function-blocking anti-dynamitin antibodies do not reduce binding of early endosomes to 
MTs, which is mediated by kinesin-1 and the minus-end directed kinesin KIFC2. However, they do 
reduce binding of late endosomes to MTs which is mediated by dynein and kinesin-2 (Bananis et al., 
2004; Brown et al., 2005). This suggests that interfering with dynactin function does not disturb the 
interaction of at least KIFC2 with its cargo and MTs. 
Although I cannot completely exclude that minus-end directed kinesins contributed to nuclear 
targeting of HSV1, I think that it is more likely that dynein in cooperation with its cofactor dynactin 
catalyzed the transport of HSV1-∆VP26 and HSV1-GFPVP26 to the nucleus. My data are in line with 
results from Desai and coworkers (1998) who showed that in the mouse ocular model, transport to the 
trigeminal ganglia is not reduced in the absence of VP26. This is consistent with my finding that VP26 
has no important function in minus-end directed MT transport during cell entry. Instead, the potential 
interaction between VP26 and the dynein light chains might play a role during HSV1 assembly, when 
cytosolic capsids are transported to the site of secondary budding (Mettenleiter, 2002; Mettenleiter, 
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2004). However, in an in vitro binding assay, capsids from HSV1-∆VP26 and HSV1-GFPVP26 bound 
dynein and dynactin from Xenopus cytosol as efficiently as capsids from HSV1-wt (Wolfstein et al., 
2006; Fig. 4). In summary, our data indicate that HSV1-∆VP26 and HSV1-GFPVP26 cytosolic 
capsids use cytoplasmic dynein and dynactin for MT transport to the nucleus as HSV1-wt does. 
Therefore, HSV1-GFPVP26 is an excellent model to study MT-mediated transport in living cells 
(Döhner, Büttner, Wolfstein, Prank, Ewers, and Sodeik; manuscript in preparation) and in vitro 
(Wolfstein et al., 2006). 
Furthermore, compared to nuclear capsids which contained VP26 but little tegument, and to low 
salt extracted capsids with inner and outer tegument, high salt extracted capsids that had partially lost 
their outer tegument showed the strongest motility along MTs and the best binding of dynein and 
dynactin (Wolfstein et al., 2006; Fig. 3 and 4 and Supplementary Figure S3). High salt extracted viral 
capsids still contained the inner tegument proteins VP1-3 and UL37 as well as VP16 which might 
connect inner and outer tegument. This suggests that inner tegument proteins like VP1-3, UL37 or 
US3 or the potential linker VP16 might mediate motor binding and motility along MTs (Wolfstein et 
al., 2006). Altogether our data argue that besides VP26, HSV1 must encode at least one additional 
receptor for dynein or dynactin, and that HSV1 inner tegument proteins are likely candidates. 
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5 Conclusions 
After entry at the presynapse, the neurotropic alphaherpesvirus herpes simplex virus (HSV1) 
moves retrogradely to the neuronal nucleus, where it eventually establishes a latent infection. After 
reactivation from latency, progeny virus travels anterogradely to the synapse (Enquist et al., 1998). 
Thus, HSV1 is conveyed over long distances and requires efficient active transport during 
pathogenesis. We developed tools to analyze MT transport quantitatively and to identify MT motors 
recruited by HSV1. 
In summary, we confirmed with quantitative assays that MTs are required for efficient nuclear 
targeting and immediate early gene expression of Ad and HSV1 in nonpolarized epithelial cells (Mabit 
et al., 2002). This is consistent with earlier studies in epithelial and neuronal cells (Kristensson et al., 
1986; Lycke et al., 1988; Topp et al., 1994; Hammonds et al., 1996; Topp et al., 1996; Sodeik et al., 
1997; Suomalainen et al., 1999; Leopold et al., 2000). 
Incoming HSV1 capsids colocalized with the minus-end directed MT motor dynein and its 
cofactor dynactin (Sodeik et al., 1997; Döhner et al., 2002). Overexpression of the dynactin cofactor 
dynamitin, which inhibits dynein and kinesin-2 catalyzed transport, reduced nuclear targeting of HSV1 
capsids, and consequently immediate-early viral gene expression. The reduced nuclear targeting in 
dynamitin overexpressing cells was not due to impaired virus binding, virus internalization, or the 
slight changes in the MT network. Since kinesin-2 is a plus-end directed motor, reduced minus-end 
directed transport after dynamitin overexpression was most likely due to interference with dynein 
function. Therefore, dynein and its cofactor dynactin mediate efficient nuclear targeting of wildtype 
HSV1 (Döhner et al., 2002).  
After overexpression of dynamitin, viral particles accumulated in the cell periphery in some cells 
(Döhner et al., 2002). This peripheral accumulation required MTs suggesting that it was mediated by a 
plus-end directed motor of the kinesin family. Minus- and plus-end directed motility was also 
observed early in infection in living cells (Döhner, Büttner, Wolfstein, Prank, Ewers, and Sodeik, 
manuscript in preparation), further supporting the idea that already early in infection HSV1 can 
engage with minus- and plus-end directed motors.  
Characterization of several virus preparations of HSV1-wildtype and mutants showed that high 
quality virus preparations with a low particle to PFU ratio were required for a meaningful evaluation 
and interpretation of cell entry experiments (Döhner, Schmidt, Radtke, and Sodeik; manuscript in 
preparation). 
VP26 can interact with the 14 kDa dynein light chains Tctex-1 and rp3 (Douglas et al., 2004), and 
this interaction might contribute to MT-mediated transport of HSV1. Therefore, I analyzed nuclear 
targeting of HSV1-∆VP26 and HSV1-GFPVP26 (Desai et al., 1998; Desai and Person, 1998). Both 
viral strains required MTs for efficient nuclear targeting and efficient expression of immediate-early 
viral genes (Döhner, Schmidt, Radtke, and Sodeik; manuscript in preparation). Nuclear targeting was 
reduced by overexpression of dynamitin, suggesting that it was mediated by cytoplasmic dynein and 
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its cofactor dynactin. Moreover, capsids of HSV1-∆VP26 and HSV1-GFPVP26 bound dynein and 
dynactin as efficiently as wildtype capsids (Wolfstein et al., 2006). In summary, these data suggest 
that besides VP26, HSV1 encodes at least one other receptor for dynein or dynactin. 
Our in vitro motility assay showed that envelope-free capsids of HSV1-GFPVP26 moved along 
Cy3-labeled MTs (Wolfstein et al., 2006). This motility required ATP and cytosolic factors including 
functional dynactin, but neither actin filaments nor membranes. Capsids which have partially lost their 
outer tegument bound more dynein and dynactin and moved more frequently along MTs in vitro than 
capsids with no tegument and capsids with inner and outer tegument (Wolfstein et al., 2006). This 
suggests that inner tegument proteins like VP1-3, UL37, and US3 as well as VP16, which might link 
inner and outer tegument, are likely candidates for motor receptors of HSV1. 
In summary, our data show that MTs, cytoplasmic dynein and dynactin mediate nuclear targeting of 
HSV1-wt, HSV1-∆VP26 and HSV1-GFPVP26. Our data suggest, that besides the potential dynein 
receptor VP26, HSV1 must encode at least one additional receptor for dynein or dynactin, and that 
HSV1 inner tegument proteins are likely candidates for this function. 
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6 Outlook  
We already started to use HSV1-GFPVP26 to analyze the early phases of HSV1 infection in living 
cells (Döhner, Büttner, Wolfstein, Prank, Ewers, and Sodeik; manuscript in preparation). To be able to 
distinguish between diffusion and restricted diffusion from directed movement, the data can be further 
analyzed by calculating the mean square displacement, and the slope of the moment scaling spectrum 
as described by Ewers et al. (2005). Furthermore, drugs which depolymerize MTs or actin filaments 
will help to discriminate between passive diffusion and active motility along MTs or actin filaments, 
and to determine whether the cytoskeleton confines diffusion. In the future, we will perform in vivo 
motility assays in the presence of dynamitin, dominant-negative kinesin constructs, after knockdown 
of molecular motors by small interfering RNAs, or after injection of function-blocking antibodies 
against motor proteins, adaptors like dynactin or against nucleocytoplasmic shuttling factors. This will 
hopefully allow us to determine if and how these factors contribute to HSV1 nuclear targeting. 
Transport from the MTOC further to the nucleus has to be analyzed in living cells rather than in fixed 
samples. For these experiments, we plan to engineer an HSV1 tagged with a photoactivable GFP 
(Patterson and Lippincott-Schwartz, 2002) which would allow selective visualization of particles on 
their way from the MTOC to the nucleus. 
In vivo and in vitro motility assays with GFP- or mRFP-tagged HSV1 deleted for or mutated in 
candidate viral genes will help us to define the viral requirements for intracellular transport. Defined 
viral mutants will be constructed using the bacterial artificial chromosome (BAC) containing the entire 
HSV1 genome that was recently generated in our lab (Nagel, Fathollahy, Strive, Borst, Messerle, and 
Sodeik; manuscript in preparation). 
To be able to interprete the in vivo motility and the cell infection experiments correctly, it is 
imperative to determine whether cytosolic capsids, capsids attached to the cytosolic surface of 
endosomes, or virions inside endosomes are tracked. While HSV1 infects many cell types by fusion of 
the viral envelope and the plasma membrane (Koyama and Uchida, 1987; Lycke et al., 1988; Wittels 
and Spear, 1991; Sodeik et al., 1997; Nicola et al., 2003; Gianni et al., 2004; Nicola and Straus, 2004; 
Nicola et al., 2005), other cells are productively infected after entry by endocytosis (Nicola et al., 
2003; Gianni et al., 2004; Nicola and Straus, 2004; Milne et al., 2005; Nicola et al., 2005). Since the 
entry mechanism into PtK2 cells that we used for in vivo and many other microscopic experiments has 
not been elucidated, it is so far unclear whether the moving GFP particles that I analyzed in living 
cells are cytosolic capsids, capsids attached to the cytosolic surface of membrane-bound organelles or 
virions inside endosomes (Döhner, Büttner, Wolfstein, Prank, Ewers, and Sodeik; manuscript in 
preparation). Similarly, it is not formerly proven, although highly likely that the viral particles that I 
studied in fixed PtK2 cells were free cytosolic capsids, and not virions inside endosomes (c.f. 2.6). 
Therefore, many of my conclusions rely on similar observations made in Vero cells, which are 
productively infected after fusion at the plasma membrane (Sodeik et al., 1997; Nicola et al., 2003; 
Nicola and Straus, 2004). 
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To further analyze the entry mechanism into PtK2 cells, I performed double-labeling experiments 
using endocytic markers like clathrin, early endosomal antigen 1, lysophosphatidic acid, cation-
independent mannose-6-phosphate receptor and caveolin. Although some incoming HSV1 particles 
colocalized with each of these markers, the majority did not, suggesting that HSV1-wt, HSV1-∆VP26 
and HSV1-GFPVP26 were not taken up by clathrin or caveolin mediated endocytosis. Since these 
experiments were not performed with high quality virus preparations, they have to be repeated before 
further conclusions can be drawn. 
In first electron microscopy experiments with PtK2 cells, I found cytosolic HSV1-wt capsids as well 
as virions inside vesicles after 1 h of infection. Vesicles often contained several viral particles. Fusion 
intermediates with the plasma membrane were not observed. These experiments have to be extended 
to earlier time points like 5 and 15 min p.i. using Vero and PtK2 cells, and comparing HSV1-wt with 
HSV1-∆VP26 and HSV1-GFPVP26 infection. It is possible that some HSV1 particles are taken up by 
endocytosis, but that this is rather a dead-end than an infectious pathway as described for Vero cells 
(Sodeik et al., 1997). 
Furthermore, I used several inhibitors of endosomal acidification (ammonium chloride and 
bafilomycin A) and endosomal trafficking (phosphatidylinositol 3-kinase inhibitor wortmannin) in 
PtK2, HeLa and Vero cells. Since Vero cells are entered by fusion at the plasma membrane, and HeLa 
cells are productively infected after endocytosis (Sodeik et al., 1997; Nicola et al., 2003; Gianni et al., 
2004; Nicola and Straus, 2004), these two cell types served as controls. So far, I was unable to 
reproduce the effects of the drugs as described in the literature (Nicola et al., 2003; Gianni et al., 2004; 
Nicola and Straus, 2004). The reasons for this are unclear, but may simply reflect a different HeLa cell 
clone or some other differences in the experimental set-up. Therefore, I will further optimize these 
assays. However, wortmannin did not reduce nuclear targeting and immediate early gene expression of 
HSV1 in Vero and PtK2 cells, suggesting that PtK2 cells were also productively infected with HSV1 
by fusion at the plasma membrane.  
Interestingly, the macropinocytosis inhibitor amiloride reduced immediate-early HSV1 gene 
expression, and its effect was highest in HeLa cells and lowest in Vero cells, wheras PtK2 cells showed 
an intermediate sensitivity to amiloride. However, amiloride causes the cytoplasm to become more 
alkaline, and this might affect other cellular structures and functions besides membrane ruffling and 
macropinocytosis. In addition, macropinocytosis should also have been inhibited by wortmannin 
(Sieczkarski and Whittaker, 2002), but wortmannin did not affect nuclear targeting of HSV1 in my 
experiments. Therefore, further experiments are required to elucidate the HSV1 entry mechanism into 
PtK2 cells. 
Endocytosis can be more specifically inhibited by dominant-negative constructs or function-
blocking antibodies. Dominant-negative dynamin constructs inhibit clathrin as well as caveolin 
mediated endocytosis. Clathrin mediated endocytosis can be specifically blocked by function-blocking 
anti-clathrin antibodies or by overexpressing dominant-negative Eps15 mutants, clathrin hub domain 
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or AP-2 µ2 subunit (Sieczkarski and Whittaker, 2002). Caveolae mediated endocytosis can be 
specifically inhibited by overexpressing dominant-negative caveolin (Pelkmans et al., 2001). 
Overexpression of Rab GTPase mutants affects endosome motility more specifically than wortmannin 
(Sieczkarski and Whittaker, 2002). In the future, I will use such constructs to further analyze the entry 
into PtK2 and HeLa cells. 
To address the question whether cytosolic capsids or virions inside endosomes are transported along 
MTs in PtK2 cells, living cells could be incubated with rhodamine-labeled dextran and HSV1-
GFPVP26. Dextran labels macropinosomes with highest efficiency because of their high volume, but 
should also stain other endocytic organelles (Renate Fuchs, Center for Physiology and 
Pathophysiology, Medical University of Vienna; personal communication). Alternating recording of 
GFP and rhodamine signals with a high temporal resolution should reveal, whether moving GFP 
particles colocalize with rhodamine-dextran. If GFP particles not colocalizing with rhodamine-
dextrane required MTs for long distance transport, this would demonstrate that cytosolic capsids rather 
than virions inside endosomes moved along MTs in PtK2 cells. Since dynamitin overexpressing cells 
can be identified by an altered localization of endosomes (Burkhardt et al., 1997; Valetti et al., 1999), 
this experiment could also be performed to characterize, whether viral particles in the periphery of 
dynamitin overexpressing cells are cytosolic capsids or virions inside endosomes. 
Additionally, HSV1 labeled with different dyes in its membrane and at its capsid would also allow 
us to differentiate between cytosolic capsids and endosomal virions in living cells. Triple-labeled 
virions with fluorescent tags on viral DNA, capsid and viral membrane would eventually even allow 
us to follow viral DNA release into the nucleus in living cells. Falk Büttner started to prepare such a 
virus during his diploma thesis using a similar approach as described by McDonald et al. (2002) and 
Lakadamyali et al. (2003). He used HSV1-GFPVP26 and the fluorescent dye DiD (1,1´-dioctadecyl-
3,3,3´,3´-tetramethylindodicarbocyanine), and could show that such an approach is feasible. Moreover, 
he was able to stain herpesviral DNA with Hoechst 33258 (Büttner, 2004). Further optimization of the 
labeling conditions should enable us to achieve efficient double and triple labelings while preserving 
viral infectivity at the same time. In addition, the envelope of HSV1-GFPVP26 could be labeled with 
quantum dots (Lidke et al., 2004) or fluorochromes (Suomalainen et al., 1999; Leopold et al., 2000; 
Pelkmans et al., 2001; Seisenberger et al., 2001). 
Another idea is to construct a virus with a GFP-tagged VP26 and an mRFP-tagged viral membrane 
protein or vice versa. Recently, the successful construction of infectious HSV1 tagged with GFP on 
the viral glycoprotein gB or gD was reported (Potel et al., 2002; Milne et al., 2005). 
The in vitro motility assay consisting of envelope-free capsids derived from HSV1-GFPVP26, Cy3-
labeled MTs and membrane-free Xenopus cytosol (Wolfstein et al., 2006) avoids the difficulties in 
discriminating between cytosolic capsids and virions inside endosomes. This in vitro assay can be 
further developed by the use of polarity-marked MTs, which would allow a distinction between plus- 
and minus-end directed motility. Then, several inhibitors of dynein and kinesin, such as EHNA, 
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vanadate (dynein), AMP-PNP (adenosine 5´-(β,γ-imido)triphosphate) or adociasulfate (kinesin) could 
be applied. More specifically, function-blocking antibodies against dynein, dynactin or several 
kinesins or immunodepletion of cytosolic components could be used to further dissect the cytosolic 
requirements for HSV1 capsid transport. Addition of excess dynamitin will also be more instructive in 
an in vitro assay with MTs of known polarity. In the future, it should also be possible to reconstitute in 
vitro motility using purified cytosolic factors instead of cytosol which is a complex mixture of many 
components. 
The molecular requirements on the viral side can be analyzed by using capsids derived from HSV1 
mutants with deletions in putative motor receptors generated by mutagenesis of a bacterial artificial 
chromosome containing the HSV1 genome (Nagel, Fathollahy, Strive, Borst, Messerle, and Sodeik; 
manuscript in preparation). Moreover, capsids isolated from synaptosomes which resemble the 
presynapse and thus the typical entry site during natural infection could be used for the in vitro 
motility assay (Borsutzky, 2000; Nagel, 2002; Nagel, Borsutzky, Wolfstein, Bauerfeind, and Sodeik; 
manuscript in preparation). With immunofluorescence and live cell imaging experiments, the in vitro 
motility and binding assays, and the possibility to generate specific HSV1 mutants we have now the 
platform to identify the viral proteins required for transport along MTs and their cellular interaction 
partners. Live cell imaging will reveal the dynamics of intracellular HSV1 transport, and since HSV1 
moves to the MT minus- or plus-ends depending on the stage of the viral life cycle, it is the ideal cargo 
to study how the direction of MT transport is regulated.  
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Function of Dynein and Dynactin in Herpes Simplex
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After fusion of the viral envelope with the plasma membrane, herpes simplex virus type 1 (HSV1)
capsids are transported along microtubules (MTs) from the cell periphery to the nucleus. The
motor ATPase cytoplasmic dynein and its multisubunit cofactor dynactin mediate most transport
processes directed toward the minus-ends of MTs. Immunofluorescence microscopy experiments
demonstrated that HSV1 capsids colocalized with cytoplasmic dynein and dynactin. We blocked
the function of dynein by overexpressing the dynactin subunit dynamitin, which leads to the
disruption of the dynactin complex. We then infected such cells with HSV1 and measured the
efficiency of particle binding, virus entry, capsid transport to the nucleus, and the expression of
immediate-early viral genes. High concentrations of dynamitin and dynamitin-GFP reduced the
number of viral capsids transported to the nucleus. Moreover, viral protein synthesis was
inhibited, whereas virus binding to the plasma membrane, its internalization, and the organiza-
tion of the MT network were not affected. We concluded that incoming HSV1 capsids are
propelled along MTs by dynein and that dynein and dynactin are required for efficient viral capsid
transport to the nucleus.
INTRODUCTION
To initiate a successful infection, animal viruses bind to the cell
surface, penetrate into the cytosol, and target their genome to the
sites of viral transcription and replication. For many viruses this is
the host nucleus (Whittaker et al., 2000). Particular neurotropic
viruses that enter at the presynaptic plasma membrane, such as
herpes simplex viruses, are transported over long distances be-
cause the site of entry is far away from the nucleus. Herpes
simplex virus type 1 (HSV1) is a human pathogen that initially
replicates in epithelial cells of the oral cavity. Amplified virus
enters neurons and is transported to the neuronal nuclei located in
the trigeminal ganglion (reviewed in Enquist et al., 1998). After
lytic infection of some neurons, a latent infection is established
(Wagner and Bloom, 1997).
We have calculated that it would take 231 years for a herpes
virus capsid to diffuse by 10 mm in the axonal cytoplasm
(Sodeik, 2000). High concentrations of protein, the cytoskele-
ton, and organelles cause molecular crowding in the cyto-
plasm, which effectively restricts free diffusion of molecules
larger than 500 kDa (Luby-Phelps, 2000). Thus, virions and
subviral particles are transported by active processes. Besides
hijacking vesicular transport during endocytosis and secretion,
viruses also exploit the host’s cytoskeleton directly for their
itinerary (Sodeik, 2000; Ploubidou and Way, 2001).
HSV1 virions consist of four structural components: DNA,
capsid, tegument, and envelope (Steven and Spear, 1997; Zhou
et al., 2000). The icosahedral capsid with a diameter of 125 nm
surrounds the double-stranded viral DNA of 152 kb. The teg-
ument, the hallmark of all herpes viruses, is an amorphous
layer of20 proteins. It is localized between the capsid and the
viral envelope that contains 12 membrane proteins.
For cell entry the envelope of HSV1 fuses with the plasma
membrane. Different molecules such as heparan sulfate pro-
teoglycans, members of the tumor necrosis receptor family
(HVEM), and the immunoglobulin family (nectins) serve as
receptors for the HSV1 viral glycoproteins gB, gC, and most
importantly gD (reviewed in Spear et al., 2000). The fusion of
the viral envelope with the plasma membrane is mediated
by the viral glycoproteins gB, gD, gH, and gL (Spear et al.,
2000).
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Figure 1. (A) Incoming wild-type HSV1 capsids colocalize with p150Glued and DIC. A significant fraction of incoming HSV1 capsids colocalizes
with p150Glued and DIC (yellow dots in the overlays, c and f). This apparent colocalization is not due to binding of rabbit IgG to the herpes virus
Fc receptor on the surface of infected cells because there is no signal from a nonimmune rabbit serum (i). Moreover, immunoblots confirmed that
there is no unspecific cross-reactivity of the anti-dynactin or anti-dynein antibodies to structural viral proteins (our unpublished results).
Immunofluorescence microscopy of PtK2 cells infected with wild-type HSV1 for 1 h in the presence of 0.5 mM cycloheximide. Cells were fixed with
PHEMO-fix at room temperature, blocked with 0.2 mg/ml pooled human IgG and 5 mg/ml BSA and double-labeled with anti-p150Glued (pAb
Portos; a), anti-DIC (pAb L5, d) or a nonimmune rabbit serum (serum, g) and anti-VP5 (mAb 5C10; b, e, and h). Note, that the anti-VP5 antibodies
cross-reacted in PtK2 cells weakly with the cortical actin and stress fibers. (B) Incoming HSV1 capsids of a gE deletion mutant colocalize with
p150Glued and DIC. Incoming HSV1 capsids of the mutant strain R7202 that does not express a viral Fc receptor colocalize with p150Glued and DIC
(yellow dots in the overlays, c and f). Moreover, there is no colocalization (i) after double labeling with a nonimmune rabbit serum (g) and capsid
antibodies (h). Immunofluorescence microscopy of PtK2 cells infected with HSV1 deleted for gE (R7202) for 1 h in the presence of 0.5 mM
cycloheximide. Cells were fixed with PHEMO-fix at room temperature, blocked with 0.2 mg/ml pooled human IgG and 5 mg/ml BSA and
double-labeled with anti-p150Glued (pAb Portos; a), anti-DIC (pAb L5, d), or a nonimmune rabbit serum (g) and anti-VP5 (mAb 5C10; b, e, and h).
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All tegument proteins and the capsid with the DNA are
released into the cytosol. In epithelial cells and in axons of
cultured neuronal cells, incoming cytosolic capsids are
transported along microtubules (MTs) to the nucleus
(Kristensson et al., 1986; Topp et al., 1994; Topp et al., 1996;
Sodeik et al., 1997). Electron microscopy and careful quan-
tification demonstrated that 70% of cytosolic capsids
bind to nuclear pores and that concomitantly these cap-
sids have lost their electron-dense core (Sodeik et al.,
1997). Using an in vitro uncoating assay, Ojala et al. (2000)
demonstrated that capsid binding to the nucleus requires
importin- and that the release of the viral DNA is trig-
gered by the interaction with the nuclear pore. Transcrip-
tion, viral replication, and capsid assembly take place in
Figure 1 (legend on facing page).
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the nucleus (for reviews see Steven and Spear, 1997; Roiz-
man and Knipe, 2001).
MTs are polar hollow protein cylinders of tubulin with a
fast-growing and -shrinking plus end usually located to-
ward the cell periphery and a minus-end mostly stabilized
by attachment to the centrosome, the major microtubule
organizing center (MTOC; Nogales, 2000). Most if not all
minus-end–directed MT transport is mediated during inter-
phase by dynein motors, whereas kinesins transport cargo
toward the opposite direction (Vallee and Sheetz, 1996; Hi-
rokawa, 1998). Cytoplasmic dynein is a 20 S MT-activated
ATPase consisting of two dynein heavy chains (DHC), two
intermediate chains (DIC), four light intermediate chains
(DLIC) and four different classes of light chains (DLC; Karki
and Holzbaur, 1999; King, 2000). Dynein is responsible for
the perinuclear localization of several organelles around the
MTOC and retrograde organelle transport in axons and is
active during mitosis (Vallee and Sheetz, 1996; Hirokawa,
1998).
In many cases dynein is assisted by a second 20 S protein
complex, called dynactin (Vallee and Sheetz, 1996; Karki and
Holzbaur, 1999). It consists of 2 copies of p150Glued, 4 mol-
ecules of dynamitin, p62, 10 copies of Arp1 (actin-related-
protein 1), possibly 1 conventional actin, Arp11, and actin
capping protein (p37 and p32), p27, p25, and p24 (Holleran
et al., 1998; Eckley et al., 1999). p150Glued can bind directly to
DIC and thus link dynein to dynactin (Karki and Holzbaur,
1995; Vaughan and Vallee, 1995). Dynamitin, at high con-
centrations after transient transfection, dissociates the dyn-
actin complex (Echeverri et al., 1996; Eckley et al., 1999).
Excess dynamitin affects all tested dynein-mediated trans-
ports in vivo and in vitro: e.g., spindle organization, chro-
mosome transport, and the subcellular localization of sev-
eral membrane organelles (Echeverri et al., 1996; Burkhardt
et al., 1997; Presley et al., 1997; Valetti et al., 1999; Sharp et al.,
2000).
Quantitative immunoelectron microscopy showed that
DHC colocalizes with incoming herpes virus capsids (So-
deik et al., 1997). Here, we demonstrate that incoming HSV1
capsids also colocalized with DIC and the p150Glued subunit
of dynactin. To test whether HSV1 capsids use cytoplasmic
dynein for their transport to the nucleus, we transiently
transfected cells with dynamitin, subsequently challenged
them with HSV1, and measured virus binding, internaliza-
tion, capsid transport to the nucleus, and immediate-early
viral gene expression. High concentrations of dynamitin and
dynamitin-GFP clearly reduced the number of viral capsids
transported to the nucleus compared with untransfected
cells. Because fewer capsids reached the nucleus, presum-
ably fewer viral genomes were delivered to the nucleo-
plasm, and the amount of viral protein synthesis was re-
duced. Overexpression of dynamitin did not downregulate
virus receptors at the plasma membrane, because both virus
binding and internalization were not reduced. We propose
that incoming HSV1 capsids are propelled by dynein along
MTs and that functional dynactin is required for their effi-
cient transport.
MATERIALS AND METHODS
Cells and Antibodies
PtK2 cells (ATCC CCL-56) were grown in 10%, Vero cells (ATCC
CCL-81) in 7.5%, and BHK-21 cells (ATCC CCL-10) in 15% fetal calf
serum. The media contained MEM, 2 mM glutamine, nonessential
amino acids, and with the exception of the PtK2 medium 100 U/ml
penicillin and 100 g/ml streptomycin.
Dynamitin expression was analyzed using mAb 50.1 (Paschal et
al., 1993) or a rabbit anti-myc antibody (Gee et al., 1997), DHC was
detected with affinity-purified rabbit pAb (Vaisberg et al., 1993), DIC
with a rabbit pAb L5 (Vaughan and Vallee, 1995), p150Glued with
rabbit pAbs D’Artagnon, Aramis, or Portos (Vaughan and Vallee,
1995), and the cation-independent mannose-6-phosphate receptor
with a rabbit pAb (Griffiths et al., 1988). MTs were visualized using
mouse mAb 1A2 (Kreis, 1987) and actin filaments with TRITC-
Phalloidin (Sigma-Aldrich, Schnelldorf, Germany). We used pread-
sorbed rabbit pAbs raised against DNA-containing capsids (anti-
HC) and empty capsids (anti-LC; Cohen et al., 1980) and a mouse
mAb 5C10 against VP5 (Newcomb et al., 1996) to detect incoming
viral capsids by immunofluorescence microscopy (Sodeik et al.,
1997). Immediate-early viral gene expression was measured with a
mouse mAb against ICP4 (Showalter et al., 1981). Viral glycopro-
teins were labeled with mouse mAb DL6 against gD and rabbit pAb
R68 against gB (Eisenberg et al., 1985, 1987). Secondary antibodies
were purchased from Dianova (Hamburg, Germany).
Virological Techniques
Preparation of Stock Virus Cold and radioactively labeled virus
stocks of HSV1 were prepared as described (Sodeik et al., 1997). We
used wild-type strain F (ATCC VR-733) and two HSV1 mutants:
strain [KOS]tk12, which expresses the LacZ gene controlled by the
immediate-early ICP4 promoter (Warner et al., 1998) and strain
R7202, which lacks the majority of the glycoprotein E codons in-
cluding the start codon and therefore does not exhibit viral Fc
receptor activity (Baines and Roizman, 1993).
Plaque Assay Virus was diluted in 10-fold steps in RPMI with 0.2%
wt/vol BSA, 20 mM HEPES, pH 7.0 (RPMI/BSA) and incubated in
six-well dishes with just-confluent Vero cells for 1 h at room tem-
Figure 2. Quantification of immediate-early viral gene expression
in transfected cells. -Galactosidase activity per cell was reduced in
dynamitin-GFP–overexpressing cells compared with untransfected
or GFP-transfected cells. Two-sided Student’s t test confirmed that
viral protein synthesis is significantly lower in dynamitin-GFP–
transfected cells compared with either GFP-transfected cells (p 
1.13 104) or to untransfected control cells (p 2.1 105). There
was no significant difference in -galactosidase expression between
control and GFP-transfected cells (p  1.58  101). The mean
values for five independent experiments each performed in dupli-
cates are shown.
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perature on a rocking platform. The inoculum was removed, and 2
ml/well normal growth medium containing 10 g/ml pooled hu-
man IgG (Sigma-Aldrich) was added. The cells were further cul-
tured for 2 d at 37°C, 5% CO2 and fixed in absolute methanol. After
incubation with a mAb to gD (DL6) and a secondary anti-mouse
antibody conjugated to alkaline phosphatase, the cells were washed
with TSM (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 5 mM MgCl2)
and treated with 0.2 mM nitroblue tetrazolium chloride and 0.8 mM
5-bromo-4-chloro-3-indolyl phosphate until dark plaques became
visible. We routinely obtained titers around 1010 PFU/ml for cold
wild-type and HSV1[KOS]tk12 virus and 107 PFU/ml for 3H-thy-
midine labeled virus.
Virus Infection Control and transfected Vero, BHK, or PtK2 cells
were inoculated with virus in RPMI/BSA for 2 h on ice to allow
virus binding. After three washes with ice-cold RPMI/BSA, they
were shifted to growth medium at 37°C and 5% CO2. In those
experiments analyzing the subcellular localization of incoming
Figure 3. Overexpression of dynamitin reduces immediate-early vi-
ral gene expression. (A) Overexpression of dynamitin (a) or dyna-
mitin-GFP (b) reduced the immediate-early viral gene expression
compared with control (a–c) or GFP-transfected cells (c). Immunoflu-
orescence microscopy of PtK2 cells transfected with dynamitin or
dynamitin-GFP and 30 h later infected with HSV1 for 3 h. Cells were
fixed with PFA and either double-labeled with anti-myc (a; top panel)
to detect transfected cells and anti-ICP4, an immediate-early protein
of HSV1 (a–c; bottom panels) or single-labeled with anti-ICP4 (b and
c; bottom panels), and the transfected proteins were detected by their
intrinsic GFP fluorescence (b and c; top panels). (B) Quantification of
viral ICP4 synthesis after transfection. The overexpression of dyna-
mitin reduced immediate-early viral gene expression. Two-sided Stu-
dent’s t test confirmed that ICP4 expression is significantly lower in
dynamitin (p  2.52  103) or dynamitin-GFP (p  3.57  103)
transfected cells compared with GFP-transfected cells. There was no
significant difference in ICP4 expression between untransfected and
GFP-transfected cells (p  1). The experiment described in A was
quantitated (three independent experiments; altogether 500 cells
analyzed for each condition). Cells overexpressing dynamitin, dyna-
mitin-GFP, or GFP and untransfected cells were divided into two classes: cells displaying a nuclear ICP4 signal and cells not displaying a
nuclear ICP4 signal.
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viral particles, 0.5 mM cycloheximide was added to prevent
synthesis of new viral proteins (Sodeik et al., 1997). When no-
codazole (50 M) was used to depolymerize MTs, cells were
pretreated for 1 h at 37°C, and the drug was present during all
further incubation steps. For immunofluorescence microscopy in
24-well plates we used 8  106 PFU/well HSV1 for entry exper-
iments, 1  107 PFU/well for virus binding experiments, and 4 
105 PFU/well for ICP4 experiments.
Light Microscopy
Cells grown on coverslips were fixed with 3% (wt/vol) paraformal-
dehyde (PFA in PBS) for 20 min followed by 50 mM NH4Cl/PBS for
10 min and 0.1% Triton X-100/PBS for 5 min. For colocalization
studies and visualization of MTs, cells were fixed with PHEMO-fix
(3.7% [wt/vol] PFA, 0.05% [wt/vol] glutaraldehyde, 0.5% Triton
X-100 in PHEMO buffer) either at room temperature or at 37°C for
10 min, and washed with PHEMO buffer (68 mM PIPES, 25 mM
HEPES, pH 6.9, 15 mM EGTA, 3 mM MgCl2, 10% [vol/vol] DMSO)
followed by 50 mM NH4Cl/PBS for 10 min.
In most experiments we used 10% (vol/vol) goat serum with 5
mg/ml BSA as blocking reagent and performed the immunolabel-
ing essentially as described (Sodeik et al., 1997). For the experiments
described in Figure 1 we used 0.2 mg/ml human immunoglobulins
(IgGs, I4506; Sigma, Taufkirchen, Germany) with 5 mg/ml BSA to
block nonspecific protein binding.
HSV1 carries in its envelope a Fc-receptor with strong affinity for
human IgGs, decreasing affinity for rabbit, sheep, and goat and no
affinity for murine IgGs (reviewed in Dubin et al., 1992). The degree
of the Fc-receptor–specific signal in the absence of human IgGs
depended strongly on the protocol used: it was most prominent
under the conditions we found optimal for the colocalization stud-
ies, namely after PHEMO fixation at room temperature, but surpris-
ingly only weak after PHEMO fixation at 37°C or after PFA fixation
followed by TX-100 (our unpublished results). Initial double-label-
ing experiments for dynein or dynactin with HSV1 capsids demon-
strated that in the presence of human IgGs, primary rabbit and
secondary goat antibodies bound only with their antigen-binding
domain but not with their Fc-domain to infected cells. Without
human IgGs, the membrane of incoming virions was also detected
by preimmune and immune rabbit sera but not by unspecific mouse
antibodies (our unpublished results).
The cells were examined with a fluorescence microscope (DM
IRB/E; Leica, Wetzlar, Germany), and micrographs were taken on
Kodak TMAX-400 (Eastman Kodak, Rochester, NY) or Ilford HP5
400 films (Ilford, Cheshire, United Kingdom). All digitized images
(using a Nikon LS-1000 35-mm film scanner; Tokyo, Japan) were
image processed using Adobe Photoshop version 5.5 (San Jose, CA).
Colocalization and expression levels were analyzed using a digital
interline charge coupled device camera (MicroMax-5MHz-782Y;
Princeton Instruments Inc., Princeton, NJ) and the Metamorph soft-
ware version 4.01 (Universal Imaging Corporation, West Chester,
PA). Dynamitin-GFP and GFP-expressing cells were scored as high
expressors (see Figure 8B) when their average gray values in the
cytoplasm were above 400 (exposure time: 0.2 s) using the function
“show region statistics” of the Metamorph software. Cells overex-
pressing dynamitin (mAb 50.1) were scored as high expressors
when their average gray values in the cytoplasm were above 600
(exposure time: 0.5 s).
Transient Transfection
Plasmids For transient transfections we used the plasmids
pEGFP-N1 (Clontech Laboratories Inc., Palo Alto, CA) expressing
enhanced green fluorescent protein (GFP) and p50 expressing myc-
tagged dynamitin (Echeverri et al., 1996). For the dynamitin-GFP–
expressing construct (p50-GFP), the full dynamitin cDNA sequence
was inserted upstream of GFP into the pEGFP-N1 vector between
the EcoRI and the BamHI sites. The proper restriction sites were
created by PCR, and subsequent products were sequenced to ensure
that no mutation was created. All constructs are under the control of
the cytomegalovirus immediate-early promotor (Clontech).
Experiments Measuring Virus Binding, Internalization, and Protein
Synthesis PtK2 cells were seeded in 10-cm diameter culture dishes at
a density of 5  105. Twenty-four hours later the cells were trans-
fected with 30 g DNA per dish using calcium phosphate (Sam-
brook et al., 1989). After 24 h, the cells were washed once with PBS,
and 10 ml/dish normal growth medium was added for 19–22 h.
Experiments Analyzed by Immunofluorescence Microscopy Trans-
fections were made with calcium phosphate or lipofectamine re-
agent (Life Technologies, Karlsruhe, Germany). For the latter, cells
were seeded onto coverslips (12-mm diameter) in a 24-well cell
culture dish at a density of 4  104 (Vero) or 3  104 (PtK2) cells per
well. After 16–18 h, the cells were washed twice with serum-free,
antibiotic-free MEM and incubated with 300 l/well serum-free,
antibiotic-free MEM containing 1.5 l/well lipofectamine and 150
ng DNA for 5 h. The transfection mixture was removed, and 1
ml/well normal growth medium was added for 24–28 h. For trans-
fections with calcium phosphate, PtK2 cells were seeded onto cov-
erslips (12-mm diameter) in a 24-well cell culture dish at a density
of 2 104 cells per well. After 24 h cells were transfected with 1.1 g
DNA per well. Twenty-four hours later 1 ml/well normal growth
medium was added for 19–22 h.
Immediate-early Viral Gene Expression
Immediate-early viral gene expression was analyzed using the mu-
tant HSV1(KOS)tk12, which expresses the bacterial LacZ gene cod-
ing for the enzyme -galactosidase under the control of the imme-
diate-early ICP4 promotor of HSV1 (Warner et al., 1998). PtK2 cells
transfected for 44 h with dynamitin-GFP or GFP were inoculated
with 2 ml per 10-cm dish RPMI/BSA containing 4–8  106 PFU of
HSV1(KOS)tk12 for 2 h on ice and then shifted to 37°C for 3–4 h.
The cells were harvested by trypsinization, and trypsin was imme-
diately inhibited by adding trypsin inhibitor, and further protein
synthesis by cycloheximide. Transfection efficiencies were deter-
mined by flow cytometry (FACSCalibur; Becton Dickinson, Heidel-
berg, Germany), cell densities by BCA assay (Pierce, Rockford, IL)
after lysis in 1% SDS/PBS, and -galactosidase activities after lysis
in 0.5% TX-100/PBS with 1 mg/ml BSA and protease inhibitors
using O-nitrophenyl--d-galactopyranoside as substrate. -Galacto-
sidase activity per cell was normalized to GFP-transfected cells.
Quantification of Virus Binding and Internalization
We assayed for virus binding and internalization essentially as
described using a protease protection assay (Sodeik et al., 1997).
PtK2 cells transfected for 44 h with dynamitin-GFP or GFP were
inoculated with 2 ml per 10-cm dish RPMI/BSA containing 3H-
thymidine labeled HSV1 (5–10 kBq and 8  106 to 1.6  107 PFU).
Cell-associated radioactivity—representing the amount of bound
virions—was determined by scintillation counting. Virus binding
was expressed as radioactivity per cell and normalized to GFP-
transfected cells. To assay for virus internalization, 3H-thymidine-
labeled virus was bound to transfected cells at 4°C for 2 h. The cells
were washed to remove unbound virus, shifted to 37°C for 30 min,
transferred back to ice, and washed with ice-cold RPMI. Cell asso-
ciated radioactivity after proteinase K treatment was determined by
scintillation counting (Sodeik et al., 1997). In these virus binding and
internalization experiments, the transfection efficiencies were mea-
sured by flow cytometry and cell densities using a hemocytometer.
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RESULTS
Colocalization of Incoming HSV1 Capsids with
Cytoplasmic Dynein and Dynactin
We have shown previously by quantitative immune electron
microscopy that in Vero cells incoming cytosolic HSV1 cap-
sids colocalize with DHC (Sodeik et al., 1997). Here, we used
PtK2 cells that are extremely flat in the periphery to analyze
the subcellular distribution of HSV1 relative to dynein and
dynactin. In uninfected cells, anti-DHC, anti-DIC, and anti
p150Glued revealed a weak diffuse labeling throughout the
cytoplasm that was strongest around the nucleus; moreover,
centrosomes and numerous tubules and vesicles concen-
trated around the nucleus were labeled (our unpublished
results). These structures might represent host organelles
that use dynein for transport along MTs (Burkhardt et al.,
1997; Sodeik et al., 1997; Harada et al., 1998; Valetti et al.,
1999; Habermann et al., 2001).
After 1 h of infection, a mouse mAb to the capsid protein
VP5 labeled numerous small fluorescent spots that repre-
sented individual capsids distributed over the entire cyto-
plasm (Figure 1, A and B, b, e, and h). After 2 h and more so
after 3 h, the majority of capsids had accumulated at the
nucleus (see Figure 7). Numerous small dots of dynactin
(Figure 1Ac), DHC (our unpublished results), and DIC (Fig-
ure 1Af) colocalized with viral capsids, whereas there was
no colocalization after double labeling with the mouse anti-
VP5 and a preimmune rabbit serum (Figure 1Ai).
HSV1 carries in its envelope the viral protein complex
gE/gI that has a strong Fc-receptor binding activity for
human IgGs, decreasing affinity for rabbit, sheep, and goat,
but does not bind to murine IgGs (reviewed in Dubin et al.,
1992). However, none of eight mouse monoclonal antibodies
generated against different subunits of dynein (DHC, DIC,
DLC) or dynactin (p150Glued, dynamitin) showed any colo-
calization with viral capsids despite testing several fixation
and permeabilization protocols. In the presence of rabbit or
goat sera, we therefore blocked the Fc-receptor with human
IgGs (cf. MATERIALS AND METHODS). Moreover, we
used the HSV1 mutant R7202, which is deleted for gE and
does not contain a Fc-binding activity (Baines and Roizman,
1993). After 1 h of infection with R7202, numerous viral
capsids were also labeled for dynactin and dynein, in the
presence (Figure 1B) and also absence (our unpublished
results) of human IgGs.
Approximately 15–20% of incoming capsids from wild-
type HSV1 and the mutant R7202 were labeled with anti-
bodies to dynactin (20% for p150Glued; n  130) and dynein
(15% for DIC; n  100). The lacking reactivity of monoclonal
antibodies and the incomplete colocalization using poly-
clonal rabbit sera directed against dynein or dynactin sub-
units might suggest that there was steric hindrance and thus
only limited epitope access in a putative ternary complex of
capsids, dynein, and dynactin. Alternatively, it is possible
that only a subset of viral capsids binds to dynein and/or
dynactin at a given time point. Because most subunits of
dynein and dynactin only exist in 20 S complexes and not as
soluble proteins, these data showed that both protein com-
plexes, dynein and dynactin, were at least transiently
present on incoming viral capsids.
Immediate-early Viral Gene Expression after
Overexpression of Dynamitin
To test whether functional dynein and dynactin were re-
quired during HSV1 entry, we transfected PtK2 cells with
dynamitin, which inhibits many dynein-mediated transport
processes (Echeverri et al., 1996; Burkhardt et al., 1997; Pres-
ley et al., 1997; Valetti et al., 1999). In cells overexpressing
dynamitin or dynamitin-GFP, mannose-6-phosphate recep-
tor containing organelles were scattered over the entire cy-
toplasm rather than concentrated in the perinuclear region
(our unpublished results), indicating that the function of
dynein was disrupted (Burkhardt et al., 1997; Valetti et al.,
1999). We routinely obtained transfection efficiencies of 65–
75% for dynamitin-GFP and 70–85% for GFP as measured
by flow cytometry (our unpublished results).
We next infected transfected PtK2 cells with a HSV1 mu-
tant expressing -galactosidase under the control of an im-
mediate-early HSV1 promoter (HSV1[KOS]tk12; Warner et
al., 1998), and the enzyme activity was quantified as an
indicator for immediate-early viral gene expression. -galac-
tosidase activity was highest in untransfected cells and low-
est in cells transfected with dynamitin-GFP (Figure 2). Over-
expressing dynamitin-GFP reduced the amount of
-galactosidase by 25% compared with overexpression of
GFP alone.
To analyze single cells, we infected PtK2 cells with wild-
type HSV1 and double-labeled them with antibodies to the
transiently expressed proteins and ICP4, an immediate-
early, nuclear herpes virus protein (Everett, 2000). After
overexpression of dynamitin and dynamitin-GFP there were
about half as many cells labeled for ICP4 compared with
GFP expressing or untransfected cells (Figure 3, A and B).
Thus, the expression of ICP4 and -galactosidase, both un-
der the control of the ICP4 promotor, were reduced after
overexpressing dynamitin or dynamitin-GFP compared
with controls. Inhibition of immediate-early viral gene ex-
pression might be due to changes in 1) the MT-network, 2)
virus binding to the cell surface, 3) virus internalization, or
4) a reduced cytosolic transport of incoming capsids to the
nucleus.
The Cytoskeleton after Transient Transfection
Dynactin contains conventional actin, Arp1 and Arp11
(Schafer et al., 1994; Eckley et al., 1999). We therefore tested
whether dynamitin overexpression affected the actin cy-
toskeleton in PtK2 cells but detected no changes in filamen-
tous actin upon transfection (our unpublished results;
Burkhardt et al., 1997). The overexpression of dynamitin can
affect the organization of MTs in fibroblastic cells (Burkhardt
et al., 1997; Quintyne et al., 1999). Because nuclear targeting
of capsids is MT dependent (Sodeik et al., 1997), we analyzed
the MT-network in PtK2 cells by immunofluorescence mi-
croscopy. In many cells, the MTs emanated to the peripheral
cytoplasm from one location in the perinuclear region that
most likely represents the position of the MTOC or centro-
some (arrows in Figure 4). However, there were also cells in
which there were several MT organizing zones around the
nucleus rather than a single, well-defined MTOC or in which
MTs emanated more broadly from the nuclear surface (as-
terisks in Figure 4). The number of cells without an apparent
MTOC increased after overexpression of dynamitin (a) or
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Figure 4. Organization of the microtubule network in transfected PtK2 cells. Immunofluorescence microscopy showing the MT network of
PtK2 cells after overexpression of dynamitin or dynamitin-GFP. In almost all cells the MTs emanated from the perinuclear region of the cell.
After overexpression of dynamitin (a) or dynamitin-GFP (b), there seemed to be fewer cells with a well-defined MTOC. In untransfected cells
(b and d) and in cells overexpressing GFP (c), the MTs were focused at the MTOC in many cells. In untransfected cells with an apparent
MTOC (arrows in d) and in cells with unfocussed MTs (asterisks in d) numerous capsids reached the nucleus (d, capsids). Twenty-eight hours
after transfection, cells were fixed with PHEMO-fix and double-labeled with anti-myc (pAb, a; top panel) and anti-tubulin (mAb 1A2, a;
bottom panel). Cells transfected with GFP proteins were only labeled with anti-tubulin (mAb 1A2, b and c; bottom panels). Note that because
of the PHEMO-fixation, GFP was relocalized to the nucleus. In unfixed cells, most of the transiently expressed GFP was localized to the
cytoplasm. In d, untransfected PtK2 cells were infected with HSV1 for 3 h and fixed with PHEMO-fix at 37°C. Capsids were labeled with
anti-LC (d; right panel) and MTs with 1A2 (d; left panel).
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dynamitin-GFP (b), whereas GFP (c) did not have such an
effect. However, also in untransfected cells without an ob-
vious MTOC and unfocussed MTs many capsids reached the
nucleus (Figure 4d, asterisks), suggesting that MTs but not
focused MTs are required for nuclear targeting of HSV1
capsids.
Virus Binding and Internalization after Transfection
Overexpression of dynamitin affects both, secretory and en-
docytic membrane traffic (Burkhardt et al., 1997; Presley et
al., 1997; Valetti et al., 1999), and the concentration of HSV1
cell surface receptors present at the plasma membrane might
therefore have been changed by the transfected proteins.
Because several different molecules can serve as HSV recep-
tors (Spear et al., 2000), we decided to measure virus binding
and internalization directly rather than trying to determine
the subcellular localization of all potential viral surface re-
ceptors. To this end, cells overexpressing dynamitin, dyna-
mitin-GFP, or GFP were infected with HSV1 for 15 min,
fixed, and then labeled for the overexpressed proteins and
viral glycoproteins. Compared with untransfected cells and
with cells overexpressing GFP, glycoprotein labeling was
unchanged by overexpression of dynamitin or dynamitin-
GFP (Figure 5). Thus, the sum of surface-bound and inter-
nalized virus was similar under all conditions tested. Next
we determined virus binding by measuring the amount of
cell-bound virus and internalization using a protease pro-
tection assay (Sodeik et al., 1997). After 2 h binding on ice
50% of 3H-thymidine–labeled HSV1 resist washing with
buffer, and 95% of the bound virus can be detached from
cells by proteinase treatment. If, however, the cells are
warmed up, 70% of the bound HSV1 enters the cells with a
half time of 8 min (Sodeik et al., 1997; our unpublished
results).
Using these assays we determined that compared with
untransfected or GFP-transfected PtK2 cells, neither binding
(Figure 6A) nor internalization (Figure 6B) of 3H-thymidine–
labeled HSV1 were reduced after overexpression of dyna-
mitin-GFP. There seemed to be a slight increase of virus
internalization in dynamitin-GFP– and GFP-transfected cells
compared with control cells (Figure 6B). The reasons for that
are unclear. However, the reduced viral protein synthesis
after overexpression of dynamitin or dynamitin-GFP could
neither result from reduced virus binding nor from reduced
internalization.
Dynamitin Reduces Cytosolic Viral Capsid
Transport to the Nucleus
The reduced amount of viral protein synthesis after overex-
pression of dynamitin could be due to impaired cytosolic
transport of incoming capsids from the periphery to the
nucleus. We therefore transiently transfected PtK2 cells with
dynamitin or dynamitin-GFP and infected them with HSV1
in the presence of cycloheximide.
Most capsids had reached the nucleus in untransfected
cells as well as in cells overexpressing GFP 3 h after infection
(Figure 7). In cells overexpressing dynamitin or dynamitin-
GFP, fewer capsids were present at the nucleus. Interest-
ingly, in many cells overexpressing dynamitin or dynamitin-
Figure 5. HSV1 binding and internalization in transfected cells. In cells overexpressing dynamitin (a) or dynamitin-GFP (b) virus binding
was not reduced compared with untransfected cells or cells overexpressing GFP (c). Immunofluorescence microscopy of PtK2 cells transfected
with dynamitin or dynamitin-GFP and 20 h later inoculated with HSV1 for 2 h at 4°C. After 2 h at 4°C cells were washed and shifted to 37°C
for 15 min to reduce unspecific binding, fixed in PFA and permeabilized with TX-100. They were double-labeled with anti-dynamitin (a; top
panel) and anti-gB (a; bottom panel), and cells transfected with GFP proteins were only labeled with anti-gD (mAb DL6, b and c; bottom
panels).
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GFP the capsids were not randomly distributed over the
entire cytoplasm as they are early in the infection (Sodeik et
al., 1997), but rather the capsids had accumulated in the cell
margins (arrows in Figure 7, a and b). Similar results were
obtained using BHK and Vero cells. However, BHK and
Vero cells sometimes showed dramatic changes in cell mor-
phology, whereas the morphology of PtK2 cells was largely
not affected by overexpressed dynamitin.
Figure 6. Quantification of HSV1 virus binding and internalization in transfected cells. (A) Virus binding after overexpression of
dynamitin-GFP or GFP was identical to virus binding to mock-transfected cells (n  2). Two-sided Student’s t test confirmed that viral
binding was not significantly different in dynamitin-GFP–transfected cells compared with either GFP-transfected cells (p  4.21  101) or
to untransfected control cells (p 4.03 101). There was also no significant difference in viral binding between control and GFP-transfected
cells (p  9.42  101). Virus binding was calculated as radioactivity per cell and expressed as percent of radioactivity per cell compared
with GFP-transfected cells. (B) Virus internalization after overexpression of dynamitin-GFP was not reduced compared with GFP-transfected
cells (n 6). Two-sided Student’s t test confirmed that viral internalization was not significantly different in dynamitin-GFP–transfected cells
compared with GFP-transfected cells (p 1.45 101). However, compared with untransfected cells, virus internalization was higher in cells
transfected with GFP (p  2.46  103) or dynamitin-GFP (p  7.11  103). Virus internalization was calculated as radioactivity per cell
and expressed as percent of radioactivity per cell compared with GFP-transfected cells.
Figure 7. Overexpression of dynamitin reduces HSV1 capsid transport to the nucleus. Three hours after infection most capsids were bound
to the nucleus in untransfected cells (a–c) and in cells overexpressing GFP (c). In cells overexpressing dynamitin (a) or dynamitin-GFP (b),
only a few capsids reached the nucleus, and several capsids were seen in the periphery of the cells (arrows in a and b, bottom panels).
Immunofluorescence microscopy of PtK2 cells transfected with dynamitin or dynamitin-GFP and 46 h later infected with HSV1 for 3 h in the
presence of cycloheximide. Cells were fixed with PFA, permeabilized with TX-100, and double-labeled with anti-dynamitin (mAb p50; a, top
panel) and anti-HC (pAb; a, bottom panel). Cells transfected with GFP proteins were labeled with anti-HC (pAb; b and c, bottom panels).
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Occasionally, there seemed to be fewer capsids visible in
cells overexpressing dynamitin or dynamitin-GFP than in
control cells. This was due to the fact that in control cells
most capsids were concentrated at the nuclear envelope and
were thus visualized in one focus plane. In contrast in cells
overexpressing dynamitin or dynamitin-GFP, capsids were
distributed throughout the entire cytoplasm and therefore
were not visualized in one focus plane. For quantification,
PtK2 cells were randomly selected and grouped into three
different classes (cf. Figure 7b): 1) cells with many capsids at
the nuclear envelope typically forming a nuclear crescent, 2)
cells with a reduced amount of nuclear capsids, and 3) cells
with very few capsids at the nucleus. The overexpression of
dynamitin or dynamitin-GFP clearly reduced the number of
cells that showed many capsids at the nucleus by 50%
compared with control or GFP-transfected cells (Figure 8A).
Similar results were obtained using Vero cells overexpress-
ing dynamitin (our unpublished results). As in other sys-
tems (Burkhardt et al., 1997; Suomalainen et al., 1999), we
noticed that the degree of inhibition on capsid transport was
dependent on the dose of the transfected protein. We there-
fore estimated expression levels using a digital camera and
specifically analyzed cells expressing high amounts of the
transfected proteins (Figure 8B). In these cells, dynamitin-
GFP and dynamitin inhibited viral capsid transport by 85%
compared with GFP-transfected or control cells.
At early time points, incoming capsids are distributed
randomly over the entire cytoplasm (Sodeik et al., 1997).
However, in the cells in which the function of dynein was
inhibited by the overexpression of dynamitin, the capsids
were often concentrated in peripheral parts of the cells (Fig-
ure 9a). If dynamitin-transfected cells were infected in the
presence of nocodazole, which disrupts the MT network, the
capsids were also distributed randomly over the entire cy-
toplasm (Figure 9b). This experiment suggested that without
the minus-end–directed MT motor dynein, the capsids
might be transported by a plus-end–directed MT motor to
the cell periphery.
In summary our data show that overexpressing dynamitin
reduced the number of cytosolic viral capsids transported to
the nucleus. Because under this condition fewer viral ge-
nomes reached the nucleoplasm, immediate-early viral gene
expression was also reduced. The inhibition of virus entry
by high amounts of dynamitin was not due to impaired
virus binding, virus internalization, or the slight changes in
the MT network but to a block of dynein function in cyto-
solic HSV1 capsid transport along MTs.
DISCUSSION
Incoming cytosolic HSV1 capsids are efficiently targeted
along MTs from the plasma membrane to the nucleus (Ham-
monds et al., 1996; Sodeik et al., 1997; Mabit, Nakano, Prank,
Saam, Do¨hner, Sodeik, Greber, unpublished data). The typ-
ical organization and polarity of MTs in cultured cells and
axons require the use of a minus-end–directed MT motor for
transport to the nucleus (Kristensson et al., 1986; Topp et al.,
1994; Sodeik et al., 1997; Bearer et al., 2000). Cytoplasmic
dynein is responsible for most minus-end–directed MT
transport during interphase and thus a prime candidate for
viral trafficking (Sodeik, 2000; Ploubidou and Way, 2001).
The dynein subunits DHC, DIC, and p150Glued, a subunit
of the dynein cofactor dynactin, colocalized with incoming
HSV1 (Sodeik et al., 1997; Figure 1). Moreover, EHNA
(erythro-9–3-[2-hydroxynonyl]adenine), an inhibitor of ax-
onemal and cytoplasmic dynein, blocks HSV1 infection in
neuronal cells (Kristensson et al., 1986). However, EHNA
also affects adenosine deaminase, cGMP-stimulated phos-
phodiesterase, and the actin cytoskeleton (Penningroth,
1986; Mery et al., 1995), and it is unclear which phase of the
viral life cycle was inhibited. We therefore asked whether
incoming HSV1 capsids use the host factor dynein for riding
along MTs to the nucleus.
Inhibition of Dynein and Dynactin Does not Affect
HSV1 Internalization
The function of dynactin and dynein can be inhibited by
transiently overexpressing one dynactin subunit, the 50-kDa
Figure 8. Quantification of viral
capsid transport in transfected
cells. For quantification, untrans-
fected and transfected cells were
randomly selected and classified
into three different groups: cells
with many capsids at the nu-
cleus, typically forming a nuclear
rim (Figure 7b, 1), cells with a
reduced amount of capsids at the
nucleus (Figure 7b, 2), and cells
with 10 capsids at the nucleus
(Figure 7b, 3). Either all (A) or
only high expressing (B) cells
were analyzed. Expression levels
in the cytoplasm were deter-
mined using a digital camera.
One can directly compare the ex-
pression levels for GFP with dynamitin-GFP (cf. MATERIALS AND METHODS). Dynamitin and dynamitin-GFP strongly inhibited HSV1
entry, whereas GFP had no effect on viral infection. Forty-five or 46 h after transfection with dynamitin, dynamitin-GFP, or GFP, PtK2 cells
were infected with HSV1 for 3 or 2 h (A and B, respectively), in the presence of cycloheximide. Cells were fixed with PFA, permeabilized with
TX-100, and double-labeled with anti-capsid (anti-HC or anti-LC) and anti-dynamitin (cf. Figure 8). Cells with aggregated protein or
abnormal morphology were excluded from analysis.
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protein dynamitin (Echeverri et al., 1996). Because endocytic
and exocytic membrane traffic involve dynein-mediated ve-
sicular transport steps (Burkhardt et al., 1997; Presley et al.,
1997; Valetti et al., 1999), the subcellular localization of viral
receptors might have been changed upon such treatment.
However, none of the transfected proteins we tested re-
duced the efficiency of HSV1 binding or particle uptake.
Thus, any influence on virus infection was not simply due to
reduced surface expression of viral receptors and less effi-
cient fusion of virions with the cells.
Inhibition of Dynein and Dynactin Blocks Cytosolic
HSV1 Capsid Transport along MTs
Although virus entered transfected cells normally, overex-
pressed dynamitin inhibited the transport of cytosolic HSV1
capsids from the cell periphery to the nucleus by 50% and
in cells expressing high levels of dynamitin even by 85%. As
a consequence viral immediate-early gene expression was
reduced, too.
Two factors may have prevented a complete inhibition of
virus infection in our set up. First, about a third of all cells
were not transfected, and immunofluorescence microscopy
confirmed that those were infected normally. Second, single
cell analysis strongly suggested that the degree of capsid
transport inhibition correlated with the level of dynamitin
expression (Figure 8). This is consistent with biochemical
experiments, which show that excess dynamitin blasts dyn-
actin into two subcomplexes of 9 and 18 S, presumably by
saturating dynamitin binding sites on them, thus destroying
the architecture of dynactin (Echeverri et al., 1996; Eckley et
al., 1999). Because this is likely to be a dose-dependent effect,
it was expected that dynactin-dependent transport and virus
infection were only completely inhibited in cells expressing
high levels of dynamitin.
As in the absence of MTs (Sodeik et al., 1997; Mabit,
Nakano, Prank, Saam, Do¨hner, Sodeik, Greber, unpublished
data), we detected a few capsids at the nuclear membrane in
cells with high concentrations of dynamitin. This was no
surprise, because virions can bind to the “apical” plasma
membrane just on top of the nucleus. Capsids derived from
these virions most likely reach the nuclear pores without
MTs or dynein and dynactin. Dynein and dynactin–medi-
ated MT transport is therefore not essential for infecting
nonpolarized cells in culture. However, it is likely to be
required during pathogenesis when HSV1 infects highly
polarized epithelial and elongated neuronal cells (Enquist et
al., 1998), but also in less polarized cells, as described here,
dynactin and the molecular motor dynein transport HSV1
capsids efficiently along MTs.
Functions of Dynein and Dynactin during HSV1
Capsid Transport?
ATP hydrolysis induces conformational changes in the DHC
head domain, which produce a power stroke toward the MT
minus end, whereas the smaller subunits DIC, DLIC, and
DLC are attached to the stem domain (Habura et al., 1999;
Tynan et al., 2000a), which is involved in cargo binding
(Vaughan and Vallee, 1995; King, 2000; Tynan et al., 2000b).
Dynactin is needed for dynein-mediated vesicle transport
(Gill et al., 1991; Schroer and Sheetz, 1991) and transport of
nonmembranous cargo such as NuMA aggregates, aggre-
somes, adenovirus capsids, neurofilaments, chromosomes,
and pericentrin particles (Merdes and Cleveland, 1997; Gar-
Figure 9. The peripheral accumulation in dynamitin expressing cells requires an intact MT network. In cells overexpressing dynamitin-GFP
(a) or dynamitin, few incoming capsids reach the nucleus, and many accumulate in the peripheral cytoplasm 3 h after infection. If such cells
are infected in the absence of MTs, incoming capsids are distributed randomly over the entire cytoplasm, and there is no peripheral
accumulation (b). Immunofluorescence microscopy of PtK2 cells transfected with dynamitin-GFP or GFP and 46 h later infected with HSV1
for 3 h in the presence of cycloheximide and in the absence (a) or presence (b and c) of nocodazole (ND). Cells were fixed with PFA,
permeabilized with TX-100, and labeled with anti-VP5 (mAb 5C10; bottom panels).
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cia-Mata et al., 1999; Suomalainen et al., 1999; Shah et al.,
2000; Sharp et al., 2000; Young et al., 2000).
Earlier electron microscopy data suggested that dynein
binds with its stem domain to HSV1 capsids (Sodeik et al.,
1997). Our immunofluorescence microscopy data are consis-
tent with either an indirect interaction via dynactin or a
direct binding of HSV1 capsids to dynein. Dynactin might
serve as an initial or permanent anchor for dynein on the
capsid (Echeverri et al., 1996) or tether between MT and
capsid while dynein is detaching from the MT to make its
next step (King and Schroer, 2000). The ATPase activity of
dynein has also been reported to be regulated by dynactin-
dependent phosphorylation (Kumar et al., 2000).
Bidirectional HSV1 Capsid Transport along
Microtubules?
Many subcellular structures and progeny GFP-tagged al-
phaherpes viruses (Smith et al., 2001; Willard, 2002) can
move bidirectionally along MTs. Interestingly, overexpres-
sion of dynamitin did not lead to a random capsid distribu-
tion but to their MT-mediated accumulation in the cell mar-
gins (Figures 7 and 9). This suggested that besides dynein,
HSV1 capsids might also use a plus-end–directed MT mo-
tor. Plus-end–directed capsid motility could be involved in
further transport from the MTOC to the nucleus, as would
be required in cells where the MTOC is not directly neigh-
boring the nucleus. MT-mediated, plus-end–directed capsid
transport could also be involved in apical entry of polarized
epithelial cells (Topp et al., 1996). Moreover, during HSV1
egress from neurons, capsids are transported anterogradely
to the presynapse (Miranda-Saksena et al., 2000; Ohara et al.,
2000). Because of the uniform polarity of MTs in axons, this
transport has to be catalyzed by a plus-end–directed motor.
If capsids were indeed able to travel along MTs in both
directions, to the minus and plus ends, specific signals must
regulate which motor the capsid is supposed to use during
the different steps of the viral life cycle. Thus, the direction
of capsid motility must be tightly controlled. The main
transport direction during virus entry must be to MT minus-
ends to ensure net movement to the cell center and the
nucleus. However, if minus-end–directed, dynein-mediated
transport was inhibited by overexpressing dynamitin, these
putative plus-end–directed motors might have taken over
and transported capsids to the cell margins.
Dynein or Kinesin Receptors Encoded by HSV1
In contrast to other cargo transported along MTs, the protein
composition of HSV1 is known. There are20 tegument and
capsid proteins that could function in motor or dynactin
binding. The HSV1 gene product of UL34 interacts with DIC
in GST pull down assays (Ye et al., 2000). However, because
UL34 has properties of a type-II membrane protein and in
pseudorabies virus is not present in purified virions (Klupp
et al., 2000; Reynolds et al., 2001), it remains to be seen how
its interaction with DIC subunit could participate in viral
capsid transport. The HSV1 tegument protein US11 was
shown recently to interact with the heavy chain of conven-
tional kinesin (Diefenbach et al., 2002). Additional candi-
dates for motor receptors include VP22 (UL49) and UL25,
that both, upon transient transfection, seem to localize to
MTs (Elliott and O’Hare, 1998; Kaelin et al., 2000). In contrast
to VP22 that dissociates from the capsid upon virus entry,
UL25 and also VP1–3 (UL36) remain on the capsid until it
reaches the nucleus (Morrison et al., 1998; Kaelin et al., 2000;
Sodeik, Szmak and Prank, unpublished results).
Reconstitution of MT capsid motility in vitro (Wolfstein,
Do¨hner, Allan and Sodeik, unpublished results) and HSV1
mutants can now be used to identify structural viral proteins
required for capsid targeting to the nucleus.
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Capsids and the enclosed DNA of adenoviruses, including the species C viruses adenovirus type 2 (Ad2) and
Ad5, and herpesviruses, such as herpes simplex virus type 1 (HSV-1), are targeted to the nuclei of epithelial,
endothelial, fibroblastic, and neuronal cells. Cytoplasmic transport of fluorophore-tagged Ad2 and immuno-
logically detected HSV-1 capsids required intact microtubules and the microtubule-dependent minus-end-
directed motor complex dynein-dynactin. A recent study with epithelial cells suggested that Ad5 was trans-
ported to the nucleus and expressed its genes independently of a microtubule network. To clarify the
mechanisms by which Ad2 and, as an independent control, HSV-1 were targeted to the nucleus, we treated
epithelial cells with nocodazole (NOC) to depolymerize microtubules and measured viral gene expression at
different times and multiplicities of infections. Our results indicate that in NOC-treated cells, viral transgene
expression was significantly reduced at up to 48 h postinfection (p.i.). A quantitative analysis of subcellular
capsid localization indicated that NOC blocked the nuclear targeting of Ad2 and also HSV-1 by more than 90%
at up to 7 h p.i. About 10% of the incoming Texas Red-coupled Ad2 (Ad2-TR) was enriched at the nucleus in
microtubule-depleted cells at 5 h p.i. This result is consistent with earlier observations that Ad2-TR capsids
move randomly in NOC-treated cells at less than 0.1 m/s and over distances of less than 5 m, characteristic
of Brownian motion. We conclude that fluorophore-tagged Ad2 and HSV-1 particles are infectious and that
microtubules play a prominent role in efficient nuclear targeting during entry and gene expression of species
C Ads and HSV-1.
Many viruses, including adenoviruses (Ads) and herpesvi-
ruses, spread by intracellular transport within infected host
cells, thus increasing the viral load in target organs and possibly
causing severe disease (44). The 51 human Ad serotypes—
classified into six species (A to F)—have distinct tropisms (19).
For example, Ad type 2 (Ad2) and Ad5 (species C) and Ad3
(species B) are associated with upper-airway infections. Other
serotypes are linked to epidemic keratoconjunctivitis (species
D), pneumonia (species E), enteric infections (species A and
F), or infections of hematopoietic cells (41). The Herpesviridae
family consists of the alpha-, beta- and gammaherpesviruses.
Like Ads, alphaherpesviruses, including herpes simplex virus
type 1 (HSV-1), infect different cell types both in cultures and
in their hosts. After infection of mucosal or damaged cutane-
ous epithelium, these neurotropic viruses establish latent in-
fections, primarily in sensory ganglia, that, upon reactivation,
lead to recurrent epidermal lesions (40, 55). The ability to
infect a broad range of postmitotic cells has made both Ads
and herpesviruses useful gene delivery vehicles (21) that are
currently being evaluated in clinical trials (29, 39). For their
application as therapeutic vectors and to identify new potential
targets for antiviral therapy, it is crucial to understand how the
genomes are targeted to the nucleus.
The entry mechanisms for Ads and herpesviruses have been
well studied. Ads are internalized by receptor-mediated endo-
cytosis that is dependent on F actin and leave the endosomal
pathway at various sites (recently reviewed in reference 11).
The species C Ads, including Ad2 and Ad5, exit from a slightly
acidic compartment of pH 6 at about 10 min postentry (16, 42),
whereas Ad7 (species B) has been reported to escape from
acidic late endosomes and lysosomes (32). In contrast, HSV-1
delivers its capsids into the cytosol upon fusion of the viral
envelope with the plasma membrane (45, 46). Both viruses
then target their capsids to the cell nucleus, uncoat, and inject
the enclosed linear double-stranded DNA genomes through
the nuclear pores into the nucleoplasm for replication (14, 35,
53).
A number of electron microscopy studies have shown that
cytoplasmic capsids of both species C Ads and alphaherpesvi-
ruses can associate with microtubules (MTs) (5, 10, 27, 28, 31,
37, 45, 47, 57). Moreover, time-lapse fluorescence microscopy
experiments of fluorophore-tagged Ads have demonstrated
that Ads move along linear tracks of MTs (25, 26, 49). The
motility of incoming particles is bidirectional, toward and away
from the nucleus, but the overall motilities are toward the
minus ends of MTs and require the major minus-end-directed
motor dynein and the cofactor dynactin. If MTs are depoly-
merized with nocodazole (NOC), then the long-range linear
motilities cease, the remaining short-range transport has no
directional control and, most importantly, the efficiency of Ad2
DNA delivery is strongly reduced, as indicated by fluorescence
in situ hybridization assays (48, 49).
Similar results have been reported for alphaherpesviruses.
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MT-depolymerizing agents block HSV-1 infections in cultures
and in animal models (17, 22, 45, 51, 52). Moreover, incoming
HSV-1 capsids colocalize with dynein and dynactin, and trans-
port to the nucleus is reduced by the dynein inhibitors erythro-
9[3-(2-hydroxynonyl)]adenine and dynamitin (6a, 22, 45). Ax-
onal herpesvirus transport occurs at rates of 0.5 to 3.5 m/s,
with peak velocities of up to 5 m/s (1, 28, 37, 43); viral
structures are transported bidirectionally along linear tracks
with high processivity over distances of up to 20 m, as dem-
onstrated by video microscopy with green fluorescent protein
(GFP)-tagged mutants (1, 43; A. Wolfstein et al., unpublished
data).
In a recent article, it was proposed that Ad5 infections do
not require MTs (8). We therefore decided to conduct a quan-
titative analysis of Ad5-mediated gene expression and Texas
Red (TR)-coupled Ad2 (Ad2-TR) subcellular localization in
cells depleted of MTs; as an independent control, we included
HSV-1. Our results show that the large majority of Ad2-TR,
Ad5, and HSV-1 particles utilize intact MTs to reach the nu-
cleus in order to infect nonpolarized epithelial cells.
MATERIALS AND METHODS
Cells and reagents. Immortalized human adenocarcinoma-derived alveolar
epithelial A549 cells (ATCC CCL-185) were maintained in Dulbecco’s modified
Eagle’s medium (Gibco Invitrogen, Basel, Switzerland) containing 7% Clone III
serum (HyClone; Socochim, Geneva, Switzerland) and 1% nonessential amino
acids, 2 mM glutamine, 100 U of penicillin/ml, and 0.1 mg of streptomycin/ml (all
from Gibco-BRL). PtK2 cells (ATCC CCL-56) and BHK-21 cells (ATCC CCL-
10) were grown in 10% and Vero cells (ATCC CCL-81) were grown in 7.5% fetal
calf serum containing minimal essential medium, 2 mM glutamine, nonessential
amino acids and, for Vero cells, 100 U of penicillin/ml and 100 g of strepto-
mycin/ml. All cell lines were cultured in a humidified 5% CO2–air atmosphere.
NOC (Sigma) and paclitaxel (Calbiochem-Novabiochem or Sigma) were dis-
solved as 1,000-fold stocks in dimethyl sulfoxide (DMSO) and used as indicated
below. For the immunofluorescence experiments, we used preadsorbed rabbit
polyclonal antibodies raised against DNA-containing capsids (anti-heavy chain
[HC]) or empty capsids (anti-light chain [LC]) to detect incoming viral capsids (4,
45). MTs were labeled with a mouse monoclonal antibody against -tubulin
(N357; Amersham, Little Chalfont, United Kingdom) (2).
Ad infection and gene expression. Ad2 was purified and coupled to TR as
described previously to yield Ad2-TR (33). This virus was as infectious as the
nonlabeled parent virus, as determined by plaque assays with A549 cells. The
Ad5 derivative AE18, lacking the E1 and E3 regions, expressed lacZ from the
cytomegalovirus (CMV) major promoter (provided by E. Vigne, Institut G.
Roussy, Villejuif, France) (54). Luc-Ad5, lacking E1 and E3, expressed luciferase
from a CMV promoter inserted into the E1 region (kindly provided by S. Hemmi
and D. Serena, University of Zu¨rich). In brief, this virus was constructed from a
pPoly plasmid backbone (3) and plasmid pTG-H5 DL324 (kindly supplied by S.
Rusconi, University of Fribourg, Fribourg, Switzerland). Cells were seeded in
24-well dishes (Costar; Integra Biosciences) or on glass coverslips 1 to 2 days
before the experiment. Prior to infection, 60 to 90% confluent cells were exposed
to NOC in DMSO or just DMSO alone in Dulbecco’s modified Eagle’s medium
for 1 h and then were infected with AE18 at 100 to 10,000 physical particles per
cell at 37°C. At various times after the addition of the virus, cells were either
analyzed for their viability or lysed, and lysates were assayed for -galactosidase
(-Gal) activity and protein content. -Gal activity was measured by a -Gal
enzyme assay (Promega Corporation). The cells in 1 well of a 24-well dish were
washed with phosphate-buffered saline (PBS) at 7, 24, 32, or 48 h postinfection
(p.i.) and lysed in 400 l of reporter lysis buffer (Promega) for 15 min at room
temperature under slowly rocking conditions. The lysates were centrifuged in a
microcentrifuge at 4°C for 2 min, and 30 l of the supernatants was mixed with
the same volume of 2 enzyme reaction buffer (Promega) and incubated at 37°C
for various times. The reactions were stopped by the addition of 100 l of 1 M
sodium carbonate. The absorbance was read at 420 nm with a spectrophotometer
(MRX microplate reader; Dynatech Laboratories; BioLogics, Gainesville, Va).
The background activity of noninfected A549 cells was subtracted from the
measurements. The protein content of each lysate was measured with Micro
BCA protein assay reagent (Pierce), and the results are expressed as enzymatic
units per milligram of protein per minute. The luciferase activity of infected cells
was determined with cell lysates at 7 h p.i. by using a commercial assay system
(Promega). The cells in 1 well of a 24-well dish were washed with PBS and lysed
in 400 l of reporter lysis buffer. The centrifuged lysates (20 l) were placed in
an opaque 96-well plate for luciferase activity measurements with a Multilabel
Counter (Wallac Victor2 1420; Perkin-Elmer), which injected 50 l of luciferase
assay reagent into each well.
HSV-1 infection and gene expression. Wild-type HSV-1 strain F (ATCC VR-
733) and mutant strain [KOS]tk12 were amplified and purified as described
previously (45). Immediate-early viral gene expression was analyzed by using
mutant [KOS]tk12, which lacks the viral thymidine kinase gene and encodes the
enzyme -Gal under the control of the immediate-early ICP4 promoter of
HSV-1 (kindly provided by P. Spear, Northwestern University, Chicago, Ill.)
(56). PtK2 cells were cultured in 24-well plates at a density of 4  104 to 5  104
cells per well for 1 day. They were pretreated with NOC or paclitaxel in DMSO
or just DMSO alone for 1 h, cooled to 4°C, and incubated with virus for 2 h as
described elsewhere (6a, 45). Unbound virus was removed by repeated washing
in PBS, and the cells were further incubated in culture medium at 37°C.
At different times, the cells were lysed with 0.5% Triton X-100 (TX-100) in
PBS containing 1 mg of bovine serum albumin/ml and protease inhibitors at 37°C
for 15 min. Lysates were then incubated with 3.5 mg of o-nitrophenyl--D-
galactopyranoside/ml in 73 mM Na2HPO4–16 mM NaH2PO4–0.2 mM KH2PO4–
0.4 mM KCl–17 mM NaCl. The enzymatic activity of -Gal was measured after
about 2 h at 420 nm by using a plate reader (Spectra Count microplate photom-
eter; Packard Instrument Company, Meriden, Conn.). On a parallel plate, cells
were fixed with 3% (wt/vol) paraformaldehyde (PFA) in PBS for 20 min, washed
with water, and then stained with 0.25 mg of crystal violet/ml in 5% ethanol for
10 min to quantify the amount of cells present after different treatments. After
several washes in water, the plates were dried, and the bound crystal violet was
dissolved in 100% ethanol and quantified by measuring the optical density at 590
nm (17). Crystal violet staining gave a linear signal over cell concentrations
ranging from at least 3  103 to 3  105 cells per well (data not shown).
Quantification of subcellular viral targeting. To analyze the subcellular dis-
tribution of incoming HSV-1 capsids, Vero or PtK2 cells were infected in the
presence of 0.5 mM cycloheximide. The cells were then (i) fixed with 100%
methanol for 4 min at 20°C after a 10-s preextraction in 0.5% TX-100–80 mM
PIPES-KOH (pH 6.8)–2 mM MgSO4–10 M paclitaxel to visualize MTs and
capsids as described previously (45), (ii) fixed and permeabilized simultaneously
with PHEMO-fix (3.7% [wt/vol] PFA, 0.05% [wt/vol] glutaraldehyde, and 0.5%
TX-100 in PHEMO-buffer [see below]) for 10 min and washed with PHEMO-
buffer (68 mM PIPES-KOH [pH 6.9], 15 mM EGTA, 3 mM MgCl2, 10% DMSO)
to label MTs, or (iii) fixed with 3% (wt/vol) PFA in PBS for 20 min and then
permeabilized with 0.1% (vol/vol) TX-100 for exactly 5 min. The remaining PFA
was inactivated by incubating the cells with 50 mM NH4Cl–PBS for 10 min.
Immunolabeling was performed as described elsewhere (6a, 45). The cells were
examined either with a modified confocal microscope (model MRC600; Bio-Rad
Laboratories, Hercules, Calif.) attached to an Axiovert microscope (Carl Zeiss,
Inc., Thornwood, N.Y.) with separate filters for each fluorochrome or with a
Leica SP1 microscope (63 oil-immersion objective; numeric aperature, 1.32)
with UV excitation at 351 and 364 nm and with fluorescein isothiocyanate (468
nm), TR (568 nm), and long-pass emission filters in sequential recording mode
at a section thickness of 0.5 m. Images were processed with Photoshop 5.0
(Adobe). The subcellular distributions of Ad2-TR and HSV-1 (immunolabeled
with an anti-LC antibody) were determined by quantitative fluorescence micros-
copy of cells fixed with PHEMO-fix by the procedure described earlier (33).
Cell viability assay. Cell viability was assessed with a live/dead viability/cyto-
toxicity two-color fluorescence assay (L-3224; Molecular Probes). This assay
measures intracellular esterase activity with the cell-permeable substrate Cal-
cein-AM, which is converted by live cells to the fluorescent polyanion calcein
(excitation, 495 nm; emission, 515 nm), which is retained in living cells by the
intact plasma membrane. In addition, we used the non-cell-permeating DNA dye
ethidium homodimer-1 (EthD-1) (excitation, 495 nm; emission, 635 nm), which
is detected in cells with compromised membranes, i.e., dead cells. In this assay,
live cells have a green fluorescent cytoplasm but no EthD-1 signal, whereas dead
cells lack green fluorescence and are stained with EthD-1. The assays were
performed by washing cells once with PBS and incubating them with Calcein-AM
(0.8 M for A549 cells and 0.2 M for PtK2 cells) and EthD-1 (0.8 M for A549
cells and 0.1 M for PtK2 cells) in Hanks’ medium (Gibco-BRL) at 37°C for 15
min. Cells were washed with Hanks’ medium, and fluorescence was analyzed with
a Leica inverted fluorescence microscope equipped with a 63 oil-immersion
objective (numeric aperture, 1.32), a band-pass excitation filter, and a double-
pass emission filter as described earlier (49). Images were recorded with Meta-
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Morph software (Universal Imaging Corporation) and batch processed with
Photoshop 5.0.
RESULTS
Glotzer et al. (8) recently suggested that Ad5 infection of the
epithelial cell line A549 occurred in the absence of MTs (8),
contradicting earlier results (26, 49). A reexamination of the
role of MTs in Ad infection was therefore warranted.
NOC is an inhibitor of Ad5 infection. We first analyzed
adenovirus transgene expression in A549 cells containing in-
tact or disrupted MTs. Cells were preincubated with different
concentrations of the MT-depolymerizing agent NOC at 37°C
for 60 min (20) and then were inoculated with -Gal-express-
ing Ad5 (-Gal–Ad5) at 10,000 physical particles per cell,
equivalent to about 300 associated particles per cell (48). The
particle-to-PFU ratio is estimated to be on the order of 20 to
100, corresponding to 3 to 15 bound infectious particles per
cell (18). -Gal activity was measured in cell lysates at 7 h p.i.,
the earliest time point that gave a reliable reading. The lowest
concentration of NOC (0.2 M) had no effect on -Gal ex-
pression, whereas 2 M NOC resulted in 40% inhibition and
20 M NOC resulted in greater than 80% inhibition compared
to the results obtained for untreated cells (Fig. 1A). The latter
conditions are sufficient to completely depolymerize MTs in
Vero cells (45) (Fig. 4A, panel d), HeLa cells (49), or A549
cells (Fig. 2A, panel e), whereas PtK2 cells require 50 M
NOC (data not shown). A549 cells were therefore treated with
20 M NOC, and -Gal activity was measured at 7, 24, and
48 h after inoculation with 1,000 and 10,000 particles per cell.
In both instances, there was a severe reduction of gene expres-
sion, with 85% inhibition at 7 h p.i. and 50 to 70% inhibition at
24 and 48 h p.i. (Fig. 1B). The effect of NOC was reversible, as
indicated by washing the cells with drug-free medium at 180
min p.i. and incubating them for another 4 h in the absence of
drug (Fig. 1C). When NOC was added at 3 h p.i., when a large
fraction of the incoming DNA had been delivered to the nu-
cleoplasm (49, 53), there was only marginal inhibition of viral
gene expression. This result indicated that most of the infec-
tious particles had reached the nucleus at 3 h p.i. In contrast,
when NOC was present throughout the infection, -Gal ex-
pression was reduced by 85% compared to that in control cells.
We next tested the effect of NOC on the gene expression of
a different virus, Luc-Ad5. This strategy enabled us to reduce
the viral load to 10 particles per cell and still measure trans-
gene activity as early as 7 h p.i. Consistent with the -Gal
activity results, 20 M NOC reduced luciferase activity by 50 to
70% at 10, 100, 1,000, or 10,000 particles per cell (Fig. 1D).
Importantly, the assay was linear in this range. We next ana-
lyzed whether NOC affected the viability of the cells either in
the presence or in the absence of -Gal–Ad5. Cells were pre-
treated with NOC (20 M) for 1 h, infected or not infected
with Ad5, and then stained with the vital dyes Calcein-AM and
EthD-1. Intact live cells excluded EthD-1 and cytosolic ester-
ases hydrolyzed Calcein-AM, thus generating green fluores-
cent Calcein. All cells on the coverslip were EthD-1 negative
and Calcein positive (Fig. 1E, panels a to f), unlike cells that
had been treated with methanol (Fig. 1E, panels g to i). Im-
portantly, there was no cell loss from the coverslips, as verified
by differential interference contrast imaging (Fig. 1E, panels c,
f, and i).
NOC blocks the nuclear accumulation of Ad2-TR. If NOC is
an early inhibitor of Ad5 infection, then it could have an effect
on genome trafficking. To visualize cytoplasmic particles, we
used fluorescent Ad2-TR containing two to four TR molecules
per hexon trimer, corresponding to 200 to 400 TR molecules
per virion (13, 33). Importantly, this virus is as infectious as
unlabeled virus and is not aggregated, as judged by electron
microscopy of negatively stained particles and population anal-
ysis of viral fluorescence (33). A recent study showed that the
DNA genome of purified Ad2 separates from the capsid at the
nuclear pore complex (NPC) and that the remainder of the
capsid tends to form aggregates or becomes undetectable (53).
A549 cells were treated with different concentrations of NOC
as described above, and Ad2-TR was bound to the cell surface
at 4°C for 1 h to synchronize the infection at 37°C in the
presence or in the absence of the drug. One set of cells was
fixed at 75 min p.i. and stained for MTs. Clearly, increasing
amounts of NOC progressively depolymerized MTs (Fig. 2A),
whereas DMSO alone had no effect on the morphology of the
MT network. By use of a fast Fourier transformation algo-
rithm, viral fluorescence was quantitated in the cell periphery,
the cytoplasmic area, and the nucleus, including a perinuclear
region of 1.5 m (33). While control cells had low peripheral
and cytoplasmic but high nuclear fluorescence signals (less
than 1 but more than 5 fluorescence units per unit area,
respectively), 20 M NOC-treated cells showed almost no
nuclear accumulation of Ad2-TR (1.6 fluorescence units per
unit area); instead, there was a significant increase in the pe-
ripheral and cytoplasmic fluorescence intensity (P 0.01) (Fig.
2B).
We next carried out a time course experiment either in the
absence or in the presence of 20 M NOC. As expected, the
nuclear and perinuclear fluorescence of control cells increased
to greater than 5 fluorescence units per unit area at 75 min p.i.
compared to 1 unit at 0 min p.i., while the peripheral and
cytoplasmic Ad2-TR fluorescence decreased to less than 0.2
unit (Fig. 2C). At 150 min, however, the viral capsid load in the
nuclear and perinuclear area decreased to less than two, in-
dicative of viral disassembly, which peaks at between 150 and
180 min p.i. (14, 53). The strong decrease in nuclear Ad2-TR
particles coincided with a robust increase in peripheral and
cytoplasmic virus, suggesting that viral capsids or fragments
were transported back to the periphery. Interestingly, the nu-
clear fluorescence increased again at 300 and 420 min p.i. (P 
0.05) and the peripheral fluorescence decreased. These results
suggested a second transport wave of Ad2-TR toward the
nucleus. This experiment confirms that in control cells, our
measurements of fluorescent capsids are quantitative at least
until 75 min p.i., the onset of capsid disassembly.
The subcellular virus distribution in NOC-treated cells was
fundamentally different from that in control cells. At up to 150
min p.i., the viral capsid load in the nuclear and perinuclear
region was no different from the charge at 0 min p.i.; i.e., there
was no enrichment of Ad2-TR near the nucleus (Fig. 2D). The
virus concentrations in the cytoplasm and the periphery were
slightly reduced. Interestingly, we found a small but significant
accumulation of Ad2-TR near the nucleus (P  0.01) at 300
min p.i. Approximately 10% of the viral fluorescence appar-
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FIG. 1. Ad5-mediated gene expression requires intact MTs. (A to D) A549 cells were not treated or treated with the indicated concentrations
of NOC for 1 h and then infected with -Gal–Ad5 (A to C) or Luc-Ad5 (D) for the indicated times at 37°C. Gene expression was normalized to
that of drug-free infected cells (A and B) or is reported as enzymatic units per milligram of protein per minute (C) or relative light units (D) at
room temperature. The reversibility of the effects of NOC was tested by washing out the drug at 180 min, and the postentry effects of NOC were
assessed by adding the drug at 180 min p.i. (C). Error bars indicate standard errors of the means. (E) Toxicity of NOC for -Gal–Ad5-infected
cells (a to c) and noninfected cells (d to f) at 7 h p.i. with ethidium bromide (a, d, and g) and calcein (b, e, and h) staining and with Nomarksi (Nom)
differential interference contrast imaging (c, f, and i). Note that dead cells were EthD-1 positive and calcein negative; see, e.g., methanol (MetOH,
70% for 30 min)-treated cells (g to i). NOC-treated or infected cells were all alive. Bar, 40 m.
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ently reached the nucleus in the absence of MTs. At least some
nuclear capsids must have been genome-containing particles,
since we detected viral gene expression in the presence of NOC.
The reduction in the nuclear capsid signal at 420 min p.i. might
have been due to capsid disassembly. In summary, these results
indicate that more than 90% of the incoming Ad2-TR did not
reach the nucleus in the absence of MTs and that this transport
block strongly reduced viral gene expression.
FIG. 2. NOC blocks nuclear targeting of Ad2-TR in A549 cells. Ad2-TR was cold bound to A549 cells not pretreated or pretreated with
different concentrations of NOC. Cells were warmed for the indicated times at 37°C in the presence or in the absence of NOC and then fixed with
PHEMO-fix. (A) Entire set of projected confocal laser scanning microscopy sections of representative cells depicting Ad2-TR (red), MTs (green),
and the nucleus (4,6-diamidino-2-phenylindole; dark blue). Note the disappearance of the MTs with increasing concentrations of NOC and the
lack of nuclear accumulation of Ad2-TR. Bar, 10 m. (B) Quantification of the subcellular localization of Ad2-TR in the periphery, the cytoplasm,
and the nuclear and perinuclear region of cells treated with different concentrations of NOC (n, number of cells analyzed). (C) Quantification of
the subcellular localization of Ad2-TR in A549 control cells over time. Note that the nuclear transport of Ad2-TR peaks at 80 to 90 min p.i., with
corresponding reductions in peripheral and cytoplasmic particles. (D) Quantification of the subcellular localization of Ad2-TR in the absence of
MTs (NOC treatment). Note the lack of nuclear transport at times before 200 min p.i. and the slight increase in nuclear accumulation at 300 min
p.i. Error bars indicate standard errors of the means.
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NOC blocks HSV-1-mediated gene expression. MTs are a
major intracellular trafficking route of alphaherpesviruses. We
therefore tested the effect of NOC on HSV-1 gene delivery
using the expression of -Gal activity controlled by the viral
immediate-early promoter of ICP4. PtK2 cells were pretreated
with different concentrations of NOC, incubated with HSV-1
[KOS]tk12 in the cold, infected in the presence or in the
absence of drug at 37°C for 4 h, and analyzed for -Gal activity.
The results clearly indicate that NOC is a dose-dependent
inhibitor of HSV-1 infection (Fig. 3A). The maximal inhibition
of approximately 90% was obtained with 25 M NOC. This
effect was due neither to cell loss, as indicated by cell quanti-
fication with crystal violet, nor to cell death, as measured by the
live/dead assay (data not shown). We next analyzed the effect
of 25 M NOC on HSV-1 infection in a time course experi-
ment at multiplicities of infection (MOIs) of 2 and 10 from 3 to
7 h p.i. Under all conditions, NOC inhibited viral gene expres-
sion in the range of 80 to 90% (Fig. 3B). However, the inhi-
bition was not complete. At an MOI of 10, there was a modest
increase in gene expression from 3 to 7 h p.i., indicating that a
small fraction of infectious virus had reached the nucleus in-
dependently of MTs.
NOC inhibits nuclear targeting of incoming HSV-1. We next
tested to what extent NOC affected MTs. Vero cells were
preincubated with different concentrations of NOC for 1 h,
incubated in the cold with HSV-1, and warmed in the presence
or in the absence of drug for 2 h. The highest concentration of
NOC (20 M) completely depolymerized MTs and led to a
random cytoplasmic localization of HSV-1 capsids (Fig. 4A,
panel d). In the absence of drug, however, the MT network was
intact and incoming HSV-1 localized predominantly to the
nucleus (Fig. 4A, panel a). Intermediate concentrations of
NOC (0.4 and 2 M) had partial effects on MTs and HSV-1
nuclear targeting (Fig. 4A, panels b and c).
To assess the effect of NOC on the subcellular trafficking of
HSV-1, we quantitated viral capsid fluorescence in the periph-
ery, the cytoplasm, and the nuclear and perinuclear region by
using the same method as that used for Ad2-TR. In the ab-
sence of drug, there was a strong enrichment of HSV-1 near
the nucleus and a significant decrease in the peripheral and
cytoplasmic viral load at 120 and 180 min p.i. (P  0.01) (Fig.
4B). NOC, however, blocked the nuclear accumulation as well
as the cytoplasmic reduction of HSV-1 at 120 and 180 min p.i.,
compared to the results obtained at 30 min p.i., but did not
affect the reduction of virus in the periphery (Fig. 4C). These
results suggested that viral trafficking through the cortex was
independent of MTs, unlike further cytoplasmic transport,
which largely required intact MTs. This conclusion was further
supported by experiments with the MT-stabilizing drug pacli-
taxel (10 M), which allowed a strong enrichment of HSV-1
near the nucleus, although this enrichment was slightly less
pronounced than that in drug-free cells. Accordingly, paclitaxel
had only minimal effects on the expression of -Gal (average
inhibition, 20 to 30%). Significantly, paclitaxel did not inhibit
the transport of virus through the cell periphery (Fig. 4D). We
conclude that HSV-1 capsid transport occurs on stabilized
MTs, suggesting that it does not depend on MT treadmilling or
dynamic instability.
DISCUSSION
Using quantitative subcellular localization of incoming viral
capsids and quantification of viral gene expression in the ab-
sence or in the presence of NOC, an MT-depolymerizing
agent, we found that MTs play a crucial role in delivering Ad
and HSV-1 genomes to the nuclei of epithelial cells. The NOC
inhibition was reversible (45, 49; this study), NOC had no effect
on cellular gene expression (data not shown), and only minor
FIG. 3. Intact MTs are required for HSV-1 mediated gene expres-
sion. (A) PtK2 cells were treated with DMSO (control) or NOC for 1 h
at 37°C and then incubated with the -Gal-expressing HSV-1 strain
[KOS]tk12 at 4°C for 2 h (MOI, 10). The unbound viruses were re-
moved, and the cells were shifted to 37°C in the presence or in the
absence of NOC to initiate infection. Cells were lysed at 4 h p.i., and
the amount of -Gal was quantitated (squares). Cells on parallel
dishes were quantified by using the binding of crystal violet (circles).
The means and standard deviations for duplicate samples are shown.
Note that with increasing NOC concentrations, the amount of imme-
diate-early viral gene expression was inhibited. (B) Time course of
HSV-1 gene expression. Cells were infected in the absence (filled
symbols) or in the presence (open symbols) of MTs with HSV-1
[KOS]tk12 (MOI of 2 [triangles] or MOI of 10 [squares]), lysed at
different times p.i., and analyzed for -Gal expression (absorbance at
420 nm). At both MOIs and at all times tested, NOC clearly reduced
immediate-early viral gene expression. The crystal violet assay showed
no significant loss of cells under these conditions (5%) (data not
shown).
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FIG. 4. NOC inhibits the nuclear targeting of HSV-1 in Vero and PtK2 cells. (A) Vero cells were infected in the absence or in the presence
of different concentrations of NOC with 50 PFU of HSV-1 per cell for 2 h and then fixed in methanol after preextraction. Samples were stained
with anti-HC (green) and antitubulin (red) and analyzed by confocal laser scanning microscopy. Note the disappearance of the MTs with increasing
concentrations of NOC and the lack of nuclear HSV-1 capsids. (B to D) Quantification of subcellular localization of HSV-1 in PtK2 cells infected
with 80 PFU per cell in the absence of drug (B), in the presence of 50 M NOC (C), or in the presence of 10 M paclitaxel (D). Cells were fixed
at 30, 120, or 180 min p.i. and labeled with anti-LC. n, number of cells. Error bars indicate standard errors of the means. MTs in Vero cells were
completely depolymerized at lower concentrations of NOC than were those in PtK2 cells (data not shown).
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effects on viral gene expression after particle transport to the
nucleus had occurred (this study). We therefore concluded, as
others have before, that NOC is not a general inhibitor of
transcription or translation but acts predominantly on the MT
network (20).
MTs are required for viral capsid transport. There are sev-
eral explanations for why NOC treatment did not completely
inhibit the delivery of viral DNA into the nucleus. Virions can
enter from the plasma membrane proximal to the nuclear
envelope. These particles are separated from the nucleus by
only a few micrometers. Another possibility is that cytosolic
virions use an MT-independent transport mechanism, such as
an actin-based system (36, 38); that they are transported on
short, randomly oriented MT filaments resistant to NOC; or
that they exploit diffusion. All of these processes would stop
when the capsid binds to the NPC, leading to particle enrich-
ment at the nucleus. Clearly, Ad2-TR particles are able to
explore a few micrometers of cytosolic space in the absence of
MTs (8, 49); thus, particles entering from the plasma mem-
brane proximal to the nucleus will most likely not require MTs
to reach the NPC. This means that careful kinetic measure-
ments are necessary to reveal the role of any cytoplasmic trans-
port system.
We predict that cells that are particularly small will be in-
fected in the absence of MTs if enough time is allowed. This
scenario may, in fact, have obscured the role of MTs in Ad
infection (5, 50). Our measurements here reveal that nuclear
transport of both Ad2 and HSV-1 from distal areas to the
nucleus is blocked in the absence of MTs. Since HSV-1 infec-
tion of polarized neuronal cells in a compartmentalized culture
absolutely depends on MTs (22), the results obtained with
HSV-1 confirm that the quantitative imaging procedures that
we used for Ad2 and HSV-1 are reliable. The role of MTs in
cytoplasmic particle trafficking is in agreement with the results
of studies of endocytic and exocytic membrane traffic and ax-
onal transport, where NOC was found to be a kinetic rather
than an absolute inhibitor of membrane traffic (9, 24).
Capsid transport and viral gene expression required neither
MT treadmilling nor the dynamic instability of MTs, since
paclitaxel (at concentrations of 180 nM to 10 M) had only
slight effects on Ad2 and HSV-1 infections. Likewise, cells
expressing MAP4, which stabilizes the MT network (34), trans-
ported Ad2 to the nucleus even faster than control cells (49);
low concentrations of paclitaxel or NOC (5 nM), suppressing
MT dynamics without depolymerizing MTs, have similar ef-
fects (6, 7). Thus, preferentially stabilized MTs effectively sup-
port viral transport to the nucleus. A further indication that
Ad2 utilizes MTs for nuclear targeting came from experiments
in which transport directionality was controlled. Ad2 was
found to stimulate two distinct signaling pathways which both
enhance the MT-dependent minus-end-directed transport of
Ad2 capsids (48). In the absence of stimulation, viral motility
was directed toward the cell periphery, dependent on intact
MTs.
Live imaging of MT-dependent and independent Ad trans-
port. Glotzer et al. (8) recently questioned the role of MTs in
Ad5 infection. They traced incoming Ad5 that contained a
GFP-tetracycline repressor fusion protein (GFP-TetR) bound
to operator sequences in the Ad5 DNA genome but were not
able to detect fast retrograde motions of GFP-TetR-tagged
Ad5, unlike other reports with fluorophore-tagged Ad (26, 48,
49).
There are several not mutually exclusive possibilities for why
Glotzer et al. (8) missed the fast minus-end-directed motility of
Ad. The first possibility involves temperature. Glotzer et al. (8)
used room temperature for their live experiments, whereas we
always conducted our live experiments at 37°C with a temper-
ature-controlled sample holder. The second possibility involves
longer intervals between subsequent frames. While we re-
corded frame intervals of 1 to 2 s, Glotzer et al. (8) used frame
intervals of 3 to 5 s. Longer intervals make it less likely that
high-speed elementary motion steps will be detected. The third
possibility involves imaging with PBS. For their tracing exper-
iments, Glotzer et al. (8) used PBS lacking glucose and other
nutrients, whereas we used growth medium without serum
(and sometimes also without phenol red). Depending on the
duration of the incubation, PBS may reduce the ATP levels in
the cells. Interestingly, the vast majority of the particles (about
15 to 20 particles, corresponding to about 95%) in the study of
Glotzer et al. (8) were apparently nonmotile during the 14-s
period depicted in their Fig. 4A. This result is again in contrast
to our imaging of 40 to 60% motile particles (7, 48, 49). The
fourth possibility involves imaging at shorter wavelengths and
longer exposure times. Glotzer et al. (8) used GFP-tagged Ad
and thus had to use an excitation beam of about 500 nm. Their
exposure times were between 1 and 1.5 s, whereas our expo-
sure times were between 0.2 and 0.4 s, i.e., four or five times
shorter and thus less phototoxic. The published images in the
study of Glotzer et al. (8) demonstrate photobleaching effects
after as few as five frames (their Fig. 4A). Phototoxicity is
known to affect the viability of cells; thus, their results are
difficult to compare with our data. We imaged the TR fluoro-
phore with a 595-nm excitation and were able to record several
hundred subsequent frames (48, 49). The fifth possibility in-
volves statistical analysis. Due to the limited data set that
Glotzer et al. (8) were able to collect, their statistical analysis
was limited. They processed between 20 and 218 frames per
assay, whereas we included several thousand frames per assay.
Thus, our standard deviations of the mean are smaller and the
differences between various conditions (e.g., plus or minus
NOC) are highly significant for our measurements (one-sided
t tests). The sixth possibility involves the subcellular area of
particle tracing. Figure 4 in the study of Glotzer et al. (8) shows
that 8 out of 11 traced particles were in a region proximal to
the nucleus, i.e., separated by less than 10 m from the nuclear
envelope. The perinuclear region is known to be elevated com-
pared to the flat periphery. Motility in this region can also
occur along the z axis and thus toward and away from the
detector; i.e., the observed velocities in the perinuclear region
might have been underestimated. Many studies, including ours,
have therefore traced organelles (23) and viruses (reviewed in
reference 12) in the peripheral flat regions of the cytoplasm
and have used cells that are extensively spread out (see, e.g.,
reference 30). The final possibility involves the nature of GFP-
TetR-tagged Ad particles. Glotzer et al. (8) used GFP-TetR-
tagged Ad5 in which GFP-TetR was bound to operator se-
quences in the genomic DNA. Using biochemical assays, they
demonstrated that the tag cofractionated with a viral DNA
binding protein at 30 min p.i., but the stability of this interac-
tion later in infection was not characterized. It is also unclear
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what fraction of the particles was recovered in their analysis at
30 min p.i., since the control fractionation sample at 0 min p.i.
was missing. They then performed all their fluorescence mo-
tility experiments at times between 30 and 80 min p.i.; thus, it
is unknown whether the tag was in fact still on the viral particle.
That the tag could prematurely dissociate from the DNA was
suggested by their observations that GFP-TetR was not found
to be imported into the nucleus but that viral DNA was ap-
parently imported. In addition, it is not known whether the
tagged DNA was completely packaged into the virion. If pack-
aging was incomplete, then it is possible that some of the DNA
dissociated from the capsid prior to capsid arrival at the nu-
cleus. The dissociated DNA might or might not have been
tagged with GFP-TetR and thus might have appeared as flu-
orescent puncta. It is likely that these puncta would have had
motilities different from those of our Ad2-TR.
Besides these important technical differences in the live flu-
orescence experiments, another major difference between the
study of Glotzer et al. (8) and our study is the effect of NOC on
the movement of particles to the nucleus. Glotzer et al. (8)
found no effect of NOC on the movement of GFP-TetR-
tagged Ad DNA. Given the limitations of their tracing exper-
iments, this result is not surprising. Glotzer et al. (8) measured
slow short-range transport in both control and NOC-treated
cells, i.e., MT-independent transport. Their static analysis,
however, showed that GFP-TetR-tagged particles were found
at the microtubule organizing center at 30 to 40 min p.i. when
MTs were present but not when they were absent. This finding
fully agrees with our findings and further supports the notion
that the live analyses of Glotzer et al. (8) had technical limi-
tations obscuring the detection of fast motility steps.
It is important that the fluorescent dots that we detected
with Ad2-TR correspond to single viral particles that have the
same infectivity as their “parental” nonlabeled particles (33).
Quantitative subcellular localization of capsids in static images
indicated that in control cells, about 65% of the Ad2-TR ac-
cumulates over the nuclear and perinuclear region at 90 min
p.i. (33). This finding is in good agreement with the Ad2-TR
motilities in epithelial and fibroblastic cells (e.g., HeLa cells,
rat kangaroo PtK2 cells, African green monkey TC7 cells, or
mouse embryo fibroblasts), which are biased toward the nu-
cleus and have net population speeds on the order of several
micrometers per minute (48, 49). Elementary motility events
were between 0.2 and 0.4 m/s and reached minus-end-di-
rected peak velocities of up to 2.6 m/s. Moreover, capsids
were transported over short ranges as well as long distances,
consistent with processive motor-driven motility. Overexpres-
sion of the p50 subunit of the dynactin complex or antidynein
antibodies indicated that the minus-end-directed MT motor
complex dynein-dynactin has a key function in transporting
Ad2 as well as HSV-1 to the nucleus (6a, 26, 49). We conclude
that MTs are instrumental for the trafficking of Ad2 and
HSV-1 particles to the nucleus.
NOC inhibits Ad and HSV-1 infections. Consistent with a
role of MTs in transporting infectious DNA to the nucleus, we
found viral gene expression to be significantly inhibited in cells
lacking MTs. These cells remained on the substratum and
showed no signs of leakiness, i.e., cell death. With different
viruses (Ad2, Ad5, and HSV-1), different cell lines (Vero,
PtK2, A549, and HeLa), different MT-depolymerizing agents
(vinblastine [45] and NOC [this study]), different genes (ICP4,
-Gal, and luciferase [45; this study]), different promoters
(HSV-1 ICP4 and CMV immediate early), and different MOIs
(from 2 to 100 PFU/cell), viral gene expression was in all
instances found to be inhibited by 50 to 90%.
Our results again contrast those of Glotzer et al. (8). These
authors reported data suggesting that NOC had no effect on
the expression of luciferase from transgenic Ad5 or on infec-
tion, as estimated by counting of immunostained cells express-
ing the immediate-early viral protein E1A. NOC also appeared
to have no effect on GFP expression encoded by Ad5, as
determined by counting of green fluorescent cells. While the
percentage of fluorescent cells can be easily determined, the
fluorescent signal may not be linear over a wide range of
protein concentrations. Measuring an enzymatic activity, such
as luciferase or -Gal, however, allows for unambiguous quan-
tification if the assay is performed within the linear range of
the enzymatic activity. Glotzer et al. (8) reported that 1,000
particles per cell gave an average of about 102 luciferase light
units at 4 h p.i., whereas 10 times as much virus (10,000 par-
ticles per cell) resulted in 5  104 light units. This value is
50-fold more than what would be expected if the measure-
ments followed linear kinetics. Moreover, there was essentially
no increase in the luciferase signal from 6 to 24 h p.i. with
10,000 particles per cell, suggesting that the assay had been
saturated.
In summary, we conclude that intact MTs and their associ-
ated motors support the transport of infectious Ad and HSV-1
particles to the nucleus and thereby enhance the kinetics of
infection. Based on earlier results (14, 15, 35, 45, 53), we argue
that the Ad and HSV-1 genomes remain enclosed in capsids
during their cytosolic passage to the nucleus. Only when these
capsids arrive at the NPC will they be disassembled and their
DNA released and imported into the nucleus for transcription
and replication.
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Abstract. 
 
Cytoplasmic dynein together with its cofactor dynactin transports incoming herpes 
simplex virus type 1 (HSV1) capsids along microtubules (MT) to the MT-organizing center 
(MTOC). From the MTOC, capsids move further to the nuclear pore where the viral genome 
is released into the nucleoplasm. The small capsid protein VP26 can interact with dynein 
light chains, and may recruit dynein to the capsid. Therefore, we analyzed nuclear targeting 
of incoming HSV1-∆VP26 capsids devoid of VP26, and of HSV1-GFPVP26 capsids 
expressing GFPVP26 instead of VP26.  
To compare the cell entry of different strains, we characterized the inocula by plaque 
titration, viral DNA content, protein composition, and particle composition. Preparations with 
a low particle to PFU ratio and efficient nuclear targeting were considered to be of higher 
quality than those containing many defective particles which were unable to induce plaque 
formation. When cells were infected with HSV1-wildtype, HSV1-∆VP26 or HSV1-
GFPVP26, viral capsids were transported along MT to the nucleus. Moreover, when dynein 
function was inhibited by overexpression of the dynactin subunit dynamitin, less capsids of 
HSV1-wildtype, -∆VP26 and -GFPVP26 arrived at the nucleus. Thus, even in the absence of 
the potential viral dynein receptor VP26, HSV1 used MT and dynein for efficient nuclear 
targeting. These data suggest that besides VP26, HSV1 encodes other receptors for dynein or 
dynactin. 
 
 
Abbreviations. 
DHC, dynein heavy chain; DIC, dynein intermediate chain; HSV1, Herpes Simplex Virus 
Type 1; GFP, green fluorescent protein; mAb, monoclonal antibody; MOI, multiplicity of 
infection; MT, microtubule; MTOC, MT organizing center; pAb, polyclonal antibody; PFU, 
plaque forming units; VP26, viral protein 26; wt, wildtype. 
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Introduction.  
Virions, subviral particles and viral proteins are actively transported during cell entry, 
assembly and egress (15, 51, 58, 61). Early in infection many viruses use microtubules (MT) 
for efficient nuclear targeting, either for cytosolic transport of naked viral particles, or for 
transport inside vesicles (14), e.g. herpes simplex virus type 1 (HSV1) (62), human 
cytomegalovirus (46), human immunodeficiency virus (38), adenovirus (33, 65), 
parvoviruses (57, 64), simian virus 40 (49), influenza virus (32) or hepatitis B virus (23). 
MT are polar cytoskeletal filaments assembled from α-/β-tubulin with a very dynamic 
plus- and a less dynamic minus-end. N-type kinesins carry cargo towards the MT plus-ends, 
and are involved in transport of viral particles to the plasma membrane during egress (28, 30, 
52, 72). Cytoplasmic dynein in cooperation with its cofactor dynactin or C-type kinesins 
catalyze transport towards MT minus-ends (48, 56, 70). In many cell types, the MT minus-
ends are clustered at the MTOC that is often in close proximity to the nucleus. Cytoplasmic 
dynein is required for nuclear targeting of human immunodeficiency virus reverse 
transcription complexes (38), and capsids of adenovirus (33, 65), canine parvovirus (64) and 
HSV1 (16). 
The HSV1 virion consists of four structural components: a double-stranded DNA genome 
of 152 kbp, a capsid shell with a diameter of 125 nm, the tegument, and a membranous 
envelope (53). The major morphological units of the icosahedral capsid are (i) the UL6 
master portal at one of the 12 vertices, (ii) 11 pentons at the remaining vertices made by 5 
copies of the major capsid protein VP5, and (iii) 150 hexons at the capsid edges and surfaces, 
that contain 6 copies of each, VP5 and the small capsid protein VP26 (42, 53, 67, 76). 
Moreover, all herpesviruses are characterized by a protein layer named tegument that consists 
of about 20 different polypeptides, which is located between the envelope and the capsid. The 
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bulk of the tegument is not icosahedrally ordered, but a small portion in the vicinity of the 
vertices shows icosahedral symmetry (27, 78). 
HSV1 infects many cell types by pH-independent fusion of the viral envelope with the 
plasma membrane, thereby inserting envelope proteins into the plasma membrane, and 
releasing the tegument and the DNA-containing capsid into the cytosol (25, 43-45, 62). In 
addition, some cell types are productively infected after entry by endocytosis, and fusion with 
the membrane of an early endosomal compartment (25, 41, 43-45). In epithelial and neuronal 
cells, the incoming capsids are transported along microtubules (MT) to the MTOC (31, 35, 
62, 66). From the MTOC capsids proceed to nuclear pores, where the viral genomes are 
injected into the nucleoplasm for viral transcription and replication (2, 47, 62).  
Incoming HSV1 capsids colocalize with dynein and its cofactor dynactin (16, 62). 
Moreover, blocking dynein function by overexpression of the dynactin subunit dynamitin 
inhibits capsid transport to the nucleus and immediate-early viral gene expression (16). 
Cytoplasmic dynein consists of two dynein heavy chains, two dynein intermediate chains, 
two dynein light intermediate chains and several dynein light chains (70). The small HSV1 
capsid protein VP26 can interact in vitro with the 14 kDa dynein light chains of the Tctex 
family (17). MT mediated nuclear targeting is considered to be essential for HSV1 in cells 
such as neurons, where the presynaptic plasma membrane is located far away from the 
nucleus (31). However in epithelial cells, depolymerization of the MT network inhibits HSV1 
infection significantly but not completely (35, 62). Thus, a structural viral protein that is not 
essential for virus replication such as VP26 (12) may be responsible for the recruitment of 
dynein or dynactin to incoming capsids.  
To study the viral requirements for HSV1 capsid transport during cell entry, we analyzed 
the nuclear targeting of incoming HSV1-∆VP26 deleted for VP26 (12), and also of HSV1-
GFPVP26 that expresses a fusion protein of green fluorescent protein (GFP) and VP26 
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instead of VP26 (13). The GFPVP26 fusion protein does not interfere with virus replication 
in tissue culture, and is incorporated into virions during capsid assembly (13). When cells 
were infected with HSV1-∆VP26 or HSV1-GFPVP26 preparations of high quality, cytosolic 
capsids distinguished from endocytosed virions by the lack of colocalization with viral 
membrane antigens accumulated at the nuclear envelope in a MT-dependent manner. 
Furthermore, interfering with dynein function by overexpression of the dynactin subunit 
dynamitin reduced nuclear targeting of both, HSV1-∆VP26 and HSV1-GFPVP26. Thus, even 
in the absence of the potential viral dynein receptor VP26, HSV1 used MT and 
dynein/dynactin for efficient nuclear targeting. Therefore, besides VP26 other HSV1 proteins 
must be able to recruit dynein either directly or via its cofactor dynactin to the incoming 
capsids for MT transport.  
 
Materials and Methods.  
Cells and primary antibodies. BHK-21 cells (ATCC CCL-10) and PtK2 cells (ATCC 
CCL-56) were grown in 10%, Vero cells (ATCC CCL-81) in 7.5% fetal calf serum 
(Invitrogen, Paisley, UK). All media contained Eagle´s MEM with 2 mM glutamine and non-
essential amino acids (Cat.-No. 04-08510; Cytogen, Sinn, Germany). Several structural 
herpes virus proteins were detected by the anti-HSV1 rabbit polyclonal antibody (pAb) 
Remus V (47), the major capsid protein VP5 by the rabbit pAb NC-1 (8) or the mouse 
monoclonal antibodies (mAbs) LP12, 5C10 or 8F5 (50, 69), US11 by mouse mAb #28 (54), 
VP16 by rabbit pAb SW7 (73), VP13/14 by rabbit pAb R220 (74). The membrane proteins 
gB and gD were immunolabeled by rabbit pAb R68 or mouse mAb DL6, respectively (19, 
20), the immediate early protein ICP0 by mouse mAb 11060 (21), and vimentin using the 
mouse mAb V9 (Boehringer, Mannheim, Germany). VP26 was visualized with a rabbit pAb 
generated against His6-tagged VP26 (provided by A. Helenius, ETH, Schweiz). To monitor 
Döhner, Schmidt, Radtke, and Sodeik, 2005; Manuscript in preparation for Journal of Virology 6
incoming viral capsids we used pre-adsorbed (62) rabbit pAbs raised against DNA-
containing (anti-HC) or empty capsids (anti-LC; (8).  
Preparation of inocula. Concentrated stocks containing secreted, extracellular virions of 
HSV1-wt strain F (ATCC VR-733), HSV1-wt strain KOS (ATCC VR-1493), HSV1-∆VP26 
strain KOS expressing β-galactosidase instead of the small capsid protein VP26 (K∆26Z; 
(12), or HSV1-GFPVP26 strain KOS in which VP26 had been replaced by GFPVP26 
(K26GFP; (13) were essentially prepared as described (62) but using linear nycodenz (Axis-
shield PoC, AS, Oslo, Norway) instead of sucrose gradients. Secreted extracellular viral 
particles were pelleted from the medium of cells infected with an MOI (multiplicity of 
infection) of 0.01 PFU per cell for two days for HSV1-wt or three days for HSV1-∆VP26 and 
HSV1-GFPVP26. The resuspended sediment was layered on top of a 10 to 40 % (w/v) 
nycodenz gradient in MNT buffer (20 mM MES, 100 mM NaCl, 30 mM Tris, pH 7.4) and 
spun at 50,000 x g for 2 h at 4°C (55). The virus band in the middle of the gradient was 
harvested, snap frozen and stored in single-use aliquots at -80 °C. 
We obtained the best virus preparations, as defined by low particle and low viral genome 
to PFU ratios, when we harvested at an early time point when nearly all cells were rounded, 
but only detached from the substrate after knocking them off, and when we used nycodenz 
instead of sucrose gradients. Due to its high osmotic strength, sucrose may induce shrinking 
of the enveloped viral particles upon entering the gradient, and abrupt swelling and even 
rupture upon diluting the virus-containing sucrose band in the inoculating medium. 
In addition, we characterized the supernatants of infected cells stored at 4°C for 2 to 5 
days without further concentration. Since we analyzed HSV1 mutants attenuated in the 
efficiency of assembly and egress compared to HSV1-wt (12, 13), virus was not harvested 
from cells infected at a very low MOI as described by Everett et al. (22), but from cells 
synchronously infected with an MOI of 3 PFU per cell. However, these supernatants 
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contained a higher proportion of particles deficient in efficient nuclear targeting than virus 
preparations purified on nycodenz gradients, and therefore the latter were used for all 
experiments described here except for Fig. 2A and Fig. 5. All virus preparations were plaque 
titrated on Vero cells (16, 62).  
Real time detection PCR. Gradient purified virions were diluted 1,000-fold in DNase I 
reaction buffer (10 mM Tris-HCl, pH 7.5, 2.5 mM MgCl2, 0.5 mM CaCl2) to a final volume 
of 495 µl. To determine the amount of viral DNA protected in capsids and virions, the 
samples were incubated either without or with 5 units of protease-free DNase I (ABgene, 
Epsom, UK) for 30 min at 37°C, and then further for 10 min at 75°C to inactivate the DNase. 
25 µg salmon sperm DNA (Invitrogen) was added as carrier subsequent to DNase I 
inactivation. After the DNA had been purified using the QIAamp DNA Blood Mini Kit 
(Qiagen, Hilden, Germany), a real time detection PCR was performed using the 
LightCycler® FastStart DNA Master HybProbe kit (Roche Diagnostics, Mannheim, 
Germany),  
the forward sense primer 5´-CCACGAGACCGACATGGAGC-3´,  
the reverse antisense primer 5´-GTGCTYGGTGTGCGACCCCTC-3´, 
the fluorescein coupled donor probe 5´-TGTTGGCGACTGGCGACTTTG-3´-fluorescein 
and, the R640 coupled acceptor probe R640-5´-TACATGTCCCCGTTTTACGGCTACCGG-
3´-phosphate which are all specific to the coding region of HSV1 gB  (gene UL27), and the 
Roche LightCycler® 1.5. After one cycle of denaturation (95°C for 10 min), 55 cycles of 
amplification were performed (95°C for 10 s, 58°C for 15 s, 72°C for 15 s). During the 58°C 
phases, the acceptor fluorescence was measured at 640 nm, and from these data the DNA 
concentration of the probes was calculated using standards of known DNA concentration.  
SDS PAGE and immunoblots. To analyze the protein composition, extracelluar virions 
were pelleted, in some cases further purified on nycodenz gradients, solubilized in sample 
buffer (50 mM Tris-HCl, pH 6.8, 1% [w/v] SDS, 1% (v/v) β-mercaptoethanol, 5% [v/v] 
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glycerol, 0.001% [w/v] bromphenolblue) and loaded onto SDS gels. Following SDS PAGE, 
proteins were either stained with 0.1% (w/v) Coomassie Brilliant Blue R-250 and 0.1% (w/v) 
Coomassie Brilliant Blue G-250 in 10% acetic acid and 50% methanol or transferred to 
nitrocellulose membranes. The membranes were washed with PBS containing 0.1% (v/v) 
Tween 20 (PBS-T). After blocking in 5% lowfat milk in PBS-T, the membranes were 
incubated with primary antibodies diluted in 5% lowfat milk in PBS-T, washed in PBS-T, 
incubated with the secondary alkaline phosphatase-conjugated goat anti-rabbit or anti-mouse 
IgG antibodies (Dianova, Hamburg, Germany) diluted in 5% lowfat milk in PBS-T. After 
washing with PBS-T, the membranes were transferred to TSM (100 mM Tris-HCl, pH 9.5, 
100 mM NaCl, 5 mM MgCl2) and stained with 0.2 mM nitroblue tetrazolium chloride and 0.8 
mM 5-bromo-4-chloro-indoyl-3-phosphate in TSM.  
To analyze HSV1 immediate early gene expression, confluent PtK2 cells grown in 6-cm 
culture dishes were pre-incubated for 1 h at 37°C without or with 50 µM nocodazole to 
depolymerize the MT network. The cells were then pre-cooled in ice-cold RPMI with 25 mM 
HEPES and 0.1 % BSA (RPMI-BSA), and inoculated for 2 h on ice with 20 PFU per cell in 
RPMI-BSA without or with 50 µM nocodazole. Unbound virus was removed by washing 
with ice-cold RPMI-BSA, and the cells were further incubated at 37°C and 5% CO2 in PtK2-
medium with or without nocodazole. After 2 to 7 h, the cells were washed with PBS, lysed in 
hot sample buffer, scraped and resuspended. Samples were incubated at 95°C, resuspended to 
shear DNA, stored at –20°C and analyzed by immunoblots as described above. 
Negative staining and electron microscopy. Preparations of HSV1-wt (F), HSV1-
∆VP26 and HSV1-GFPVP26 were purified via nycodenz gradients and diluted to 8 x 106 
PFU/5 µl with 25% nycodenz solution. After adsorption on carbon-coated copper grids and 
washing with PBS and water, the preparations were negatively stained using 2% uranyl 
acetate (Merck, Darmstadt, Germany). Samples were analyzed with an EM 10 electron 
microscope (Carl Zeiss AG, Jena, Germany) at 80 kV. 
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Transfection. For transient transfections we used the plasmids pEGFP-C1 (BD 
Biosciences, Mountain View, CA, USA) expressing enhanced green fluorescent protein 
(GFP) and pDynamitin-EGFP expressing dynamitin-GFP under the control of the 
cytomegalovirus immediate-early promoter (16). PtK2 or Vero cells were seeded in 24-well 
plates at a density of 3 x 104 cells/well for 19 h, and then transfected with 0.3 µg/well DNA 
and 0.75 µl/well Gene Juice reagent (Merck Biosciences, Schwalbach, Germany) according 
to the manufacturer’s protocol. 30 h post transfection, the cells were infected with HSV1. 
Immunofluorescence microscopy. PtK2 or Vero cells grown on coverslips in 24-well 
dishes were synchronously infected with HSV1 in the absence or presence of 50 µM 
nocodazole. To prevent synthesis of progeny virus, 0.5 mM cycloheximide (Sigma-Aldrich) 
was added. The cells were fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton-
X-100 and labeled with antibodies as described previously (16, 62). Nuclei were stained by 1 
µg/ml Hoechst 33258 (Sigma-Aldrich, Taufkirchen, Germany). The specimens were 
analyzed with a Nikon Eclipse E800 microscope (Nikon Instruments, Kanagawa, Japan) 
equipped with the appropriate fluorescence microscopy filter sets. The cell margins and 
nuclei were visualized by phase contrast, and images were taken with a digital interline 
charge coupled device camera (Micromax-5MHz-782Y; Princeton Instruments Inc. USA) 
controlled by the IPLab 3.2 software. Images were further processed using the programs 
Metmorph 5.0.5 (Univeral Imaging Corporation, West Chester, USA) and Adobe Photoshop 
6.0.  
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Results 
Viral inocula differ in the particle to PFU ratio. To be able to compare HSV1-wildtype 
(wt) with the mutants HSV1-∆VP26 and HSV1-GFPVP26 in cell entry experiments, we 
characterized the particle composition of the inocula. Different viral particles can be released 
from HSV1 infected cells into the culture medium either by secretion or by cell lysis (Fig. 1): 
(i) vesicles containing viral membrane proteins but neither tegument nor capsid proteins, (ii) 
so called L-particles which consist of tegument surrounded by an envelope with viral 
membrane proteins (63), (iii) enveloped and tegumented capsids which lack the viral DNA, 
(iv) non-infectious and (v) infectious virions. Such particles can be detected by several 
methods. Antibodies raised against viral membrane proteins detect all particles, anti-
tegument antibodies all particles except vesicles with viral membrane but without tegument 
proteins, and anti-capsid antibodies recognize only the capsid containing particles. Using a 
viral genome specific PCR, the number of particles containing viral genomes can be 
quantified, whereas only infectious virions will form plaques. Compared to HSV1-wt, the 
mutants HSV1-∆VP26 and HSV1-GFPVP26 are assembled less efficiently (11-13). Virus 
preparations of the mutants might therefore contain a higher number of defective particles 
that can be impaired in any stage of the viral life cycle including cell entry, and the relative 
amounts of the different particle types might differ between wildtype and mutant 
preparations.  
First of all, we confirmed the specificity of the generated anti-VP26 antibodies, and the 
identity of the viral mutants. Immunoblotting using VP5 as a loading control (Fig. 2A, right) 
showed no anti-VP26 reactive bands for HSV1-∆VP26, whereas in HSV1-wt and HSV1-
GFPVP26 samples VP26-positive bands were detected at the expected molecular weights of 
VP26 and GFPVP26, respectively (Fig. 2A, left).  
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To compare the efficiency of cell entry and nuclear targeting, and to identify inocula with 
the lowest possible amount of defective particles, several virus preparations of HSV1-wt 
strains F and KOS, HSV1-∆VP26 and HSV1-GFPVP26 were compared regarding the titer of 
infectious particles (PFU), viral DNA content, protein composition, number of viral particles, 
and nuclear targeting. To reduce the amount of possible cellular contaminants, we did not use 
virions from infected cells. Instead, we always harvested released virions from the medium of 
infected cells, and purified them on linear nycodenz gradients (except for Fig. 2A and Fig. 5). 
Different preparations of the same strain or the same mutant varied in their viral DNA to 
PFU ratio (Table 1). Our best HSV1-wt and HSV1-GFPVP26 virus preparations had a viral 
DNA to PFU ratio of 2 to 3, whereas the best HSV1-∆VP26 preparation had a viral DNA to 
PFU ratio of about 5. The preparations were further analyzed by Coomassie stained SDS gels 
and immunoblots. Preparations characterized by a low viral genome to PFU ratio (Fig. 2B, 
lanes 1-4) had also lower amounts of viral proteins than preparations with a high viral genome 
to PFU ratio (lanes 5-7) when equal quantities of PFU were loaded (lanes 1-5 and 7; in lane 6 
only ~25% of PFU were loaded compared to all other lanes). The overall protein composition 
of all three strains, and the relative ratios of glycoproteins, tegument and capsid proteins were 
similar suggesting that neither deletion nor GFP-tagging of VP26 altered the ratios of the 
different particles present in the medium of infected cells significantly (fig. 2B and 2C). 
Electron microscopy (Fig. 2D-G) demonstrated that in comparison to virus preparations with 
a low viral genome to PFU ratio, preparations with a high viral genome to PFU ratio 
contained much more particles per volume. Thus, a low viral genome to PFU ratio correlated 
with a low particle to PFU ratio. 
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HSV1 preparations with a low particle to PFU ratio showed efficient nuclear 
targeting. Next, we used immunofluorescence microscopy to analyze the nuclear targeting 
efficiency of different virus preparations. In all experiments analyzing the subcellular 
localization of incoming HSV1 particles (Fig. 3-4 and 6-8), cycloheximide was added to 
prevent the synthesis of progeny virus. PtK2 cells were infected for 3 h with an MOI of 50 
PFU/cell with HSV1-wt (F), HSV1-wt (KOS), HSV1-∆VP26 or HSV1-GFPVP26, and 
double-labeled with antibodies against capsids (anti-HC; in red in Fig. 3) and the HSV1 
membrane protein gD (DL6; green in Fig. 3). Capsids derived from HSV1-wt characterized 
by low viral genome to PFU ratio reached the nuclear envelope with high efficiency (a: strain 
F, c: strain KOS). In contrast, capsids of an HSV1-wt preparation with a high viral genome to 
PFU ratio also accumulated at the nucleus, but relatively more particles remained in the cell 
periphery (Fig. 3b). Therefore, virus preparations with a low genome/PFU ratio were assumed 
to be of high quality, whereas preparations with a high genome/PFU ratio were supposed to 
be of lower quality. Similar results were obtained for the capsids derived from the mutants 
(Fig. 3e-h). However, if compared to HSV1-wt of high quality (Fig. 3a and c), after 3 h of 
infection with our best HSV1-∆VP26 preparation (Fig. 3e) relatively more capsids remained 
in the cell periphery. At 3 h p.i. the gD signal of virus preparations of lower quality (Fig. 3b) 
was higher than the gD signal of high quality virus preparations (Fig. 3a, c, g). 
We concluded that for meaningful entry experiments, high quality preparations of wt and 
mutant viruses had to be used. The quality of virus preparations was assessed by evaluating 
the results from plaque assays, PCR, protein gels, immunoblots and microscopic experiments. 
If we had compared a HSV1-∆VP26 mutant preparation of lower quality characterized by a 
high viral DNA/PFU ratio (Fig. 3f) with an HSV1-wt preparation of high quality (Fig. 3a 
and c), we would have erroneously concluded that VP26 was required for efficient nuclear 
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targeting. However, the best HSV1-∆VP26 preparations showed efficient nuclear targeting 
(Fig. 3e), although less pronounced than HSV1-wt (Fig. 3a) and HSV1-GFPVP26 (Fig. 3g). 
 
HSV1-∆VP26 and HSV1-GFPVP26 do not develop mature VP5 hexon epitopes. When 
we analyzed the subcellular localization of incoming HSV1, we noticed that in contrast to 
HSV1-wt strains F and KOS, the capsids of HSV1-∆VP26 and HSV1-GFPVP26 were not 
labeled with the monoclonal antibodies 5C10 (Fig. 4) and 8F5 (not shown). 5C10 and 8F5 
recognize different VP5 epitopes that are displayed on mature hexons but not on pentons (69). 
In contrast, the monoclonal antibody LP12 (50) and the polyclonal antibody NC-1 (8), both 
directed against VP5, as well as the polyclonal antibodies anti-HC and anti-LC against DNA-
containing and empty capsids, respectively (8), labeled capsids of the four tested HSV1 
strains with similar efficiencies (not shown; for anti-HC c.f. Figs. 3, 6, 7, 8). These data 
suggest that the formation of the VP5 epitopes 5C10 and 8F5 epitopes, which are specific to 
mature hexons, required VP26 during virus assembly, and did neither form in the absence of 
VP26, nor in the presence of GFPVP26. 
 
HSV1-∆VP26 and HSV1-GFPVP26 require MT for viral gene expression. Efficient 
expression of HSV1 immediate-early genes from wt strains requires MT (35, 36, 62). To test 
whether this was also true for HSV1-GFPVP26 and HSV1-∆VP26, PtK2 cells were infected 
at an MOI of 20 PFU/cell in the presence or absence of 50 µM nocodazole, which reversibly 
depolymerizes MT (29). The immediate early HSV1 protein ICP0 was detected as early as 2 
h post infection, and increased until 7 h post infection, the latest time point analyzed (not 
shown). The ICP0 expression of HSV1-wt was higher than ICP0 expression of HSV1-∆VP26 
and HSV1-GFPVP26 (Fig. 5). However, in all HSV1 strains tested, viral gene expression at 
7 h p.i. was strongly reduced when cells were infected in the presence of nocodazole (Fig. 5). 
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Thus, HSV1-∆VP26 and HSV1-GFPVP26 required MT for efficient immediate-early gene 
expression.  
 
MT mediate the nuclear targeting of HSV1-∆VP26. Reduced expression of ICP0 in the 
absence of MT (Fig. 5) could either be due to impaired capsid transport, or due to reduced 
nuclear targeting of the HSV1 transcription factor VP16 which is provided by the incoming 
tegument (5, 16, 62). Therefore, the subcellular localization of incoming HSV1-wt, HSV1-
∆VP26 and HSV1-GFPVP26 was determined using antibodies to capsids and to gD, an HSV1 
envelope protein. Unless epitopes are degraded during infection, anti-capsid and anti-gD 
antibodies label virions bound to the cell surface or inside endosomes, while cytosolic capsids 
are only recognized by capsid antibodies and lack viral membrane epitopes. 
In PtK2 cells infected with HSV1-wt (Fig. 6, a and d), the majority of capsids (a, red in d; 
arrowheads) was already separated from gD (green in d) as early as 30 min p.i.. Few capsids 
still colocalized with gD (arrows in d). At 3 h p.i., capsids (b, red in e) accumulated around 
the nucleus as described before (16, 35, 62). Particles at the nuclear envelope did not 
colocalize with gD (green in e) suggesting that they were not virions in endocytic 
compartments but cytosolic capsids as has been shown before by electron microscopy  (62). 
However, the gD signal was severely reduced at 3 h p.i. (e) when compared to 30 min p.i. (d). 
A reduction of glycoprotein signal during infection was also observed with gB, and both 
signals were already decreased at 2 h p.i. (not shown). This suggested that viral glycoproteins 
of the inoculum were degraded or at least denatured early in infection. In contrast, the 
intensity of the capsid signal increased between 0 min and 2 h p.i. (not shown, but compare a 
and b of Fig. 6; (62), indicating that the accessibility of capsid epitopes might increase during 
this period. When MT were depolymerized, nuclear targeting was reduced (c, red in f). 
Similar results were obtained when infecting with HSV1-∆VP26 (Fig. 6g-l). At 30 min 
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p.i., the capsid (g, red in j) and gD (green in j) signals were distributed over the entire 
cytoplasm. Many capsids had already separated from the gD signal (arrowheads in j), while 
other capsid signals still colocalized with gD (arrows in j). Compared to infection with HSV1-
wt (d), the fraction of capsid signals that colocalized with gD at 30 min p.i. was higher after 
infection with HSV1-∆VP26 (j). In the presence of MT, most HSV1-∆VP26 capsids 
accumulated at the nuclear envelope at 3 h p.i. (h, red in k). However, compared to wt-HSV1, 
there were relatively more viral particles distributed over the entire cytoplasm (see also Fig. 
3). Capsids at the nucleus or in the perinuclear area (arrowheads) did not colocalize with gD 
(green in k), suggesting that they had lost their envelope, whereas several viral particles in the 
cell periphery contained both, capsid as well as gD antigens (arrows in k). The latter either 
represented virions bound to the plasma membrane, or internalized into endosomes. When 
MT were depolymerized, HSV1-∆VP26 particles were randomly distributed over the entire 
cytoplasm at 3 h p.i. (i, red in l), but in contrast to early time points, the majority of the 
capsids (arrowheads) did no longer colocalize with gD (green in l). Therefore, as HSV1-wt, 
HSV1-∆VP26 also required MT for efficient nuclear targeting. 
 
MT mediate the nuclear targeting of HSV1-GFPVP26. Next, we analyzed the 
subcellular localization of incoming HSV1-GFPVP26 particles (Fig. 7a-f). In PtK2 cells 
infected for 30 min, the capsids (red in d) were distributed over the entire cytoplasm and in 
most cases colocalized with GFP (a, green in d; arrowheads), but not with the gD signal (blue 
in d). There was also a partial colocalization of capsid and gD signals (arrows in d) and of 
GFP and gD signals (asterisks in d). At 3 h p.i., capsids accumulated at the nuclear envelope 
(red in e). Compared to HSV1-wt, there was a slightly higher proportion of viral particles that 
remained in the cell periphery (compare Fig. 3c and 3g). Particles at the nucleus labeled with 
anti-capsid antibody (red in e) did not colocalize with gD (blue in e), suggesting that particles 
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at the nuclear rim had lost their envelope and represented cytosolic capsids. Nuclear targeting 
of HSV1-GFPVP26 was clearly reduced in the absence of MT (c and f). Like HSV1-wt, 
HSV1-GFPVP26 required MT for nuclear targeting and immediate-early viral gene 
expression. Thus, attaching GFP to VP26 did not interfere with efficient nuclear targeting of 
incoming capsids. 
 
HSV1-∆VP26 and HSV1-GFPVP26 nuclear targeting in Vero cells. Since HSV1 
productively infects some cells after entry by endocytosis (25, 41, 43-45), and since the entry 
mechanism into PtK2 cells is so far unclear, it was possible that viral particles were 
transported to the PtK2 nucleus inside endosomes, and that this cytoplasmic transport of 
endosomes was therefore not affected by deleting a capsid protein. In contrast, Vero cells are 
known to be productively infected by fusion of the viral envelope and the plasma membrane 
(44, 45, 62). We therefore infected Vero cells with HSV1-wt, HSV1-∆VP26 and HSV1-
GFPVP26. In Vero cells, HSV1-∆VP26 and HSV-GFPVP26 also reached the nuclear 
envelope in a MT-dependent manner (Fig. 7g-l). Thus, VP26 is not essential for MT transport 
during cell entry, and HSV1 must contain additional receptors for minus-end directed MT 
motors in the tegument or on the capsid. 
 
Dynamitin overexpression reduces nuclear targeting of HSV1-∆VP26 and HSV1-
GFPVP26. Dynein and its cofactor dynactin catalyze MT-mediated nuclear targeting of 
HSV1-wt (16, 62). To test whether they were also required for nuclear targeting of HSV1-
∆VP26 and HSV1-GFPVP26, we overexpressed the dynactin subunit dynamitin (Fig. 8) 
which blocks dynein mediated transport (4, 18).  
In both, PtK2 (a-c) and Vero cells (g-i) overexpressing dynamitin-GFP (nuclei marked by 
N) less HSV1-wt (a and d), HSV1-∆VP26 (b and e) and HSV1-GFPVP26 (c and f) capsids 
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reached the nucleus compared to untransfected cells (nuclei marked by N). More viral 
particles were still distributed over the entire cytoplasm (arrowheads) or located in the cell 
periphery (arrows) at 3 h p.i.. In contrast, overexpression of GFP (d-f; j-l; nuclei of 
transfected cells marked by N) had no effect on nuclear targeting of capsids. Thus, in PtK2 
and Vero cells, HSV1-∆VP26, HSV1-GFPVP26 and HSV1-wt used MT and dynein/dynactin 
for transport to the nucleus.  
 
Discussion 
Incoming cytosolic HSV1 capsids utilize dynein and dynactin for efficient MT mediated 
transport from the cell periphery to the nucleus (16, 62). Although the small capsid protein 
VP26 has been shown to interact with dynein light chains of the Tctex family (17), an HSV1 
strain deleted for VP26 (HSV1-∆VP26) and an HSV1 strain in which VP26 had been 
replaced by GFPVP26 (HSV1-GFPVP26) also required MT and dynein for efficient nuclear 
targeting. Thus, other HSV1 structural proteins besides VP26 could provide a viral receptor 
for cytoplasmic dynein or its cofactor dynactin. 
 
High quality virus preparations are required to study virus cell entry. The 
characterization of several HSV1-wt and mutant virus preparations by plaque titration, PCR, 
biochemical and microscopic approaches revealed that different preparations of the same 
strain varied significantly with regard to their particle to PFU ratio. Virus preparations with a 
higher viral genome to PFU ratio contained more viral protein and more viral particles, and 
were less efficiently targeted to the nucleus. Therefore, these virus preparations were 
considered to be of lower quality than preparations with a lower DNA to PFU ratio.  
According to this definition, the best HSV1-∆VP26 preparations were of lower quality 
than the best wild type preparations. This was most likely due to a less efficient assembly of 
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the mutants (11, 12). Based on the analysis of an HSV1-∆VP26 preparation of lower quality, 
we would have concluded that VP26 was required for efficient MT transport. Therefore, it 
was crucial to carefully characterize the inocula and to identify high quality virus 
preparations, especially when the entry of the HSV1 mutants was analyzed. HSV1-∆VP26 
incoming capsids of good preparations were efficiently transported to the nucleus, although 
less completely than capsids of HSV1-wt or HSV1-GFPVP26. 
 
The formation of some hexon-specific VP5 epitopes requires VP26. VP26 is localized 
on VP5 hexons but not on VP5 pentons even if present in 8-fold molar excess (3, 68, 79, 80). 
In contrast to HSV1-wt strains F and KOS, viral particles of HSV1-∆VP26 and HSV1-
GFPVP26 did not display 8F5 and 5C10 epitopes, while other anti-VP5 antibodies such as the 
mAb LP12 (50), anti-NC-1 (8), anti-HC, and anti-LC (8) recognized HSV1-wt, HSV1-∆VP26 
and HSV1-GFPVP26 with similar affinity.  
The mAbs 5C10 and 8F5 recognize specifically mature VP5 in hexons (7, 24, 37, 69). 
Their epitope formation requires ATP (9), as does the assembly of VP26 onto the hexons of 
angularized capsids (6). Our data indicated that VP26 binding was not a consequence of 
8F5/5C10 epitope formation, but that their formation required VP26 during virus assembly. 
This suggests that VP26 might induce conformational changes in VP5 which lead to epitope 
formation. 5C10 or 8F5 epitopes neither formed in the absence of VP26, nor in the presence 
of GFPVP26.  
 
HSV1-∆VP26 and HSV1-GFPVP26 capsids require MT for efficient nuclear 
targeting. VP26 interacts with the 14 kDa dynein light chains Tctex-1 and rp3 in yeast two 
hybrid and GST-pulldown assays (17), and this interaction could contribute to the dynein 
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mediated MT transport of incoming HSV1 capsids. Thus, we tested the roles of MT and 
dynein during the entry of HSV1-∆VP26 and HSV1-GFPVP26. 
After infection with HSV1-∆VP26 or HSV1-GFPVP26, efficient expression of the 
immediate-early HSV1 gene ICP0 required MT. Moreover, HSV1-∆VP26 and HSV1-
GFPVP26 capsids accumulated at the nuclear envelope of PtK2 cells in a MT-dependent 
manner. However, compared to infection with HSV1-wt, the nuclear targeting of HSV1-
∆VP26 was slightly less efficient, but this was most likely due to the higher amount of 
defective particles present in the mutant virus preparation. HSV1-∆VP26 and HSV1-
GFPVP26 particles at the nuclear envelope did not colocalize with the viral membrane 
protein gD suggesting that these particles were free cytosolic capsids.  
Since the gD signal decreased during infection, we could not completely rule out that 
capsid signals not colocalizing with gD represented virions inside endosomes whose gD had 
been degraded or denatured. However, during infection with HSV1-wt, particles at the 
nuclear envelope were shown to be cytosolic capsids by electron microscopy (47, 62). 
Therefore, most probably these gD-free HSV1-∆VP26 and HSV1-GFPVP26 particles around 
the nucleus also represented free cytosolic capsids. 
HSV1 can productively infect some cell types after entry by endocytosis (25, 41, 43-45). 
In contrast, Vero cells are shown to be productively infected after fusion at the plasma 
membrane (44, 45, 62). 30 min p.i., the capsid signal of HSV1-∆VP26 colocalized more 
frequently with gD than that of HSV1-wt. This might reflect that, compared to wt-HSV1, the 
HSV1-∆VP26 virus preparations contained more defective particles that might have bound to 
the plasma membrane, but did not enter cells, or that were taken up by endocytosis. However, 
HSV1-∆VP26 and HSV1-GFPVP26 also accumulated at the nuclear envelope of Vero cells 
in a MT-dependent manner. Even after endocytic uptake, capsids are released from 
endosomes as early as 30 min p.i. (45). At this time point, the capsid signal was still 
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distributed over the entire cytoplasm, suggesting that after an early release from endosomes, 
cytosolic capsids rather than endocytosed virions were transported to the nucleus. Taken 
together these data suggest that cytosolic capsids of HSV1-∆VP26 and HSV1-GFPVP26 
were transported along MT to the nucleus. 
 
HSV1-∆VP26 and HSV1-GFPVP26 require dynein/dynactin for efficient nuclear 
targeting. HSV1-∆VP26 lacking the potential dynein receptor VP26 (17) also utilized MT 
for efficient nuclear targeting, and as a consequence viral immediate-early gene expression. 
In addition to dynein and its cofactor dynactin, some C-type kinesins are involved in minus-
end directed MT transport during interphase (48), and could theoretically have transported 
HSV1 to the nucleus in the absence of VP26. Therefore, we overexpressed the dynactin 
subunit dynamitin to test whether dynein and its cofactor dynactin were involved in nuclear 
targeting of HSV1-∆VP26 and HSV1-GFPVP26. Overexpression of dynamitin disrupts the 
dynactin complex and reduces dynein and kinesin-2 mediated transport processes (10, 56).  
In PtK2 and Vero cells, nuclear targeting of HSV1-∆VP26 and HSV1-GFPVP26 was 
reduced by dynamitin overexpression. Kinesin-2, the second target of dynamitin 
overexpression, is a plus-end directed MT motor (28), and therefore unlikely to catalyze 
minus-end directed transport of HSV1. To our knowledge, an effect of dynamitin 
overexpression on minus-end directed kinesins has not been reported. Furthermore, anti-
dynamitin antibodies do not reduce binding of early endosomes to MT, which is mediated by 
kinesin-1 and the minus-end directed kinesin KIFC2. Rather, they reduce binding of late 
endosomes to MT which is mediated by dynein and kinesin-2 (1). This suggests that 
interfering with dynactin function does not disturb the interaction between minus-end directed 
kinesins, their cargo and MT. Although we cannot formerly exclude that minus-end directed 
kinesins contributed to nuclear targeting of HSV1, it seems more likely that dynein in 
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cooperation with its cofactor dynactin catalyzed the transport of HSV1-∆VP26 and HSV1-
GFPVP26 to the nucleus.  
In summary, our data indicate that cytosolic capsids of HSV1-∆VP26 and HSV1-
GFPVP26 as HSV1-wt use cytoplasmic dynein and dynactin for MT transport to the nucleus. 
Therefore, HSV1-GFPVP26 provides an excellent model to study MT-mediated transport in 
living cells. Our data concur with results from Desai et al. (1998) who showed that in the 
mouse ocular model transport to trigeminal ganglia is not reduced in the absence of VP26. 
This is consistent with our data suggesting that VP26 has no important function in minus-end 
directed transport during cell entry. Instead, the potential interaction between VP26 and the 
dynein light chains might play a role during HSV1 assembly, when cytosolic capsids are 
transported to the site of secondary budding (39, 40). 
However in an in vitro binding assay, capsids of HSV1-∆VP26 and HSV1-GFPVP26 
bound dynein and dynactin as efficiently as capsids of HSV1-wt (77). Furthermore, compared 
to capsids which contained VP26 but no tegument or capsids with complete tegument, capsids 
whose outer tegument had been partially removed bound dynein and dynactin most 
efficiently. Moreover, the latter showed the strongest motility along MT in vitro (77). Such 
capsids contained the inner tegument proteins VP1-3 and UL37 as well as VP16, which might 
connect inner and outer tegument (71, 77). These data suggested that VP26 was not sufficient 
and that inner tegument proteins and/or VP16 were required for motor recruitment and MT 
motility. Moreover, excessive tegument coating rather reduced transport. Supposedly, 
removal of outer tegument proteins either renders a hidden motor receptor accessible or 
dislodges a viral transport inhibitor (77). 
These hypotheses are supported by in vivo studies demonstrating that most of the HSV1 
tegument and VP11/12, VP13/14, VP16 and VP22 of pseudorabies virus, the porcine 
alphaherpesvirus, detach from the incoming capsid upon fusion and stay at the plasma 
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membrane, whereas the inner tegument proteins VP1-3, UL37 and US3 remain attached to the 
capsids (26, 34, 62, 75). In neurons, GFP-tagged pseudorabies virus particles undergo 
bidirectional transport during entry and egress, with retrograde transport predominating 
during entry and anterograde transport during egress (59, 60). The direction of net transport 
during entry and egress of alphaherpesviruses may be controlled by varying the tegument 
composition, by the tegument-associated kinases US3 and UL13, or by regulating the activity 
of MT motors during the different stages of the viral life cycle (34, 60). 
Altogether the in vivo and in vitro experiments suggest that besides VP26, HSV1 must 
encode at least one additional receptor for dynein or dynactin and that HSV1 inner tegument 
proteins are likely candidates.  
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Tables. 
 
Table 1. Characterization of various HSV1 inocula. 
Virus genomes/ml 
(x 109) 
PFU/ml 
(x 109) 
viral 
DNA/PFU 
nuclear 
targeting 
12.4 (5.0) 4.4 2.8 (1.2) +++ HSV1-wt strain F 42.3 (33.5) 2.8  15.1 (12.0) - 
HSV1-wt strain KOS 15.8 (8.3) 7.0 2.3 (1.1) +++ 
15.9 (6.7) 3.0  5.3 (2.3) ++ HSV1-∆VP26 4.2 (1.5) 0.45  9.4 (3.4) + 
4.2 (1.8) 1.6  2.6 (1.1) +++ HSV1-GFPVP26 12.8 (10.2) 3.1  4.1 (3.3) + 
 
Various preparations of HSV1-wt, HSV1-∆VP26 or HSV1-GFPVP26 were plaque titrated on 
Vero cells (PFU/ml; in quadruplets), and the amount of viral DNA was determined by 
quantitative real time detection PCR (genome/ml; in duplicates) either without or after DNase 
I treatment (data in brackets), followed by DNase I inactivation. The best HSV1-∆VP26 
preparations had a higher viral DNA/PFU ratio than the best HSV1-wt and HSV1-GFPVP26 
stocks. In all cases, preparations with low viral DNA/PFU ratios were more efficient in 
nuclear capsid targeting than those of a high viral DNA/PFU ratio. All virus preps contained 
viral DNA that was not encapsidated, since DNase I treatment reduced the amount of 
genomes detected by PCR. 
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Figure legends 
 
Figure 1: HSV1 viral particles potentially present in an inoculum. The inoculum may 
consist of vesicles with viral membrane proteins, vesicles with viral membrane and tegument 
proteins (L-particles), enveloped particles with tegument and capsid, but without viral DNA, 
non-infectious and infectious virions. Antibodies raised against viral membrane proteins 
detect all depicted particles, and anti-tegument antibodies recognize all particles except 
vesicles with viral membrane but without tegument proteins. Capsid antibodies detect the 
capsid containing particles. DNA-containing particles are identified by PCR, whereas only 
infectious virions are perceived by plaque assays.   
 
Figure 2: HSV1 preparations of the same strain or the same mutant vary in the 
particle to PFU and the genome to PFU ratios. A: Viral particles harvested from the 
medium of cells infected with HSV1-wt strain F (1), HSV-GFPVP26 (2), or HSV1-∆VP26 (3) 
were subjected to linear 8-16% SDS-PAGE, blotted, and probed with antibodies against VP26 
(left) or VP5 (right). HSV1-wt (1) and HSV1-GFPVP26 (2), but not HSV1-∆VP26 (3) 
contained anti-VP26 positive bands at the respective molecular weights of VP26 (12 kDa) and 
GFPVP26 (39 kDa) (left). Anti-VP5 (NC-1) was used as a loading control (right). 
B and C. Gradient purified virus preparations of HSV1-wt strain F (lanes 1, 5), HSV1-wt 
strain KOS (lane 2), HSV1-GFPVP26 (lanes 2, 6), or HSV1-∆VP26 (lanes 3, 7) were 
subjected to SDS-PAGE, and the gels were either stained with Coomassie (B), or blotted and 
probed with antibodies to VP26, VP5, US11, gB, VP16, VP13/14, and Remus V, an antibody 
that recognizes several capsid, tegument and glycoproteins of HSV1 (C). HSV1-wt strain F, 
HSV1-wt strain KOS, HSV1-∆VP26 or HSV1-∆VP26 had a very similar overall protein 
composition (B and C). When 1.3 x 108 PFU per lane were loaded, virus preparations with a 
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low viral DNA/PFU ratio (lanes 1 to 4) contained less protein than preparations with a higher 
DNA/PFU ratio (lanes 5 to 7). Gradient purified virus was subjected to linear 7.5 to 18% SDS 
PAGE at a concentration of 1.3 x 108 PFU/lane (lanes 1 to 5, 7) or 0.4 x 108 PFU/lane (lane 
6). Note that only 25% of the PFU of HSV1-∆VP26 with a high viral DNA/PFU ratio (lane 6) 
had been loaded onto the gel resulting in a protein concentration similar to the 100% loaded 
for HSV1-wt strain F (lane 1).  
D to G. An HSV1-wt (F) preparation with a low viral genome to PFU ratio (2.8; D) 
contained less particles than a preparation of the same virus with a high viral genome to PFU 
ratio (15.1; E). Both preparations contained unenveloped capsids (arrowhead) as well as 
enveloped virus (arrow). HSV1-∆VP26 (F) and HSV1-GFPVP26 (G) preparations with viral 
genome to PFU ratios of 2.6 and 4.1, respectively contained similar amounts of particles. 
8x106 PFU/sample gradient purified virus preparations of HSV1-wt strain F (D and E), 
HSV1-∆VP26 (F) and HSV1-GFPVP26 (G) were analyzed by electron microscopy after 
negative staining. 
 
Figure 3: Incoming capsids derived from high quality preparations were efficiently 
transported to the nucleus. After infection with virus preparations with a low DNA/PFU 
ratio (a, c, e, g), a larger proportion of viral particles labeled with anti-HC (red) reached the 
nucleus within 3 h p.i. than after infection with a preparation with a higher DNA/PFU ratio 
(b, f, h). HSV1-wt preparations of high quality (a, c) showed the most efficient nuclear 
targeting, followed by HSV1-GFPVP26 preparations with a low DNA/PFU ratio (g). Nuclear 
targeting of HSV1-∆VP26 preparations with a medium DNA/PFU ratio (e) was somewhat 
lower when compared to HSV1-wt (a, c) or HSV1-GFPVP26 (g) stocks with a low 
DNA/PFU ratio. Cells infected with virus preparations of high quality (a, c, g) showed little 
labeling for the viral membrane protein gD (green) compared to cells infected with virus 
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preparations with high DNA/PFU ratios at 3 h p.i. (b, f, h). PtK2 cells were infected with 
HSV1-wt, HSV1-∆VP26 or HSV-GFPVP26 preparations at an MOI of 50 PFU/cell in the 
presence of cycloheximide. The cells were fixed, permeabilized and labeled with anti-HC 
(red) and anti-gD (green). The nuclei (N) and cell margins were indicated by dashed or 
continuous white lines, respectively.  
 
Figure 4: No mature VP5 epitopes on HSV1-∆VP26 or HSV1-GFPVP26 capsids. The 
mAb 5C10 detected incoming nuclear HSV1-wt (a), but not HSV1-∆VP26 (b) or HSV1-
GFPVP26 (c) capsids. In contrast, cells infected in parallel and labeled with the capsid 
antibody anti-HC (see Figs. 3, 6, 7, or 8) had a strong punctuate signal at the nuclear 
envelope. PtK2 cells were infected for 4 h in the presence of cycloheximide at an MOI of 50 
PFU/cell with HSV1-wt strain F (a) HSV1-∆VP26 (b) or HSV1-GFPVP26 (c) or mock-
infected (d), fixed, permeabilized and labeled with the mAb 5C10 (a-d). Nuclei were stained 
with Hoechst 33258 (e-h). The Hoechst images were individually processed due to 
differences in the labeling intensity.  
 
Figure 5: HSV1-wt, HSV1-GFPVP26 and HSV1-∆VP26 required MT for efficient 
immediate-early viral gene expression. For all three viruses, there was less ICP0 expressed 
when the cells had been infected in the presence of nocodazole which depolymerizes MT. 
PtK2 cells were infected for 7 h at an MOI of 20 PFU/cell in the absence or presence of  50 
µM nocodazole. Cell lysates were loaded onto 5.5 to 18 % SDS gels, blotted, and probed with 
anti-ICP0, an immediate-early HSV1 protein (upper panel), and anti-vimentin antibody as a 
loading control (lower panel). Note that the molecular weight of ICP0 was higher in the KOS 
strains HSV1-GFPVP26 and HSV1-∆VP26 than in the HSV1-wt strain F. 
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Figure 6: Subcellular localization of HSV1 capsid and membrane proteins during the 
early phase of infection. (a-f) 30 min after infection with HSV1-wt strain KOS, capsids (a, 
red in d) and gD (green in d) were distributed over the entire cytoplasm. Already this early, 
most capsids were devoid of gD (arrowheads in d), only few capsid signals still colocalized 
with gD (arrows; yellow in d). At 3 h p.i., most HSV1-wt capsids accumulated at the nuclear 
envelope (b, red in e), where they did not colocalize with gD (green in e). The gD signal was 
reduced after 3 h compared to 30 min p.i. in the presence (green in e) and absence of MT 
(green in f). When MT had been depolymerized (c and f), most capsids remained distributed 
over the entire cytoplasm even 3 h after infection (c, red in f).  
(g-l) 30 min after infection with HSV1-∆VP26, the capsid signal was distributed over the 
entire cytoplasm (g, red in j), and often had already separated from gD (arrowheads in j). 
Some capsid signals (arrows in j) still colocalized with gD (green in j). At 3 h post infection, 
the majority of HSV1-∆VP26 capsids accumulated at the nuclear envelope (h, red in k), 
where they did not colocalize with gD (green in k). The gD in the cell periphery was often 
clustered and colocalized with the peripheral capsid signal (yellow in k; arrows). In the 
absence of MT, the capsid signal remained distributed over the entire cytoplasm at 3 h p.i. (i, 
red in l), but in most cases no longer colocalized with gD (green in l). In the cell periphery, 
there was some co-localization of capsid with gD (yellow in l; arrows). 
PtK2 cells were infected in the presence of cycloheximide with HSV1-wt strain KOS (a-f) 
or HSV1-∆VP26 (g-l) at an MOI of about 50 PFU/cell for 30 min (a, d, g, j) or 3 h in the 
absence (b, e, h, k) or presence of 50 µM nocodazole (c, f, i, l). Cells were fixed, 
permeabilized and labelled with anti-capsid (a-c and g-i; red in d-f and j-l; anti-HC) and anti-
gD antibodies (green in d-f and j-l; DL6). The nuclei (N) and cell margins were indicated with 
dashed or continuous lines, respectively (d-f and j-l). To visualize the degree of 
colocalization, the pixel shift between the red and green channel was not corrected in the 
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overlays (d-f, j-l). 
Figure 7: Efficient nuclear targeting of HSV1-GFFPVP26 capsids required MT. PtK2 
cells (a-f). The GFP signal was distributed over the entire cytoplasm (a, green in d) and often 
colocalized with the capsid signal (red in d; arrowheads) at 30 min p.i. with HSV1-GFPVP26. 
In contrast, the gD signal (blue in d) was mostly separated from the capsid/GFP signal and 
rarely colocalized with capsid (arrows) or GFP (asterisks) signals. At 3 h post infection, GFP 
particles had accumulated at the nucleus (b, green in e). Not all of the particles labeled with 
anti-capsid antibodies (red in e) also displayed GFP fluorescence (b, green in e). Neither the 
nuclear anti-capsid nor the GFP signal colocalized with gD (blue in e). The gD signal was 
strongly diminished 3 h p.i. (e). In the absence of MT, HSV1-GFPVP26 particles were 
randomly distributed over the entire cytoplasm even after 3 h of infection (c and f). The cells 
were infected in the presence of cycloheximide at an MOI of about 50 PFU/cell for 30 min (a 
and d) or 3 h in the absence (b and e) or presence of 50 µM nocodazole (c and f). Cells were 
fixed, permeabilized and labeled with anti-capsid (d-f in red; anti-HC) and anti-gD antibodies 
(d-f in blue; DL6). GFP (a-c and d-f in green) was detected by its intrinsic fluorescence. The 
nuclei (N) and cell margins were indicated with dashed or continuous lines, respectively (d-f). 
The pixel shifts between the red, green and blue channels were not corrected (d-f).  
Vero cells (g-l). At 3 h p.i., many HSV1-wt (g), HSV1-∆VP26 (h) and HSV1-GFPVP26 
(i) capsids accumulated around the nucleus of Vero cells. When MT had been depolymerized 
during infection, HSV1-wt (j), HSV1-∆VP26 (k) and HSV1-GFPVP26 (l) capsids remained 
randomly distributed over the entire cytoplasm. Vero cells were infected in the presence of 
cycloheximide for 3 h with wt-HSV1 strain KOS (a, d), HSV1-∆VP26 (b, e) or HSV1-
GFPVP26 (i, l) at an MOI of 50 PFU/cell in the absence (a-c) or presence of 50 µM 
nocodazole (d-f). Cells were fixed, permeabilized and labeled with anti-capsid antibody (anti-
HC). The nuclei (N) and cell margins were marked with dashed and continuous lines, 
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respectively. Arrowheads indicate capsids which colocalize with GFP, arrows point to capsid 
signals which colocalize gD, and asterisks show GFP signals which colocalize with gD (d-f).   
 
Detailed Figure 7, for reviewer’s information, corresponds to Fig. 7, a-f:  
Efficient nuclear targeting of HSV1-GFFPVP26 capsids required MT. After 30 min 
infection with HSV1-GFPVP26, the GFP signal was distributed over the entire cytoplasm (a, 
green in d) and often colocalized with the capsid signal (a’, red in d; arrowheads). In contrast, 
most of the gD signal (a’’, blue in d) was separated from the GFP/capsid signal. Only few gD 
signals colocalized with capsid (arrows) or GFP (asterisks) signals.  At 3 h p.i., capsids had 
accumulated at the nucleus (b’, red in e). Not all of the particles labeled with anti-capsid 
antibodies also displayed GFP fluorescence (b, green in e). Neither the nuclear anti-capsid, 
nor the GFP signal colocalized with gD (b’’, blue in e). The gD signal was strongly 
diminished 3 h post infection (b’’, blue in e). In the absence of MT, the HSV1-GFPVP26 
particles were randomly distributed over the entire cytoplasm even after 3 h of infection (c, c’ 
and f). PtK2 cells were infected in the presence of cycloheximide with HSV1-GFPVP26 at a 
MOI of 50 PFU/cell for 30 min (a, a’, a’’, d) or 3 h in the absence (b, b’, b’’, e) or presence of 
50 µM nocodazole (c, c’, c’’, f). Cells were fixed, permeabilized and labeled with anti-capsid 
(a’-c’; anti-HC) and anti-gD (a’’-c’’). GFP (a-c) was detected by its intrinsic fluorescence. 
The nuclei (N) and cell margins were marked with dashed or continuous lines, respectively 
(d-f). The pixel shifts between the red, green and blue channels were not corrected (d-f). 
Arrowheads indicate capsids which colocalize with GFP, arrows capsid signals which 
colocalize gD, and asterisks GFP signals which colocalize with gD (d-f). 
 
Figure 8: Dynamitin reduced nuclear targeting in the presence and absence of VP26. 
In PtK2 cells (a-f) or Vero cells (g-l) overexpressing dynamitin-GFP (a-c; g-l), less HSV1-wt 
(a, g), HSV1-∆VP26 (b, h) and HSV1-GFPVP26 (c, i) capsids reached the nucleus than in 
Döhner, Schmidt, Radtke, and Sodeik, 2005; Manuscript in preparation for Journal of Virology 31
untransfected cells. The overexpression of GFP (d-f; j-l) had no effect on nuclear targeting of 
HSV1-wt (d, j), HSV1-∆VP26 (e, k) or HSV1-GFPVP26 (f, l) capsids. The cells were 
transfected with dynamitin-GFP (a-c; g-i) or GFP (d-f; j-l) for 30 h and then infected with 
HSV1-wt strain KOS (a, d, g, j), HSV1-∆VP26 (b, e, h, k) or HSV1-GFPVP26 (c, f, i, l) for 3 
h in the presence of cycloheximide at an MOI of 50 PFU/cell. Cells were fixed and labeled 
with an anti-capsid antibody (anti-HC). Dynamitin-GFP and GFP were detected by their 
intrinsic fluorescence (not shown). Overexpressing cells were marked by an N in italics, 
untransfected cells by a normal N. The nuclei and cell margins were indicated with dashed 
and continuous white lines, respectively. Arrows point to capsids in the cell periphery, 
arrowheads to capsids distributed in the cytoplasm. 
 
Additional information to Figure 8 for reviewer’s information: PtK2 and Vero cells 
overexpressing dynamitin-GFP or GFP.  PtK2 cells (a-f) or Vero cells (g-l) overexpressing 
dynamitin-GFP (a-c; g-i) or GFP (d-f; j-l) were detected by their intrinsic fluorescence. In 
Figure 8 overexpressing cells were marked by an N in italics, while untransfected cells are 
indicated by a normal N. 
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Abstract Upon infection, virions or subviral nucleoprotein complexes are transport-
ed from the cell surface to the site of viral transcription and replication. During viral
egress, particles containing viral proteins and nucleic acids again move from the site
of their synthesis to that of virus assembly and further to the plasma membrane. Be-
cause free diffusion of molecules larger than 500 kDa is restricted in the cytoplasm,
viruses as well as cellular organelles employ active, energy-consuming enzymes for
directed transport. This is particularly evident in the case of neurotropic viruses that
travel long distances in the axon during retrograde or anterograde transport. Viruses
use two strategies for intracellular transport: Viral components either hijack the cy-
toplasmic membrane traffic or they interact directly with the cytoskeletal transport
machinery. In this review we describe how viruses—particularly members of the
Herpesviridae, Adenoviridae, Parvoviridae, Poxviridae, and Baculoviridae—make
use of the microtubule and the actin cytoskeleton. Analysing the underlying princi-
ples of viral cytosolic transport will be helpful in the design of viral vectors to be
used in research as well as human gene therapy, and in the identification of new an-
tiviral target molecules.
1
Introduction
As obligate intracellular parasites, viruses use and manipulate the cells
machinery for membrane trafficking, transcription, splicing, nuclear
pore transport and protein synthesis. In fact, these cellular processes
were elucidated to a large extent by studying viral systems. Here, we dis-
cuss the molecular interactions of viruses with the host cytoskeleton
and the mechanisms of viral cytoplasmic transport.
Any viral life cycle can be divided into the following phases: (1) ad-
sorption to the cell, (2) penetration of the plasma or endosome mem-
brane, (3) genome uncoating and release from a viral nucleoprotein
complex or capsid, (4) early viral protein synthesis, (5) genome replica-
tion, (6) late viral protein synthesis, (7) virus assembly/maturation and
finally (8) viral release or egress. We define phases (1)–(3), up to the
stage at which the viral genome has been unpacked for transcription
and replication, collectively as “viral cell entry”.
Virions, subviral particles or nucleoprotein complexes are transport-
ed during cell entry from the cell surface to the site of viral transcription
and replication, as well as from the site of synthesis to that of virus as-
sembly and back to the plasma membrane for virus egress (for recent
reviews see Cudmore et al. 1997; Sodeik 2000; Ploubidou and Way 2001;
Smith and Enquist 2002). Because free diffusion of molecules larger than
500 kDa is restricted in the cytoplasm compared to dilute solutions,
viruses as well as cellular organelles and chromosomes depend on active
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mechanisms for directed transport (Luby-Phelps 2000). This is particu-
larly evident in the case of neurotropic viruses that travel long distances
in the axon during retrograde or anterograde transport (Smith and
Enquist 2002). For example, it would take a herpes virus capsid 231 years
to diffuse 10 mm in the axonal cytoplasm (Sodeik 2000).
Viruses use two alternative strategies for intracellular transport. One
is to hijack cytoplasmic membrane traffic. During cell entry many virus-
es pass through the endocytic pathway to the cell centre (see the chapter
by Sieczkarski and Whittaker, this volume). After budding, virions travel
inside vesicles derived from the endoplasmic reticulum and the Golgi
apparatus to the plasma membrane for viral egress (see the chapter by
Maggioni and Braakman, this volume). Alternatively, viral components
interact directly with the cytoskeletal transport machinery. It is helpful
to distinguish between cytoplasmic and cytosolic transport. The first is
a general term referring to both transport inside a membrane and cyto-
solic transport. The latter involves direct interactions between cytosolic
viral components and the cytoskeleton (Sodeik 2000).
We begin with an overview of the organisation and function of the cy-
toskeleton and then discuss selected viruses whose cytoplasmic trans-
port is either well characterised in molecular terms, such as herpesvirus
and adenovirus, or mechanistically unique, as for vaccinia virus and
baculovirus (Table 1).
2
The Cytoskeleton
The host cytoskeleton forms a three-dimensional network which is regu-
lated by many accessory proteins and defines the cells shape as well as
its internal organisation. It mediates physical robustness, cell–cell con-
tact, cell crawling, cell division, organelle or RNA transport during inter-
phase and chromosome movement during mitosis or meiosis. Cytoskel-
etal filaments are assembled by non-covalent binding from protein sub-
units: Monomeric actin polymerises into microfilaments with a diameter
of 5–6 nm, dimeric tubulin assembles hollow tubes of 25 nm and pro-
teins such as keratin or vimentin form 10-nm intermediate filaments.
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2.1
Intermediate Filaments
The intermediate filament proteins show a characteristic tripartite do-
main organization. N- and C-terminal globular head and tail domains of
varying size and sequence flank a centrally located rod domain which
mediates lateral interactions during assembly (Coulombe et al. 2001).
The rope-like intermediate filaments span the entire cytosol and provide
mechanical strength against shear forces.
Intermediate filaments do not seem to play any role in intracellular
transport because they have no polarity and no motor proteins have
been identified which use them as tracks.
During the late phase of many viral infections, intermediate filaments
are rearranged or disassembled by viral proteases (Chen et al. 1993;
Ferreira et al. 1994; Luftig and Lupo 1994; Brunet et al. 2000). If the in-
termediate filaments are disassembled, microinjected beads can diffuse
more freely (Luby-Phelps 2000). One could assume that the same holds
true for viral particles, and that viral modification of the intermediate
filaments facilitates egress.
The formation of aggresomes also leads to the reorganisation of inter-
mediate filaments into a perinuclear cage in a cellular attempt to seques-
ter misfolded and unassembled protein subunits (Garcia-Mata et al.
1999; Kopito 2000). African Swine Fever virus might actually exploit this
pathway in order to concentrate viral structural proteins for assembly in
a viral factory (Heath et al. 2001).
2.2
Actin Filaments
The most abundant protein of many cells, actin, exists in monomeric
form as globular actin or G-actin and in filamentous form called F-actin
or microfilaments. Polymerisation proceeds by the reversible endwise
addition of actin subunits that stimulates hydrolysis of bound ATP. Each
filament is polarised, and its ends have distinct biochemical properties.
The fast-growing end is called the barbed or plus-end, and the slow-
growing end the pointed or minus-end (Welch and Mullins 2002). In
cells, polymerisation occurs primarily at the plus-end and must be tight-
ly regulated, because the turnover of actin subunits in vivo is 100–200
times faster than with pure actin (Zigmond 1993).
Actin filaments are flexible structures which are organised into a vari-
ety of linear bundles and arrays, two-dimensional networks or three-
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dimensional gels. Numerous G- and F-actin binding proteins regulate
the monomer pool, the formation of filaments and higher-order net-
works as well as filament depolymerisation for monomer recycling. For
example, binding of the Arp2/3 complex to the lateral side of actin fila-
ments leads to a dendritic pattern of actin filament nucleation (Welch
and Mullins 2002).
Besides actin filaments dispersed throughout the entire cell, all cells
contain a cortical network of actin filaments, generally oriented with
their plus-ends facing towards the plasma membrane. This actin cortex
is the key player in various cell motility processes which are based on
filament assembly and the action of myosins (Welch and Mullins 2002;
Kieke and Titus 2003).
However, the actin cortex beneath the plasma membrane can also be
an obstacle for virus entry or budding (Marsh and Bron 1997). This may
be the reason why many viruses enter cells via endosomes which easily
traverse the actin cortex (see the chapter by Sieczkarski and Whittaker,
this volume). Certain viruses might even fuse with either the plasma
membrane or an endosome depending on the cell type they are infecting
(Miller and Hutt-Fletcher 1992; Nicola et al. 2003).
The cortical actin might also be a barrier for virus assembly at the
plasma membrane. The cortical actin might be locally depolymerised,
or the force of actin polymerisation could be used to drive the budding
process (Cudmore et al. 1997; Garoff et al. 1998). Recent evidence sug-
gests that a shell of cortical actin also surrounds many membrane or-
ganelles. Thus viruses could pick up actin and actin-binding proteins
during budding as has been shown for human immunodeficiency virus
(HIV) (Ott et al. 1996; Liu et al. 1999; Wilk et al. 1999).
Regulated binding to cytosolic actin filaments can control the subcel-
lular localisation of a protein; an example is the nucleoprotein of influ-
enza virus (Digard et al. 1999). Despite many reports on nuclear actin
only recent evidence supports a role of nuclear actin in chromatin re-
modelling, splicing, nuclear import and export (reviewed in Rando et al.
2000; Pederson and Aebi 2002). Many viruses use actin during replica-
tion, but with the exception of nucleocapsid assembly of some bac-
uloviruses (Kasman and Volkman 2000) and the export of unspliced
genomic HIV-1 RNAs (Kimura et al. 2000; Hofmann et al. 2001), these
activities all occur within the cytoplasm.
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2.3
Microtubules
Microtubules (MTs) are long, hollow cylinders assembled from het-
erodimers of a- and b-tubulin and MT-associated proteins (MAPs). The
head-to-tail association of tubulin into 13 protofilaments leads to the for-
mation of MTs, which are further stabilised by lateral interactions between
adjacent protofilaments. MTs are, like actin filaments, polar structures
with a dynamic fast-growing plus-end and a less dynamic minus-end
(Desai and Mitchison 1997; Downing 2000). The overall subcellular MT
organisation is highly polarised. MT dynamics vary considerably between
different regions of a cell, during the cell cycle and throughout differentia-
tion. Thus MT turnover is tightly controlled in space and over time.
The plus-ends of MTs are the primary sites of MT growth and short-
ening, resulting in a phenomenon called dynamic instability (Mitchison
and Kirschner 1984). After subunit addition at the end, the GTP bound
to b-tubulin is slowly hydrolysed. The consecutive loss of this GTP-tubu-
lin cap leads to catastrophic MT depolymerisation. GTP-tubulin is more
likely to be added to a GTP-tubulin cap than to a MT rapidly depoly-
merising. Plus-end binding proteins such as CLIP-170, EB1 or APC sta-
bilise a region of about 1 mm at the plus-end of MTs and thus enable
them to interact with the plasma membrane, organelles or the kineto-
chores of chromosomes. This search-and-capture mechanism prevents
depolymerisation, and the MT stabilisation can even reorient the MTOC
and thus the entire MT network (Howard and Hyman 2003).
In most animal cells, minus-ends are attached to a MT-organising
centre (MTOC) called a centrosome and typically located close to the cell
nucleus whereas the plus-ends are pointing towards the cell periphery
and plasma membrane. However, several cell types contain a substantial
number of non-centrosomal MTs (Keating and Borisy 1999). Even at
steady state—when a population of MTs has reached constant mass—
individual MTs may be polymerising or depolymerising, and such
dynamics modulate intracellular transport (Keating and Borisy 1999;
Giannakakou et al. 2002). Polarised epithelial cells are characterised by
an apical and a basal MT web and longitudinally arranged MTs which
point with their minus-ends to the apical and with their plus-ends to the
basal membrane (Topp et al. 1996). Neuronal MTs in axons are also lon-
gitudinally arranged with their minus-ends pointing to the soma and
their plus-ends to the axon terminal, whereas most dendrites have MTs
of mixed polarity (Goldstein and Yang 2000; Hirokawa and Takemura
2003).
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Many MAPs such as tau contain a basic domain which interacts with
MTs via the acidic C-terminal domains of tubulin which are exposed on
the MT surface (Downing 2000). Also, viral proteins with a basic domain
such as many RNA- or DNA-binding proteins have the potential to inter-
act with the MT surface (Elliott and OHare 1997; Ploubidou et al. 2000;
Mallardo et al. 2001).
MTs are involved in long-distance transport as highlighted by the
transport requirements through neuronal dendrites and axons. More-
over, the reversible association to MTs and motors regulates the subcel-
lular localisation of important signalling proteins and transcription fac-
tors (Ziegelbauer et al. 2001; Giannakakou et al. 2002; Schnapp 2003).
3
Molecular Motors
Many proteins interact with tubulin and actin to regulate their structural
organisation. A subset of those, the motor proteins, use conformational
changes powered by ATP hydrolysis to transport cargo along the fila-
ments. If motors are fixed on a surface such as a membrane, they move
the filaments relative to that surface. If instead the filament is fixed, mo-
tors transport cargo along that filament.
Myosins mediate translocation along actin filaments, whereas dynein
and kinesins move on MTs. It has been suggested that in animal cells
long-range transport occurs along MTs and short-range transport along
actin filaments (reviewed in Brown 1999; Verhey 2003). A viral particle
could be transported either by directly recruiting a motor or by attach-
ing to a cargo of a given motor. Moreover, polymerising actin filaments
can push around different cargo such as endocytic vesicles, intracellular
bacteria or vaccinia virus (Frischknecht and Way 2001).
3.1
Myosins
All myosins share a common N-terminal motor domain of about
500 amino acids that binds to actin filaments (www.mrc-lmb.cam.ac.uk/
myosin/myosin.html). A flexible neck region connects the motor domain
to a tail region of variable size which determines the specific function of
each myosin and the specificity of cargo binding. Myosins have been
grouped into 18 classes according to homologous sequences in the tail
domain (Kieke and Titus 2003).
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Most myosins walk towards the plus-ends of actin filaments, with the
exception of myosin VI and possibly myosin IXb, which are minus-end-
directed motors (Kieke and Titus 2003). The myosin IIs are often called
conventional myosins and include the best-studied example of skeletal
muscle myosin. Cytoplasmic myosin II consists of two heavy chains and
two pairs of light chains. Myosin II generates contractile forces during
cytokinesis, maintains cortical tension and is crucial for cell motility.
Myosin I, V and VI are involved in membrane traffic; moreover, myosin
I plays a role in cell motility and signal transduction (Kieke and Titus
2003).
3.2
Kinesins
Kinesins transport membranes, cytoskeletal filaments, viral particles,
mRNAs and proteins along MTs and are engaged in organising the mi-
totic spindle as well as chromosome translocation (Hirokawa and Take-
mura 2003). The defining criterion for a kinesin is a MT-binding motor
domain of 320 amino acids, which is folded into a core with an overall
structure similar to myosins and G proteins (Schliwa and Woehlke 2003;
www.proweb.org/kinesin//index.html). The motor domain is linked to
structural and regulatory domains, which attach to other cofactors,
adaptor proteins or interaction modules (Karcher et al. 2002; Schnapp
2003). The kinesins are sorted into three groups according to the posi-
tion of the motor domain at the N-terminus, an internal position, or the
C-terminus, hence the names Kin-N, Kin-I and Kin-C kinesins, and
based on homology into 14 classes (Hirokawa and Takemura 2003).
N-type kinesins, which include conventional kinesin (kinesin-1,
KIF5), move towards MT plus-ends. Kinesin-1 is a heterodimer of two
heavy chains (KHC) that each contain a motor domain, an a-helical
stalk responsible for dimerization and a C-terminal tail domain that
binds two light chains (KLC). The KLCs can dock onto adaptors or cargo
receptors and link kinesin to the cargo (Hirokawa and Takemura 2003).
Kinesin-1 transports various cargos such as axonal vesicles, mitochon-
dria, lysosomes, endocytic vesicles, tubulin oligomers, intermediate fila-
ment proteins or mRNA complexes (Hirokawa and Takemura 2003). Ki-
nesin-1 is also responsible for the transport of vaccinia virus (VV) to
the plasma membrane (Rietdorf et al. 2001).
The respective cargos of the N-type kinesins KIF1A and KIF1B are
synaptic vesicles and mitochondria (Nangaku et al. 1994; Okada et al.
1995). The N-type heterotrimeric kinesin with the KIF3 heavy chains
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mediates axonal transport of fodrin-containing vesicles, and in epithelial
cells KIF3 interacts with APC, a MT plus-end binding protein (Takeda et
al. 2000; Jimbo et al. 2002). Kin-C kinesins move towards the MTminus-
ends (Hirokawa and Takemura 2003). Most C-type kinesins act during
mitosis, but some are implicated in membrane transport in neuronal
dendrites and polarised epithelial cells (Hanlon et al. 1997; Saito et al.
1997; Noda et al. 2001; Xu et al. 2002). Kin-I kinesins most likely do not
work as motors but destabilise MTs (Desai et al. 1999; Hunter et al.
2003).
3.3
Cytoplasmic Dynein
Axonemal and cytoplasmic dyneins transport cargo towards MTs mi-
nus-ends. Axonemal dyneins provide the driving force for the beating
movement of cilia and flagella (King 2003). Cytoplasmic dynein plays an
essential role during mitosis and is responsible for the perinuclear local-
isation of several organelles around the MTOC as well as retrograde or-
ganelle transport in axons (Karki and Holzbaur 1999). Cytoplasmic dy-
nein is also required for the transport of non-membranous cargo such
as NuMA, aggresomes, viral capsids, neurofilaments and pericentrin
particles (Merdes and Cleveland 1997; Garcia-Mata et al. 1999; Suoma-
lainen et al. 1999; Shah et al. 2000; Sharp et al. 2000; Young et al. 2000;
Dhner et al. 2002). It is even involved in the transport of mRNAs and
proteins regulating transcription (Galigniana et al. 2001; Giannakakou et
al. 2002; Tekotte and Davis 2002).
Cytoplasmic dynein is a 20 S protein complex in the shape of a Y and
consists of two dynein heavy chains (DHCs; 530 kDa), two intermediate
chains (DICs; 70–80 kDa), four light intermediate chains (DLICs; 50–
60 kDa), and three families of light chains (DLCs, 7–14 kDa, see below;
Karki and Holzbaur 1999; King 2003). DHCs are members of the AAA
family of ATPases and mediate MT binding, ATP hydrolysis and force
generation (King 2000). The DICs belong to the WD-repeat protein fam-
ily and are located at the base of the dynein motor. DLICs, DICs and
DLCs have been implicated in motor regulation and cargo binding (King
2003). The subunits differ in their subcellular localisation and tissue ex-
pression, suggesting that cytoplasmic dynein exists in many distinct iso-
forms with unique subunit composition (Nurminsky et al. 1998; Tai et
al. 2001).
For most, if not all, minus-end-directed transport processes cytoplas-
mic dynein requires a cofactor called dynactin (Karki and Holzbaur
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1999). Dynactin is another large 20 S protein complex consisting of 11
different subunits (Holleran et al. 1998; Eckley et al. 1999). The p150Glued
subunit of dynactin binds directly to the DICs. Interestingly, dynactin
was recently reported to also play a role in melanosome transport catal-
ysed by heterotrimeric kinesin (Deacon et al. 2003).
3.3.1
Binding Partners of Dynein Light Chains
Many DLC binding partners have been identified in yeast two-hybrid
screens, sometimes supported by GST-pull down or co-immunoprecipi-
tation assays after transient overexpression of the proteins. However, it
has often been difficult to confirm these interactions with endogenous
proteins under physiological conditions, and to prove that they lead to
the recruitment of a motor. Based on sequence homology, DLCs have
been grouped into the LC7/Roadblock, LC8/PIN and Tctex families (King
2003).
Members of the LC7 family bind to DICs and play a role in intracellu-
lar transport and mitosis in Drosophila (Bowman et al. 1999; Susalka et
al. 2002). A mammalian member, mLC7, interacts with transforming
growth factor-b (Tang et al. 2002).
DLCs of the LC8/PIN family bind to neuronal nitric oxide synthase
and are therefore also called PIN for protein inhibitor of nitric oxide
synthase (Jaffrey and Snyder 1996). Further interaction partners are
IkBa, Bim of the Bcl-2 family, postsynaptic density-95/guanylate kinase
domain-associated protein, nuclear respiratory factor, the erect wing
gene product in Drosophila, swallow protein, DIC and, interestingly, the
30-UTR of parathyroid hormone RNA (King 2003). LC8/PIN is also a
subunit of the actin motor myosin V (Espindola et al. 2000). The inter-
action often involves a conserved K/R-XTQT or G-I/V-QVD sequence
motif in the DLC binding partner (Lo et al. 2001; Rodriguez-Crespo et
al. 2001; Martinez-Moreno et al. 2003).
LC8/PIN also interacts with the phosphoprotein of rabies and Mokola
virus (Raux et al. 2000; Jacob et al. 2000). Rabies virus spreads via neu-
rons and travels long distances from the site of entry to the neuronal cell
body. Axonal transport of rabies virus requires intact MTs, but it is un-
clear whether vesicles containing virions or cytosolic capsids are trans-
ported (Ceccaldi et al. 1989; Tsiang et al. 1991). Rabies viruses deleted
for the LC8 binding motif no longer incorporate LC8, but pathogenesis
is only impaired in already attenuated strains, and only in very young
mice (Mebatsion 2001; Poisson et al. 2001). LC8/PIN also binds to p54 of
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African swine fever virus, whose infection is inhibited if dynein is
blocked (Alonso et al. 2001; Heath et al. 2001). Yeast two-hybrid screens
revealed an interaction between HIV integrase and DYN2, a putative
LC8-like yeast dynein light chain of 92 amino acids (Richard de Soultrait
et al. 2002). Several additional potential viral interaction partners for
LC8/PIN such as HSV1 helicase, adenovirus protease, vaccinia virus
(VV) polymerase and, surprisingly, the extracellular domain of respira-
tory syncytial virus attachment protein have been identified by screen-
ing libraries of overlapping dodecapeptides in ligand blots (Martinez-
Moreno et al. 2003).
DLCs of the Tctex class bind to Doc2, p59fyn kinase, rhodopsin, FIP1,
Trk receptors, DIC, the cytosolic tail of CD5 and CD155, often via the
binding motif K/R-K/R-XX-K/R (King 2003). CD155 is the receptor for
poliovirus that invades the CNS by haematogenous or neural spread
(Mueller et al. 2002). After binding to the receptor the poliovirus ge-
nome is released into the cytosol through a membrane pore. It is unclear
whether pore formation occurs already at the plasma membrane or after
delivery to an endosome (Hogle 2002). If axonal transport occurs inside
an endocytic membrane, the binding of CD155 to Tctex-1 and thus
possibly dynein could mediate retrograde transport of virus-containing
vesicles to the cell body of the motor neuron (Mueller et al. 2002).
4
Experimental Approaches
4.1
The Tool Kit
There are several reversible pharmacological drugs that target cytoskele-
tal proteins. The response of different cell types to these drugs varies
greatly, and therefore each inhibitor is tested initially with different con-
centrations and incubation times (Jordan and Wilson 1999).
Cytochalasin and latrunculin depolymerise actin filaments, whereas
jasplakinolide promotes actin polymerisation (Cooper 1987; Bubb et al.
1994; Ayscough 1998). Colchicine, colcemide, vincristine, vinblastine
and nocodazole (podophyllotoxin) depolymerise MTs, whereas taxol
(paclitaxel) stabilises the MT network (Jordan and Wilson 1999). Be-
cause all these are not competitive inhibitors but interfere with the dy-
namic equilibrium between subunits and filaments, the cells need to be
treated for quite some time, until an effect on the steady-state distribu-
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tion of the cytoskeleton is manifested (Cooper 1987; Jordan and Wilson
1999).
Butanedione monoxime (BDM) inhibits ATP hydrolysis of myosin II,
V, VI and possibly I (Herrmann et al. 1992; Cramer and Mitchison
1995). However, higher concentrations may also target other ATPases
(Schlichter et al. 1992; Mojon et al. 1993; Phillips and Altschuld 1996).
KT5926, wortmannin and ML-7 block the activity of myosin light chain
kinase, and thus the only known downstream target, the non-muscle
myosin II (Nakanishi et al. 1990; Nakanishi et al. 1992; Ruchhoeft and
Harris 1997). Adociasulfate blocks kinesins (Sakowicz et al. 1998), and
dyneins are inhibited by erythro-9-[3-(2-hydroxynonyl)]adenine that
also affects adenosine deaminase and cGMP-stimulated phosphodiester-
ase (Penningroth 1986; Mery et al. 1995).
Microinjecting function-blocking antibodies, adding anti-sense or
small interfering RNAs or overexpressing a dominant-negative protein
can inhibit many motors. For example, excess dynamitin blocks dyn-
actin and overexpression of the cargo-binding domain of KLC inhibits
conventional kinesin (Echeverri et al. 1996; Burkhardt et al. 1997; Valetti
et al. 1999; Rietdorf et al. 2001).
Testing many inhibitors aiming at alternative targets by different mo-
lecular mechanisms provides a guide for analysing the role of the cyto-
skeleton in virus infection. To determine which viral proteins are in-
volved in cytoplasmic transport, viral mutants with defined genotypes
have been generated.
4.2
Video Microscopy
Intracellular movement of host and viral particles is best analysed by vi-
deo or digital time-lapse microscopy (Lippincott-Schwartz et al. 2000;
Zhang et al. 2002). This technique adds another dimension to the analy-
sis of fixed cells, because not only the steady-state distribution of viral
components but also the dynamics of their transport is analysed. Be-
cause of their small size and limited contrast, viral particles with the ex-
ception of vaccinia virus need to be tagged with a fluorescent molecule
for tracking in live cells.
Direct chemical coupling to small fluorescent dyes was used to ana-
lyse cytoplasmic transport of non-enveloped viruses (Georgi et al. 1990;
Leopold et al. 1998; Suomalainen et al. 1999). Because many viruses un-
dergo substantial disassembly steps during entry (Greber et al. 1993),
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one needs to identify the protein to which the dye has been attached
and, if possible, analyse trafficking of differently tagged viral structures.
To analyse the infection of enveloped viruses, the fluorescent tag must
be linked to a structure which after membrane fusion remains associat-
ed with the genome during its cytosolic passage. Green fluorescent pro-
tein (GFP)-tagged capsid or core proteins have been used to track pseu-
dorabies virus and HIV (Smith et al. 2001; McDonald et al. 2002). Be-
cause all viral particles can be taken up by endocytosis, even if that is
not their physiological entry port (see the chapter by Sieczkarski and
Whittaker, this volume), experiments using fluorescently labelled virions
require care to distinguish cytosolic particles from those in endosomes
(Suomalainen et al. 1999; McDonald et al. 2002; Sodeik 2002). Likewise,
when analysing viral egress, one needs to distinguish GFP-tagged virions
from GFP-fusion protein in the biosynthetic pathway or in the cytosol
(Rietdorf et al. 2001). The recent improvements in the design of fluores-
cent proteins allow dual-colour imaging of different viral particles in live
cells (Zhang et al. 2002).
Attaching multiple fluorescent molecules to a virus or subviral parti-
cle could alter virus assembly and subsequently virus entry. Fluorescent
dyes are usually quite hydrophobic, and GFP is a protein of 27 kDa re-
sulting in a rather large mutation of any viral protein. Therefore, it is
crucial to test with several assays that a GFP-tagged virus behaves simi-
larly to the unlabelled virus. Among the physiological cargo of dynein
are aggregated protein complexes that are packed into aggresomes at the
MTOC (Garcia-Mata et al. 1999; Kopito 2000). Thus the cells might send
many non-functional viral proteins along MTs to the MTOC for refold-
ing or final degradation (Sodeik 2002).
Many of these issues can now be overcome by single-molecule imag-
ing techniques (Seisenberger et al. 2001). However, they require spe-
cialised equipment to visualise the emission with a low signal-to-noise
ratio. Most results so far have been obtained with a high ratio of dye to
particle. With the use of fluorescent proteins with improved excitation
and emission spectra and digital cameras with increasing sensitivity,
movies of viral cytoplasmic transport at physiological conditions can
now be recorded.
4.3
Virological Assays, Cytoskeletal Cooperation, and Viral Modifications
Besides suitable tools to analyse the cytoskeleton, many experiments
have been developed to study individual phases of a viral life cycle. In
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addition to blocking cytoplasmic transport, the inhibitors used could
also influence viral infection in other ways.
For example, because a cells membrane traffic relies heavily on actin
and MT transport, important host factors, such as viral receptors, could
mis-localise, thus resulting in a reduced or increased virus binding, inter-
nalisation or other changes in the viral life cycle (Dhner et al. 2002). If
the readout for cytoplasmic transport during virus entry is nuclear viral
gene expression, a potential role of nuclear actin or myosin in viral tran-
scription should be considered (Pederson and Aebi 2002). The host cyto-
skeleton can also directly influence viral transcription as shown for
paramyxoviruses or reverse transcription and viral budding as in the case
of HIV (Sasaki et al. 1995; Bukrinskaya et al. 1998; Gupta et al. 1998).
Moreover, the three types of cytoskeletal filaments are interdependent
entities which operate together in cells (Fuchs and Yang 1999; Goode et
al. 2000). The last years have shown a close interaction between MT
plus-ends and the actin cortex, and several proteins provide physical
links between different filament types (Coulombe et al. 2000; Allan and
Nthke 2001; Leung et al. 2002). Thus a prolonged incubation with any
of the inhibitors could lead to pleiotropic effects. For example, targeting
MTs with depolymerising drugs or with antibodies to stable MTs also re-
sults in the collapse of intermediate filaments to a perinuclear region
(Gurland and Gundersen 1995).
Many cells contract, and in the extreme case completely round up, if
actin filaments are disassembled, because their substrate adhesion via
focal contacts is weakened (Ayscough 1998). This reduces the transport
distances, for example from the plasma membrane to the nucleus, and
cargo could reach a particular binding site such as the nuclear pore in
the absence of the appropriate filament system by diffusion rather than
by active transport as under physiological conditions. Moreover, al-
though cytoskeletal filaments provide tracks for cytoplasmic viral trans-
port, they also restrict the space that is open for translocation (Luby-
Phelps 2000). Thus depolymerising cytoskeletal filaments removes both
transport trails and steric barriers.
For these reasons, it is sometimes difficult to determine the precise
functional role of the cytoskeleton during virus infection. In addition,
late in infection the cytoskeletal filaments are often rearranged, compli-
cating the analysis of their role during assembly and egress (Avitabile et
al. 1995; Brunet et al. 2000; Dreschers et al. 2001). However, by taking
these caveats and limitations into consideration, we have learnt an amaz-
ing amount about the molecular cross-talk between viruses and the host
cytoskeleton.
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5
Neurotropic Herpesvirus and Cytoplasmic Transport
5.1
Microtubule Transport During Entry
Neurotropic viruses are dependent on efficient transport because they
travel long distances during pathogenesis. Prominent examples are the
alphaherpesviruses such as human herpes simplex virus (HSV). After
initial replication in exposed mucosal epithelia, progeny virions enter lo-
cal nerve endings of peripheral neurons and the capsid without the en-
velope is retrogradely transported to the nucleus located in a peripheral
nerve ganglion. Here, HSV1 establishes a latent infection that on stress
can be reactivated to a lytic infection of the neuron. Newly synthesised
virus is then released from the nerve endings and re-infects the periph-
eral epithelial tissue (Roizman and Knipe 2001; Smith and Enquist
2002). MTs are required in epithelial and neuronal cells as well as
during entry and egress (Kristensson et al. 1986; Topp et al. 1994, 1996;
Avitabile et al. 1995; Sodeik et al. 1997; Miranda-Saksena et al. 2000;
Kotsakis et al. 2001; Mabit et al. 2002).
The fusion of the HSV1 envelope with the plasma membrane releases
into the cytosol a capsid and about 20 different proteins of the tegument,
a protein layer encasing the capsid. The capsid, associated with a subset
of tegument proteins, is transported along MTs to the MTOC, localised
in the cell centre, and further to the nucleus (Kristensson et al. 1986; Ly-
cke et al. 1988; Sodeik et al. 1997; Mabit et al. 2002). The docking of
the capsid at the nuclear pore induces the translocation of the viral ge-
nome into the nucleoplasm (Ojala et al. 2000), where viral replication,
transcription and later during infection capsid assembly take place
(Fig. 1A).
Incoming HSV1 capsids co-localise with cytoplasmic dynein and dy-
nactin in epithelial cells (Sodeik et al. 1997; Dhner et al. 2002). Electron
micrographs of detergent-extracted, infected cells reveal structures re-
sembling the Y-shaped cytoplasmic dynein at the capsid vertices (Sodeik
et al. 1997), where the tegument has a more ordered structure and the
tegument protein VP1-3 might be located (Zhou et al. 1999). Moreover,
inhibiting dynein function by the overexpression of dynamitin reduces
transport of HSV1 capsids to the nucleus and early viral gene expression
without having any effect on virus binding or internalisation (Dhner et
al. 2002). Whether and how capsids move further from the MTOC to the
nuclear pore complex is unclear (Sodeik 2002).
82 K. Dhner · B. Sodeik
In vivo analysis of the entry into epithelial cells by time-lapse digital
fluorescence microscopy showed that GFP-tagged capsids moved along
MTs towards and away from the nucleus with maximal speeds of
1.1 m/s (Dhner, Bttner, Wolfstein, Schmidt and Sodeik, in prepara-
tion). Incoming pseudorabies virus, another alphaherpesvirus, moves at
rates averaging 1.3 m/s. The transport is saltatory and bi-directional,
Fig. 1A–C. Cytosolic transport during virus entry. A After fusion of the envelope of
herpes simplex virus type 1 (HSV1) with the plasma membrane, the capsid (dark
green) and the tegument proteins (green) are released into the cytosol. The capsid
with a subset of tegument proteins associated binds to microtubules (red) and is
transported by dynein and dynactin (blue) to the MT-organising centre where the
MT minus-ends are located. After capsid (light green) binding to the nuclear pore
complex, the viral DNA is injected into the nucleoplasm. B Human immunodeficien-
cy virus type-1 (HIV-1) enters cells by fusion with the plasma membrane. During
passage through the cytosol, the viral RNA genome is reverse transcribed into DNA
in a structure called reverse transcription complex or preintegration complex (PIC;
green). This structure co-localises with microtubules (red) and requires dynein
(blue) for its transport to the nucleus. The proviral DNA is imported into the nucle-
us and integrated into a host chromosome. C Adenovirus of the subgroup C is inter-
nalised by receptor-mediated endocytosis and induces lysis of the endosome (grey)
to access the cytosol. The cytosolic capsid (green) binds to microtubules (red) and is
transported by dynein and dynactin (blue) to the cell centre. During entry, the cap-
sids are stepwise disassembled (indicated by the different shades of green). At the
nuclear pores, the viral DNA and associated proteins are released from the capsid
(light green) and imported into the nucleoplasm
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but in neuronal processes with a retrograde bias towards the cell body
(Smith and Enquist 2002).
Alphaherpesvirus capsids must possess a viral receptor either for dy-
nein or for dynactin, which allows them to engage the host MT system
for efficient transport from the plasma membrane to the host nucleus, a
particularly long distance after infection of neurons via a synapse. In
unpolarised epithelial cells capsids show minus- and plus-ended direct-
ed transport during entry, whereas in cultured neurons the retrograde
transport towards the nucleus predominates.
5.2
Microtubule Transport During Egress
Herpesvirus capsids assemble in the nucleus and after genome packag-
ing acquire a primary envelope by budding at the inner nuclear mem-
brane. The traditional view was that from then on the virus particle re-
mained within the secretory pathway and was released from infected
cells by fusion of a vesicle containing the enveloped virion with the plas-
ma membrane (reviewed in Roizman and Knipe 2001; Mettenleiter
2002). In this scenario, all tegument proteins were added to the capsids
already in the nucleus, and cytoplasmic transport was mediated by the
interaction of membrane vesicles, possibly modified by the addition of
viral proteins, with the host cytoskeleton.
Several studies in the last decade suggested that many if not all her-
pesviruses use an alternative pathway. Accordingly, transiently en-
veloped viral particles leave the periplasmic space by fusion with the
outer nuclear envelope or the membrane of the endoplasmic reticulum
which is continuous with the nuclear envelope (Roizman and Knipe
2001; Mettenleiter 2002). By this procedure, capsids traverse the nuclear
envelope and reach the cytosol. The naked cytosolic capsids can recruit
tegument proteins and engage the host cytoskeleton to travel to the site
of secondary envelopment. Newly synthesised HSV1 particles tagged
with GFP-VP11/12 move along MTs over distances of up to 49 m with
average velocities of 2 m/s (Willard 2002).
In unpolarised epithelial cells, secondary envelopment most likely oc-
curs at the trans-Golgi network (TGN) or an endosome (Skepper et al.
2001; Mettenleiter 2002). In non-infected cultured cells, these organelles
are clustered around the MTOC in close proximity to the nucleus. Thus,
at least early during assembly, again dynein possibly assisted by dyn-
actin could transport the capsids to the desired location. However, later
during infection, the MTs are marginalised in bundles to the periphery
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Fig. 2A, B. Cytosolic transport during virus egress. A After nuclear HSV1 capsid as-
sembly and genome packaging, the capsid (dark green) acquires a primary envelope
by budding at the inner nuclear membrane. This primary envelope is lost by subse-
quent fusion with the outer nuclear membrane, and the capsid is released into the
cytosol. Most if not all tegument proteins (light green) are acquired in the cytosol or
during the second envelopment. In neurons, capsids with associated tegument and
membrane vesicles (grey) containing viral envelope proteins are transported along
microtubules (red) to the presynapse. Axonal transport is mediated by conventional
kinesin (dark blue). Presumably, secondary envelopment occurs in the nerve end-
ings. B The intracellular mature form (IMV) of vaccinia virus containing the core
(green) is assembled in viral factories located in the cytoplasm. The IMV is trans-
ported to the MTOC region along MTs by dynein (blue) and dynactin (light blue). At
the MTOC, the IMV is enwrapped by a membrane cisterna derived from the trans-
Golgi network or an early endosome, resulting in the formation of the intracellular
enveloped virus (IEV). The IEV requires MTs and conventional kinesin (dark blue)
for its transport to the plasma membrane. Shortly before or after fusion of the outer
IEV membrane with the plasma membrane, polymerisation of actin filaments
(orange) is induced. The cell-associated virus (CEV) is pushed on top of a long mi-
crovillus into the medium or a neighbouring cell
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of the cytoplasm, and there is no longer an obvious MTOC (Avitabile et
al. 1995; Elliott and OHare 1998, 1999; Kotsakis et al. 2001). The reor-
ganisation of the MT network most likely also changes the steady-state
distribution of the membrane organelles. The localisation of MT plus-
or minus-ends has not been determined late in infection, and therefore
it is difficult to predict which MT motors would then catalyse capsid
transport to the organelle of secondary envelopment.
In a typical neuronal axon, the MT plus-ends are uniformly oriented
towards the synapses and the minus-ends to the cell body (Goldstein
and Yang 2000). There are no reasons to believe that this organisation is
changed during a herpesvirus infection. Progeny virus spreads via the
axons, and the traditional model predicted that axonal transport of fully
assembled virions occurs inside vesicles. However almost 10 years ago
Cunningham and collaborators demonstrated that in human primary
sensory neurons HSV1 naked capsids were closely associated with ax-
onal MTs (Penfold et al. 1994). This study suggested that in neurons the
secondary envelopment might take place in the presynapse (Fig. 2A).
Immune labelling showed that the glycoproteins are transported in
vesicles, separately and with different kinetics from the capsids (Holland
et al. 1999; Miranda-Saksena et al. 2000; Ohara et al. 2000). In pseudora-
bies virus, the type II integral membrane protein US9 is required for tar-
geting of all tested viral membrane proteins to the axon, but not for ax-
onal transport of capsids and some tegument proteins (Tomishima and
Enquist 2001). Immunoelectron microscopy showed that progeny axonal
cytosolic capsids co-localise with conventional kinesin (Diefenbach et
al. 2002). As during virus entry, GFP-tagged pseudorabies virus is trans-
ported in both directions in axons late in infection. But during egress
the anterograde transport predominates. Average plus-end-directed ve-
locities are 2 m/s and minus-end directed velocities 1.3 m/s (Smith et
al. 2001).
Thus, during axonal transport, progeny capsids recruit a plus-end
MT motor, most likely conventional kinesin. In epithelial cells a minus-
end-directed MT motor could ensure, at least early during assembly,
transport to the organelle of secondary envelopment.
5.3
Biochemical Analysis of Viral Capsid Transport
Several assays have been developed to characterise the host factors as
well as the viral receptors involved in MT transport. GFP-labelled cap-
sids were isolated after detergent extraction of purified virions (Bearer
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et al. 2000; Wolfstein, Nagel, Dhner, Allan and Sodeik, in preparation).
Bearer et al. (2000) injected such capsids into the giant axon of the squid
Loligo paelei, a classic system to analyse fast MT-mediated transport.
HSV1 capsids labelled with co-packaged VP16-GFP that had been ex-
pressed from a complementing cell line moved in a continuous fashion
in retrograde direction with average velocities of 2.2 m/s. This unidi-
rectional, non-saltatory movement is different to the motility of GFP-
tagged herpes particles after infection of vertebrate cells (Smith et al.
2001; Willard 2002; Dhner, Bttner, Wolfstein, Schmidt and Sodeik, in
preparation).
Wolfstein et al. (in preparation) reconstituted capsid motility in vitro
with Cy3-labeled MTs, VP26GFP-tagged capsids, an ATP-regenerating
system and a cytosolic protein fraction. In vitro transport was also salta-
tory, with long continuous runs of more than 10 mm in one direction,
and the capsids often changed MTs. In this assay capsid transport along
MTs depended on their tegument composition. It could be inhibited by
the addition of recombinant dynamitin, suggesting that the motility was
catalysed by dynein or heterotrimeric kinesin (Wolfstein, Nagel, Dhner,
Allan and Sodeik, in preparation). Such biochemical assays can now be
used to characterise the molecular interactions between viral and host
factors.
5.4
Interaction of Herpesvirus with Cytoskeletal Proteins
VP22, one of the major tegument proteins of HSV1, and GFP-VP22 co-
localise with MTs after transfection, whereas in infected cells VP22 does
not show a prominent enrichment on MTs (Elliott and OHare 1997,
1999; Kotsakis et al. 2001). The transient restructuring of the MT net-
work during virus infection coincides with the translocation of VP22
from the cytoplasm to the nucleus (Kotsakis et al. 2001). Transient ex-
pression of VP22 or infection with HSV1 leads to a stabilisation and hy-
peracetylation of MTs (Elliott and OHare 1998, 1999). A basic VP22
fragment contains the MT binding domain (Martin et al. 2002).
In addition, VP22 interacts with non-muscle myosin II, and the myo-
sin inhibitor BDM reduces virus yields (van Leeuwen et al. 2002). Be-
cause VP22 is released into the cytosol on HSV1 fusion with the plasma
membrane, this interaction could also facilitate the penetration of the
actin cortex by the incoming viral capsid.
The first herpesvirus protein reported to interact with the DIC sub-
unit of cytoplasmic dynein in GST pull down assays was the UL34 of
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HSV1, with a predicted type II integral membrane topology (Ye et al.
2000; Reynolds et al. 2002). UL34 of HSV and pseudorabies virus is tar-
geted to the inner nuclear membrane, where during budding it is incor-
porated into the primary envelope of periplasmic virions (Klupp et al.
2000; Reynolds et al. 2002). In contrast to the inner nuclear membrane,
cytoplasmic membranes and extracellular virions do not contain UL34;
thus it cannot be involved in viral cytoplasmic transport.
The heavy chain of conventional kinesin interacts with the HSV1
tegument protein US11. Moreover, US11 and the major capsid protein
VP5 were reported to be transported with similar kinetics into the axons
of dissociated rat neurons (Diefenbach et al. 2002).
6
Retrovirus Entry and Budding
HIV, the most prominent representative of retroviruses, enters cells pri-
marily by membrane fusion at the plasma membrane (Greene and Peter-
lin 2002), although some strains can also infect cells via endocytic up-
take (Fackler and Peterlin 2000). During passage through the cytosol,
the viral RNA genome is reverse transcribed into DNA in a structure
named the reverse transcription complex (RTC) or pre-integration com-
plex (PIC). PIC is targeted to the nuclear pore complex and imported
into the nucleus, and the HIV genome is integrated into a chromosome
(Greene and Peterlin 2002; see the chapter by Byland and Marsh, this
volume, and Fig. 1B).
Cytochalasin prevents the co-clustering of the HIV receptors CD4 and
CXCR4 on gp120 binding and thus somehow inhibits efficient HIV fu-
sion with the plasma membrane (Iyengar et al. 1998). On cell fraction-
ation RTCs are localised in a cytoskeletal fraction, and reverse transcrip-
tion requires intact actin filaments (Bukrinskaya et al. 1998).
Intracellular trafficking of HIV can be visualised with a GFP-Vpr fu-
sion protein which is packaged into virions (McDonald et al. 2002). By
live cell imaging GFP-Vpr-labelled subviral particles co-localise with
MTs, move in curvilinear paths in the cytoplasm and accumulate around
the MTOC as early as 2 h after infection. HIV transport is completely
blocked in the presence of both nocodazole and latrunculin, but not by
either one alone. The incoming PIC of human foamy virus, another ret-
rovirus, also accumulates around the MTOC by a MT depending trans-
port (Saib et al. 1997).
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When dynein is inhibited by a microinjected antibody, the relative
transport of RTCs to the nucleus is reduced (McDonald et al. 2002). In-
terestingly, in this situation the RTCs accumulate in the cell periphery,
similar to what has been described for HSV capsids after overexpression
of dynamitin (Dhner et al. 2002). Moreover, yeast two-hybrid assays
showed an interaction of HIV integrase with the yeast homologue of dy-
nein LC8 (Richard de Soultrait et al. 2002).
Most likely, HIV subviral particles that are assembled in the cyto-
plasm also use active transport to reach the plasma membrane, where
retrovirus budding often takes place (Greene and Peterlin 2002). Both
MTs and the binding motive for the host factor hnRNPA2 present in ge-
nomic HIV RNA are involved in trafficking of RNA granules (Mouland
et al. 2001). The human T cell leukaemia virus, a retrovirus distantly re-
lated to HIV, requires a cell-cell junction and MTs for efficient transmis-
sion. T cell adhesion induces a rapid reorganisation of the MT network
towards the junction that becomes a kind of virological synapse for bud-
ding (Igakura et al. 2003).
Filamentous actin and myosin seem to play important roles during
HIV budding at the plasma membrane (Sasaki et al. 1995). The interac-
tion of the HIV negative effector Nef with Vav, the host guanine nucleo-
tide exchange factor of Cdc42 and Rac—two small GTPases regulating
the actin cytoskeleton—could modify the actin cortex before virus bud-
ding (Fackler et al. 1999). Nef is also packaged into virions (10–100 mo-
lecules/particle) and has an important role in viral entry early after virus
fusion but before the completion of reverse transcription (Schaeffer et
al. 2001; Forshey and Aiken 2003). It is tempting to speculate that Nef,
possibly in concert with other proteins of the RTC, could again remodel
the actin cortex to facilitate access to the MT plus-ends for further
transport.
The kinesin motor KIF4A is abundantly expressed in neurons and
transports vesicles containing the cell adhesion protein L1 (Peretti et al.
2000). Yeast two-hybrid assays and chromatography showed that Gag
polyproteins and matrix protein of murine leukaemia virus, HIV and
SIV bind to KIF4 (Kim et al. 1998; Tang et al. 1999). Such an interaction
could mediate a plus-end-directed transport of the RTC during entry, as
well as the transport of RNA granules to the plasma membrane for as-
sembly.
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7
Adenovirus Entry and Microtubules
The cell entry of adenovirus is characterised by the stepwise disassem-
bly of incoming virions (Greber et al. 1993; Fig. 1C). Adenoviruses are
internalised by receptor-mediated endocytosis and induce the lysis of
endosomal membranes to gain access to the cytosol (Shenk 2001). Ad2
and Ad5 virions of the subgroup C attach to MTs in vitro and in vivo
(Luftig and Weihing 1975; Miles et al. 1980). If cells have been treated
with vincristine to induce MT paracrystals, the virions display projec-
tions emanating from the vertices that are shorter and thicker than the
fibre, and thus might represent bound host factors (Dales and Chardon-
net 1973). The capsids use dynein for transport along MTs towards the
MTOC because depolymerising the MT network, overexpressing dyna-
mitin and microinjection of function-blocking dynein antibodies all in-
hibit Ad2 and Ad5 infection (Suomalainen et al. 1999; Leopold et al.
2000; Mabit et al. 2002).
As with herpesvirus, it is unclear whether and how viral capsids
which have reached the MTOC are forwarded to the nuclear pores. Dy-
namic MTs are not required for nuclear targeting of incoming Ad parti-
cles. In fact, suppressing MT dynamics enhances the nuclear targeting
efficiency of Ad2 (Giannakakou et al. 2002; Mabit et al. 2002). At the nu-
clear pores the viral DNA is injected into the nucleoplasm (Greber et al.
1993; Trotman et al. 2001), where viral replication, transcription and
capsid assembly take place.
Analysing Ad2 particles that were visualised by the covalent attach-
ment of fluorescent dyes, Suomalainen et al. (1999) described two types
of motilities. Several transport events last for several seconds with an av-
erage velocity of 0.3–0.5 m/s, depending on the cell type, and peak ve-
locities of up to 2.6 m/s which are directed exclusively towards the
MTOC. Other particles rapidly alter direction towards or away from the
nucleus with speeds of up to 0.5 m/s. As with many other viruses, the
incoming Ad2 particles induce a complex signalling cascade, which in
this case activates protein kinase A and p38/MAPK pathways to boost
minus-end-directed MT capsid transport (Suomalainen et al. 2001). In
contrast to Ad2, Leopold et al. (1998, 2000) showed that labelled Ad5
particles rarely switch directions but also move along curvilinear tracks
with an average speed of 2.2 m/s. In the absence of a MT network, both
groups detected only short-range random movements (Suomalainen et
al. 1999; Leopold et al. 2000).
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Glotzer et al. (2001) labelled Ad5 particles by co-packaging a GFP-la-
belled protein that bound to specific sequences engineered into the viral
genome. Such particles moved both towards and away from the nucleus
and, surprisingly, with comparable peak velocities of 1 m/s and average
velocities of 0.32 m/s or 0.26 m/s, irrespective of the presence or ab-
sence of MTs. Moreover, viral gene expression is not reduced if MTs have
been depolymerised before infection (Glotzer et al. 2001). To explain
these conflicting results on cytosolic adenovirus capsid transport, the
parallel analysis of differently labelled particles with an identical experi-
mental set-up and time resolution will be necessary (for a discussion,
see Mabit et al. 2002).
The adenoviral protein Ad E3-14.7K, an inhibitor of TNFa-induced
cell death, interacts with a small GTPase called FIP1, which in turn inter-
acts with TCTEL1, a human homologue of the DLC Tctex-1 (Lukashok et
al. 2000). Because Ad E3-14.7K is not a structural protein, it cannot have
a role in cytosolic transport of Ad particles. However, many cellular pro-
teins require MT-mediated transport to reach their final destination
(Giannakakou et al. 2000), and the interaction of Ad E3-14.7K with a
FIP1-TCTEL1 complex could aid in its cytosolic trafficking.
Altogether these studies suggest that adenovirus capsids possess a vi-
ral receptor either for dynein or for dynactin, which allows them to use
MTs for efficient transport to the host nucleus after exit from the endo-
some. The disruption of the intermediate filament network facilitates vi-
ral egress (Chen et al. 1993), and progeny adenoviruses are released by
cell lysis.
8
Parvovirus Entry and Microtubules
Parvoviruses enter cells by receptor-mediated endocytosis and seem to
cross endosomal membranes at different stages of the endocytic path-
way. Canine parvovirus (CPV) is detected in clathrin-coated vesicles, re-
cycling endosomes, late endosomes and finally lysosomes, and CPV-con-
taining vesicles are often associated with MTs. The transport from early
to late endosomes as well as that of CPV-containing vesicles to the peri-
nuclear area requires intact MTs and cytoplasmic dynein (Aniento et al.
1993; Suikkanen et al. 2002). Injected anti-capsid antibodies block CPV
infection, suggesting that capsids enter the cytosol during infection.
Moreover, nocodazole and a microinjected anti-dynein antibody block
the nuclear accumulation of the injected capsids, suggesting that cyto-
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solic CPVare transported by dynein along MTs to the nucleus (Suikkanen
et al. 2003).
Adeno-associated virus (AAV) particles also move in a nocodazole-
and cytochalasin B-sensitive manner to the nucleus. However, it remains
to be determined whether virions are transported inside vesicles or
freely in the cytosol (Sanlioglu et al. 2000). Real-time imaging of viral
particles labelled with a single fluorescent molecule shows diffusion of
free virions, diffusion of virus within endosomes and directed MT-
dependent motion with velocities of 1.8–3.7 m/s (Seisenberger et al.
2001).
9
Poxviruses—Multiple Cargos for Microtubules and Actin Tails
9.1
Cytosolic Vaccinia Virus Cores
The most complicated virus in terms of entry and assembly is vaccinia
virus (VV), a poxvirus. One of its unique features is the formation of
two infectious viral particles. Assembly commences in viral factories
leading to the formation of the intracellular mature virus (IMV; Sodeik
et al. 1993), a large enveloped brick-shaped particle. Relative to the IMV,
the extracellular enveloped virus (EEV) has one additional membrane,
the so-called envelope (Smith et al. 2002; Sodeik and Krijnse-Locker
2002).
Because both forms lead to infection, they must differ in how the
DNA genome is uncoated and released into the cytosol where viral repli-
cation takes place. There are conflicting reports on whether both EEV
and IMV, or only IMV, require actin filaments for entry and whether
both or only IMV enter directly at the plasma membrane rather than by
endocytosis (Payne and Norrby 1978; Doms et al. 1990; Vanderplasschen
et al. 1998). In a recent study, the cells responded only to IMV but not
EEV with the formation of long cell surface protrusions which were in-
duced by a signalling cascade involving the actin-binding protein ezrin
and the small GTPase Rac (Krijnse Locker et al. 2000). Accordingly, the
IMV but not the EEV requires actin dynamics and filopodia for entry at
the plasma membrane.
Although VV entry is still poorly understood, at the end of this pro-
cess cores lacking any membrane are delivered into the cytosol. Early
VV mRNAs are first transcribed inside these cores and then accumulate
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in large granular structures which recruit ribosomes for translation and
are some distance away from the cores (Mallardo et al. 2001). Both the
cores and the early mRNAs are associated with MTs, and nocodazole re-
duces mRNA synthesis (Mallardo et al. 2001). The in vitro binding of
isolated cores to MTs requires the DNA- and RNA-binding protein L4R
and the core protein A10L, which both co-localise with stabilised MTs in
infected cells (Ploubidou et al. 2000; Mallardo et al. 2001).
Next, the incoming genome is uncoated, released from the core and
amplified in specialised replication sites that are surrounded by mem-
branes of the endoplasmic reticulum (Tolonen et al. 2001). After synthe-
sis of the structural proteins from the late mRNAs, IMVs are formed
within cytoplasmic viral factories from non-infectious precursors called
crescents and immature virions (Fig. 2B).
9.2
Particle Transport During Virus Egress
Overexpression of dynamitin, or the deletion of the IMV protein A27L,
inhibits the minus-end-directed MT transport of IMV particles from the
viral factories to the MTOC (Ploubidou et al. 2000; Sanderson et al.
2000; Fig. 2B). At the MTOC, the IMV is wrapped in a membrane cister-
na derived from the -TGN or an early endosome and intracellular en-
veloped virus (IEV) with two additional membranes relative to the IMV
is formed (Smith et al. 2002). If cells are infected in the presence of no-
codazole, no IEVs are made and there is a threefold reduction in the
amount of IMVs synthesized (Ploubidou et al. 2000).
IEVs move to the plasma membrane in a saltatory and directional
manner with an average speed of 1–2 mm/s along MTs and even switch
from one MT to another (Geada et al. 2001; Hollinshead et al. 2001;
Rietdorf et al. 2001; Ward and Moss 2001). IEVs co-localise with ki-
nesin-1, and the overexpression of the cargo-binding domain of KLC in-
hibits their transport (Rietdorf et al. 2001). Besides kinesin, the integral
membrane protein A36R and the peripheral membrane protein F12L are
necessary for IEV transport to the plasma membrane (Rietdorf et al.
2001; van Eijl et al. 2002).
Shortly before or after the fusion of the outer membrane of IEV with
the plasma membrane, the polymerisation of actin filaments is induced
(Hollinshead et al. 2001). The cell-associated virus (CEV) that remains
attached to the plasma membrane for quite some time is pushed on top
of a long microvillus into the medium or a neighbouring cell at a speed
of 2.8 mm/s (Cudmore et al. 1995). This process facilitates VV spread in
The Role of the Cytoskeleton During Viral Infection 93
a cell monolayer and in the tissue. The IEV protein A36R, which has an
unusual long cytosolic tail and no obvious mammalian homologues, is
the vaccinia actin tail nucleator. Tyr phosphorylation of A36R by a
member of the Src-kinase family leads to the recruitment of the adaptor
proteins Nck and Grb2, the WASP-interacting protein (WIP) as well as
N-WASP (Wiskott-Aldrich syndrome protein). WASP activates the Arp2/
3 complex and thus motility based on actin polymerisation (Frisch-
knecht et al. 1999; Moreau et al. 2000; Scaplehorn et al. 2002). Another
interesting rearrangement of the host actin cytoskeleton is the induction
of cell migration that depends on early VV gene expression and the for-
mation of cellular projections up to 160 mm in length that requires late
VV gene expression (Sanderson et al. 1998).
Considering how many different types of large VV particles have to
be shuffled around during entry and assembly, it is probably not sur-
prising that there is considerable cross-talk between VV proteins and
both cytosolic transport systems, MTs and microfilaments.
10
Actin Remodelling During Baculovirus Infection
Baculoviruses such as Autographa californica M nuclear polyhedrosis vi-
rus (AcMNPV) catalyse several distinct rearrangements of the actin cy-
toskeleton during different stages of the viral infection.
After virus uptake by endocytosis and acid-induced endosomal es-
cape, the incoming cytosolic capsids induce prominent transient actin
cables which often have a single capsid at one end and seem to be in-
volved in capsid transport to the nucleus (Charlton and Volkman 1993;
van Loo et al. 2001). Isolated AcMNPV capsids can nucleate actin poly-
merisation in vitro, and competition data with cytochalasin suggest
that these capsids bind to the minus-end of the filaments (Lanier and
Volkman 1998). Two AcMNPV proteins, p39 and p78/83, can bind to
actin directly (Lanier and Volkman 1998). Moreover, p78/83 contains
regions of homology to WASP which bind monomeric actin and the
Arp2/3 complex which nucleates assembly of new actin filaments (Mach-
esky et al. 2001). This suggests that p78/83 could function as a viral
WASP homolog in inducing actin filament assembly.
Interestingly, in contrast to other viruses, depolymerising the MTs
with nocodazole speeds up the onset of baculovirus gene expression, at
least in transduction experiments using mammalian cells, whereas infec-
tion in the presence of cytochalasin reduces the infection efficiency (van
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Loo et al. 2001). The myosin inhibitor BDM inhibits capsid transport to
the nucleus, suggesting that a myosin could also be involved in capsid
transport (Lanier and Volkman 1998).
The expression of the early viral protein Arif-1 (actin rearrangement-
inducing factor 1) is responsible for second modification of the actin cy-
toskeleton, the appearance of actin aggregates localised at the plasma
membrane (Roncarati and Knebel-Mrsdorf 1997). The amino acid se-
quence of Arif-1 predicts a N-terminal signal peptide and three trans-
membrane regions of about 20 amino acids each, and, moreover, Arif-1
seems to be phosphorylated at tyrosine residues (Dreschers et al. 2001).
Arif-1 is not required for infection of cultured cells but might play a role
during pathogenesis in insects.
The later phases of baculovirus infection are characterized by the ap-
pearance of F-actin inside the nucleus in a ring close to the nuclear
membrane which is essential for nucleocapsid morphogenesis (Ohkawa
and Volkman 1999). Six gene products of AcMNPV are required for the
recruitment of G-actin to the nucleus (Ohkawa et al. 2002).
11
Perspectives
There is probably not a single virus for which the cytoskeleton does not
play important roles during entry, replication, assembly or egress. With
the emerging technologies in digital time-lapse microscopy, the further
characterisation of viral transport will improve our understanding of
the underlying host mechanisms.
Deciphering the molecular interactions between viruses and the cyto-
skeleton could provide important new targets for the development of an-
tiviral therapy. Although the cytoskeletal filaments and associated mo-
tors play major roles in the cellular metabolism, viruses might interact
with these structures via unique sites different from the cellular interac-
tion partners. Other potential targets might be specific host proteins
which viruses use to hook onto the cytoplasmic transport machinery.
In our quest to develop efficient vectors for therapeutic gene expres-
sion, it has become apparent that the transport of naked DNA to the nu-
cleus, where transcription usually takes place, is a major barrier for the
transfection of non-dividing cells, and hence for the application of hu-
man non-viral gene therapy vectors in vivo. However, several viruses
have found effective solutions to this problem, namely successful negoti-
ation with the host cytoskeleton to ensure efficient cytoplasmic trans-
The Role of the Cytoskeleton During Viral Infection 95
portation to the nuclear pores of the nuclear envelope. The future design
of viral vectors will include these specific nuclear targeting mechanisms
while deleting any factors responsible for cell toxicity and the induction
of the immune response.
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RViral stop-and-go along microtubules:
taking a ride with dynein and kinesins
Katinka Do¨hner, Claus-Henning Nagel and Beate Sodeik
Institute of Virology, Hannover Medical School, D-30623 Hannover, GermanyBox 1. Microtubules (MTs) are part of the host cytoskeleton
MTs are long, hollow cylinders assembled from equally oriented
heterodimers of a- and b-tubulin and MT-associated proteins [79].
This head-to-tail association gives MTs an intrinsic structural
polarity with distinct ends: the ‘minus’-end depolymerizes if not
stabilized by other proteins, and it polymerizes three times slower
than the opposite ‘plus’-end. MTs grow primarily at the plus-end, but
can also depolymerize from the plus-end, a phenomenon called
dynamic instability that leads to alternating phases of growth and
shrinkage. This dynamic instability anables temporal and spatial
flexibility in MT organization. Tubulin dimers are arranged in 13
protofilaments that are nucleated by the MT-organizing centre
(MTOC). MTs can detach from an MTOC, and the resulting non-
centrosomal MTs either depolymerize or are stabilized by minus-end
protein complexes [77]. Plus-end-binding proteins stabilize the plus-
end, and enable interaction with the actin cortex, organelles or
kinetochores. This search-and-capture mechanism together withIncoming viral particles move from the cell surface to
sites of viral transcription and replication. By contrast,
during assembly and egress, subviral nucleoprotein
complexes and virions travel back to the plasma
membrane. Because diffusion of large molecules is
severely restricted in the cytoplasm, viruses use ATP-
hydrolyzing molecular motors of the host for propelling
along the microtubules, which are the intracellular
highways. Recent studies have revealed that, besides
travelling inside endocytic or exocytic vesicles, viral
proteins interact directly with dynein or kinesin motors.
Understanding the molecular mechanisms of cyto-
plasmic viral transport will aid in the construction of
viral vectors for human gene therapy and the search for
new antiviral targets.MT-associated proteins can stabilize an existing MT network [80].
Different cell types contain different MT arrays that reach the entire
cytosol [78] (see Figure 1 in main text).
Box 2. Cytoplasmic dynein and its cofactor dynactin
Most minus-end-directed microtubule (MT) transport is catalyzed by
cytoplasmic dynein, a 20 S protein complex consisting of two dynein
heavy chains (DHCs; 520 kDa), two dynein intermediate chains (DICs;
74 kDa), several dynein light intermediate chains (DLICs; 53–57 kDa)
and a series of dynein light chains (DLCs) from the LC8, Tctex/rp3
and LC7/roadblock families [7]. The C terminus of DHC comprises
both the globular head that hydrolyses ATP and a stalk that
terminates in a MT-binding domain. The N terminus mediates DHC
dimerization and binding to DLIC and to DIC, which also binds to
DLCs. DIC, DLIC and DLC are implicated in cargo binding and
regulation of motor activity. There are two DHC, two DIC, two DLIC,
two LC7 and three LC8 genes, and further diversity is generated by
different isoforms of DIC and DLIC. Dynein holoenzymes with
different subunit composition can recognize diverse cargos.
Cytoplasmic dynein is assisted by another large protein complex
of 20 S called dynactin, which enhances the processivity of dynein-
mediated transport, and is involved in cargo binding [8]. Dynactin
consists of a filament of the actin-related protein 1 (Arp1) and a
flexible sidearm projecting from this filament (see Figure 2 in main
text). The Arp1 filament is capped at its plus-end by the actin-capping
protein CapZ, and at its minus-end by a heterotetrameric complex of
Arp11, p62, p25 and p27. The projecting side arm consists of two
copies of p150Glued, four molecules of dynamitin and the homodimer
p24/p22. The latter two form a shoulder-like structure that connects
the p150Glued sidearm to the Arp1 filament. If dynamitin is present inIntracellular trafficking
Viruses are obligate intracellular parasites and therefore
depend on the cellular machinery for membrane traffick-
ing, nuclear import and export, and gene expression. In
fact, the molecular mechanisms of these processes have
been elucidated to a large extent by studying viral
systems. Although diffusion is efficient for translocation
over very short distances, it does not provide a means for
directed long-distance transport. Moreover, the free
diffusion of molecules larger than 500 kDa is restricted
in the cytoplasm if compared with diluted buffers, this
being a result of molecular crowding by organelles, the
cytoskeleton and high protein concentrations [1]. It has
been calculated that a herpes simplex virus (HSV) capsid
would need 231 years for a diffusional translocation of
1 cm in axonal cytoplasm [2]. Thus, for intracellular
transport, viruses again use host machinery [2–5].
The cellular and viral solution to master intracellular
trafficking is an organized network of three cytosolic
filaments – actin filaments, intermediate filaments and
microtubules (MTs) – which are regulated by many
kinases and phosphatases, in addition to tubulin- or
actin-binding proteins (Box 1). Moreover, these filaments
operate together, and several proteins provide direct links
between them [5,6]. The highways for long distance
transport are polar MTs (Box 1) with distinct minus- and
plus-ends; their ATP-hydrolyzing motors are dyneins
(Box 2) and kinesins (Box 3). Because a particular motor
moves only in one direction, the cell-specific organizationReview TRENDS in Microbiology Vol.13 No.7 July 2005large excess, the 20 S dynactin complex separates in two non-
functional subcomplexes.Corresponding author: Sodeik, B. (Sodeik.Beate@MH-Hannover.de).
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Box 3. The many members of the kinesin family
Kinesins are members of a superfamily containing 45 human
proteins [9] (http://www.proweb.org/kinesin/MotorSeqTable.html;
see Figure 2 in main text). They contain a microtubule (MT)-binding
motor domain of 320 amino acids that is folded similarly to myosins
and G proteins.
‘Conventional kinesin’ has two heavy chains (KHCs; kinesin-1;
120 kDa) and two light chains (KLCs; 64 kDa). KHCs are composed of
a N-terminal motor domain, followed by a coiled-coil region that
mediates dimerization. The N terminus of KLC interacts with the C
terminus of KHC, and a tetratricopeptide motif (TPR) in the C terminus
of KLC and the KHC tail mediate cargo binding. Three KHC and three
KLC genes create different motors. Kinesin-1 can interact with
cytoplasmic dynein through KLC and dynein intermediate chain [67].
Two members of the kinesin-2 family and the kinesin-associated
protein (KAP) form a ‘heterotrimeric kinesin’, which mediates axonal
and intraflagellar transport. The p150Glued subunit of dynactin
interacts with KAP3 [66]. Members of the kinesin-3 family are
monomeric in solution, but dimerize on membranes, and thus
become processive. They have a pleckstrin-homology domain that
facilitates membrane attachment and transport vesicles to the nerve
terminals of motor neurons and mitochondria. Kinesin-4 is a
homodimer involved in vesicle transport and mitosis. Kinesin-14
proteins carry their motor domain at the C terminus, and catalyse
minus-end-directed transport.
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Rof the MT determines the destination a specific motor can
reach (Figure 1). Cytoplasmic dyneins [7,8] and C-type
kinesins [9] power transport to MT minus-ends, whereas
the N-type kinesins propel cargo to plus-ends [9].
Cells require MTs for long-term normal physiology, and
viruses are obligate cellular parasites that completely
depend on the physiology of the host cell [7–9]. Thus, it is
no surprise that most, if not all, viral life cycles require
MTs for efficient replication. Moreover, there is a growing
list of reports showing that MT motors also catalyze the
intracellular transport of many viral structures. To
accomplish this, viruses use two alternative strategies:
(1) hijacking of cytoplasmic membrane traffic, namely
endocytosis for cell entry and exocytosis for egress, or (2)
direct interaction of viral components with MT motors [2].
The latter is the focus of this review.
The membrane vesicles occupied by viruses might
‘know’ which motor to recruit, or cytosolic domains of
viral membrane proteins could modify motor recruitment
of the vesicle. Recent studies have revealed several
potential direct interactions between viral components
and MT motors (Table 1). Although the cell often usesTRENDS in Microbiology 
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Figure 1. Organization of microtubules (MTs) in different cell types. (a) MTs (red) of
unpolarized fibroblasts or epithelial cells radiate from the MT-organizing centre
(MTOC) to the cell periphery, where their plus-ends (C) are located. The MTOC
nucleates MT minus-ends (K) and is often close to the nucleus (N) [77]. (b) In
polarized columnar epithelial cells, MTs form an apico-basal array with their plus-
ends near the basal surface and the minus-ends pointing to the apical membrane.
Moreover, there is an apical and a basal MT web composed of short filaments. Only
few MTs are associated with the MTOC under the cell apex [77]. (c) In polarized
hepatic epithelial cells, MT minus-ends point towards the bile canaliculi (BC; apical
domain), whereas plus-ends face the basolateral membrane. Only few MTs are
associated with the MTOC [78]. (d) In the soma of neurons, MTs are radially
arranged with their minus-ends attached to the MTOC. Axons and dendrites contain
noncentrosomal MTs. Axons have MTs of uniform polarity, with their plus-ends
pointing towards the synapse. In the proximal region of dendrites, the polarity of
MTs is mixed, whereas in the distal end, the polarity is the same as in the axon [9].
(e) During formation of a virological synapse (e.g. between an human T-cell
leukaemia virus (HTLV)-infected T cell and an uninfected T cell), the MTOC of the
infected cell is polarized towards the side of cell–cell contact [37].
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Table 1. Motor subunits interacting with viral proteinsa
Motor Subunit Viral interaction partner Methods Refs
Dynein DIC-1a HSV-1 nuclear protein UL34 GST-pulldown [54]
LC8 HSV-1 capsid protein VP5 Pepscanb [81]
HSV-1 helicase UL9 Pepscan [81]
HIV-1 integrase Yeast two-hybrid [82]
Foamy virus Gag protein Coimmunoprecipitation [45]
Ad protease Pepscan [81]
VV polymerase Pepscan [81]
ASFV p54 Yeast two-hybrid, Pepscan, coimmunoprecipitation,
affinity chromatography, colocalization
[48,83]
Rabies virus phosphoprotein Yeast two-hybrid, Pepscan, coimmunoprecipitation [83–85]
Mokola virus phosphoprotein Coimmunoprecipitation, colocalization, Pepscan,
yeast two-hybrid
[83,86]
Human papillomavirus E4 protein Pepscan [81]
HRSV; extracellular domain of attachment
glycoprotein
Pepscan [81]
Human coxsackievirus capsid protein Pepscan [81]
Baculovirus ORF AMV179 Pepscan [81]
Yam mosaic potyvirus polyprotein Pepscan [81]
Tctex-1, rp3 HSV-1 capsid protein VP26 Yeast two-hybrid, GST-pulldown [52]
TCTEL1 Ad 2; E3–14.7K through FIP-1 Yeast two-hybrid, GST-pulldown,
coimmunoprecipitation
[87]
Tctex-1 Poliovirus through poliovirus receptor CD155 Yeast two-hybrid, GST-pulldown,
coimmunoprecipitation
[88,89]
Kinesin-1 KHC HSV-1 US11 Affinity chromatography, GST-pulldown [35]
PAT1, subunit
of a kinesin?
HSV-1 US11 Yeast two-hybrid, GST-pulldown, colocalization after
transfection
[58]
KLC VV A36R Yeast two-hybrid, GST-pulldown [57]
Kinesin-3 KIF1A HSV-2 UL56 Yeast two-hybrid, GST-pulldown, colocalization [61]
Kinesin-4 Retroviral Gag Yeast two-hybrid, GST-pulldown,
coimmunoprecipitation
[62,90]
aAbbreviations: Ad, adenovirus; ASFV, African swine fever virus; FIP-1, 14.7K-interacting protein; GST, glutathione-S-transferase; HIV, human immunodeficiency virus;
HRSV, human respiratory syncytial virus; HSV, herpes simplex virus; KHC, kinesin heavy chain; KIF, kinesin superfamily protein; KLC, kinesin light chain; ORF, open reading
frame; PAT1, protein interacting with amyloid precursor protein tail 1; VV, vaccinia virus.
bBinding to synthetic dodecapeptides covalently bound to cellulose membrane.
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Radaptors to link a cargo with a specific motor [7–10], all
viral examples described so far showed either transport
inside vesicles or a direct interaction of a viral protein and
a motor subunit. The recent advances in live cell imaging
revealed that many cellular and viral cargos move along
MTs in both directions, suggesting the recruitment of
multiple motors and a careful regulation of motor activity
[11,12]. This raises the questions as to how net transport is
achieved, and which potential benefits such seemingly
ATP-wasting phenomena might provide.
Analysing viral transport along microtubules
A broad spectrum of cell biology and virology tools is
available to study the role of MT motors during viral
infection [4,5,8]. Fluorophores or fluorescent proteins can
be attached directly to a viral structure. Although such a
tag might alter assembly or subsequent virus entry,
quantitative virological, cell biological and genetic assays
provide excellent controls to ascertain that a given fusion
protein has taken the place and function of its wild-type
counterpart [4,5]. The fluorescent signals might represent
aggregated viral proteins, vesicles containing viral
proteins, subviral intermediates in the assembly or
disassembly pathway, cytosolic viral particles attached
to vesicles, viruses inside vesicles, or extracellular
virus. Simultaneous tagging of multiple viral and
cellular components can distinguish between these
possibilities [13–15].
Using fluorescent tags, viral particles were shown to
move along MTs at a speed ofw0.2–4 mm secK1, similar towww.sciencedirect.com
eprinted from Trends in Microbiology, Vol. 13, Döhner, Nagel & Sodeik, Viral sto
Copyright (2005), with perspeeds of cellular cargoes [13,15–25]. These are faster
transport rates than are achieved by random walk [2].
Single molecule measurements showed that, under load,
cytoplasmic dynein and kinesin-1 make steps of 8 nm
[26,27]. For a processive motor that runs with 2 mm secK1,
this calculates to w250 steps secK1. A human 100 m run
roughly requires 50 steps and as little as 10 s, which
corresponds to 5 steps secK1. Fluorescently tagged viral
particles also enable the reconstruction of motility with
defined components in vitro [8,18]. Such experiments
facilitate the distinction of virus transport inside vesicles
from direct interactions of MT motors.
Microtubule function during viral infection
Many viruses require MTs during cell entry for efficient
nuclear targeting (Figure 1), either for cytosolic transport
of naked viral particles or for transport inside vesicles.
Examples are herpes simplex virus (HSV) [28], human
cytomegalovirus [29], human immunodeficiency virus
(HIV) [22], adenovirus (Ad) [16], parvoviruses [20,30],
simian virus 40 (SV40) [19], influenza virus [24] or
hepatitis B virus [31]. Even incoming cores of vaccinia
virus (VV), which replicates in cytoplasmic viral factories,
are transported alongMTs [14]. MTs and the RNA-binding
VV protein L4R are required for efficient transcription and
translation of early VV mRNAs [32]. Nuclear targeting
has been demonstrated in vivo with green fluorescent
protein (GFP)-VP26-tagged pseudorabies virus (PRV) in
neurons [15], GFP-Vpr-tagged HIV [22], fluorescent dyes
directly coupled to Ad, SV40 and adeno-associated virusp-and-go along microtubules: taking a ride with dynein and kinesins, p. 320-327
mission from Elsevier
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R[16,17,20] or intercalated in the membrane of influenza
virus [24]. However, transgene expression of baculovirus
in mammalian cells is increased if MTs are depolymerized
[33]. Incoming baculovirus capsids induce prominent actin
cables that are possibly involved in transport to the
nucleus and, in this situation, the MTs might be obstacles
rather than highways.
During assembly and egress, viruses also need MTs for
trafficking inside exocytic vesicles or for cytosolic trans-
port of capsids and nucleoprotein particles to the budding
compartment. Whereas virus yields are reduced if MTs are
depolymerized during assembly, the radial MT organiz-
ation (Figure 1) of undifferentiated epithelial cells is lost
late in HSV infection: MTs are marginalized in bundles to
the cell periphery, and a microtubule-organizing centre
(MTOC) is no longer recognizable [34]. Nevertheless,
herpesvirus particles tagged with GFP-VP11/12 or
GFP-VP26 translocate along MTs over distances of up to
49 mm [21,23]. If budding occurred at endosomes or the
Golgi apparatus, which are mostly clustered around the
MTOC, capsids should move to MT minus-ends; by
contrast, in neurons, viral structures use plus-end-
directed transport to axon terminals [4,5,15,35].
For budding, subviral HIV particles assembled in the
cytosol are transported to the plasma membrane. Both
MTs and the binding motif for the host RNA-binding
protein hnRNP A2 present in genomic HIV RNA are
involved in the trafficking of viral RNA granules [36].
Budding and transmission of the human T-cell leukaemia
virus occurs at a virological synapse formed after adhesion
between an infected cell and an uninfected T cell. In the
infected cell, the MTOC rapidly moves towards the
adhesion site, resulting in many MT plus-ends pointing
towards the cell junction [37].
After assembly, the intracellular mature virus (IMV) of
VV is transported from the viral factories to the MTOC
[38,39], where it is wrapped by a membrane cisterna to
form the intracellular enveloped virus (IEV; Figure 2).
During its saltatory and directional transport to the cell
periphery, the IEVoccasionally switches MT [13]. The IEV
outer membrane fuses with the plasma membrane. While
still attached to the plasma membrane, the resulting cell-
associated extracellular virus induces a cytosolic actin tail
that can push it into a neighbouring cell [40]. Despite all
this transport, the ability of the MTOC to nucleate MTs is
destroyed during assembly of VV and African swine fever
virus (ASFV) [38,41].
Viral interactions with dynein
By microinjecting function-blocking anti-dynein anti-
bodies or overexpressing dynamitin (Box 2), the role of
dynein was established for the efficient nuclear targeting
of HSV, Ad or canine parvovirus (CPV) capsids
[16,17,30,42], HIV reverse transcription complexes [22]
and influenza virus [24]. Moreover, incoming HSV capsids
colocalize with dynein and its cofactor dynactin [28,42],
and Ad [43] in addition to CPV [30] capsids can interact
with dynein and MT in vitro.
Dynein transports endosomes containing virions or
cytosolic incoming viral particles to the MTOC, which in
many cells is located close to their final destination, thewww.sciencedirect.com
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particles move from the MTOC further to the nucleus [44].
Although viral capsids initially accumulate at the nuclear
site facing the MTOC, they later distribute over the entire
nuclear surface, suggesting additional transport mechan-
isms [28,42,45]. Recent analysis on retrograde transport
in injured axons shows that dynein can interact with the
nuclear import receptor importin-a and recruit a nuclear
import cargo that is bound to importin-b [46]. In this
axonuclear communication, minus-end-directed MT
transport is coupled to nuclear import. Several viral
proteins and even viral capsids bind to host importins
[47]. Besides providing a mechanism to recruit dynein,
importins could facilitate transport from the MTOC to the
nucleus. Alternatively, viral particles might use plus-end-
directed MT motors to proceed.
During virus assembly and egress, dynein can trans-
port subviral particles to a budding organelle located close
to the MTOC. ASFV infection is inhibited by MT
depolymerization and dynamitin overexpression [48,49].
Dynein catalyses the transport of the IMV form of VV from
the virus factory to the MTOC, where the wrapping in a
membrane cisterna results in the formation of IEVs
[38,39]. Moreover, dynein conveys newly synthesized
Gag to the MTOC in Mason–Pfizer monkey virus infection
[50]. The Env complex, which is localized in the
pericentriolar recycling compartment, then triggers
further transport to the plasma membrane.
These examples raise the question as to which viral
proteins interact with which subunit of dynein or dynactin
(Box 2). Dynactin is a multifunctional adaptor that helps
MT motors to interact with many cellular cargos [8].
However, so far, only dynein subunits, mainly the dynein
light chain (DLC), have been identified as potential direct
interaction partners of viral proteins (Table 1). A human
foamy virus vector lacking the LC8 binding motif in its
Gag is less infectious, suggesting that Gag and dynein
could mediate the MTOC localization during virus entry
[45]. In many instances, the putative cargo-binding region
on the different DLCs overlaps with their dynein
intermediate chain (DIC)-binding region. Thus, this
region could only be responsible for cargo recruitment if
one subunit of the DLC dimer interacts through DIC with
the dynein motor, and the other subunit of the DLC dimer
interacts with the putative cargo [7,51]. This scenario
would leave one DLC-binding site on the DIC dimer
unoccupied. Moreover, LC8 is also present in other protein
complexes, and binding to LC8 might have functions
independent of dynein [7].
The small capsid protein VP26 of HSV-1 can interact
with the DLCs Tctex-1 and rp3 [52]. Whereas micro-
injected capsids with VP26, but not capsids without VP26,
accumulate at the nucleus [53], a VP26 deletion mutant
delivers viral genomes as efficient as wild type to the
neuronal nuclei in the trigeminal ganglia [53]. The HSV-1
primary envelope protein UL34 can interact with DIC
[54]. Nevertheless, UL34 is unlikely to have a role in HSV
cytoplasmic transport because it is absent from cyto-
plasmic membranes and cytoplasmic, in addition to
extracellular, virions [55].p-and-go along microtubules: taking a ride with dynein and kinesins, p. 320-327
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Figure 2. The morphology of viral cargos and microtubule (MT) motors. MTs (red)
are hollow cylinders with a diameter of 25 nm. Cytoplasmic dynein heavy chains
(DHC; dark blue) comprise the globular heads with a diameter of 12 nm and a 9 nm
stalk that terminates in a MT-binding domain. The N-terminal DHC stem binds
dynein light intermediate chains (DLCs) and dynein intermediate chains (DICs; light
blue; [7]). Dynactin consists of a 10 nm!40 nm rod made mainly of Arp1, and a
flexible sidearm of p150Glued projecting with a length of 25–50 nm from this filament
[8]. Dynein and other motors are thought to bind to dynactin along or near the base
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The kinesin family has a large variety of kinesin motor
subunits [9] (Box 3). Thus, viruses can choose from many
different plus-end-directed MT motors (Table 1).
The IEVof VVand ASFV particles that are transported
from the trans-Golgi network to the cell surface colocalize
with kinesin-1, and the overexpression of the cargo-
binding domain of the KLC reduces the number of
particles in the cell periphery [13,56]. VV mutants lacking
the IEV protein A36R are arrested in the perinuclear
region, and KLC binds directly to the cytosolic tail of A36R
[13,57]. At the plasma membrane, the tyrosine kinase Src
phosphorylates A36R, and thus mediates the transition
from kinesin-1 transport to actin-tail formation [40].
Axonal HSV progeny capsids also colocalize with
kinesin-1, and the predicted cargo-binding domain of
kinesin heavy chain (KHC) recruits the major capsid
protein VP5 and the tegument proteins VP16, VP22 and
US11 from an infected cell lysate [35]. With VP16 and
VP22 also binding to US11, the latter is considered the
direct binding partner of KHC. This is also because
recombinant US11, in contrast to VP16, binds to KHC,
and because VP5 is not very accessible on the capsid
surface after tegumentation. Recombinant US11 neither
binds kinesin light chain (KLC) nor competes for its
binding site on the KHC tail [35]. US11 also interacts with
PAT1 in a region that has sequence similarity to the cargo-
binding domain in KLC of kinesin-1 [58]. PAT1 is a
nucleocytoplasmic host protein that binds to the cytosolic
tail of amyloid precursor protein (APP) and to MTs in a
nucleotide-dependent manner, but it is unclear whether it
functions as a motor subunit [59]. The promiscuous
C-terminal basic region of US11 binds to KHC and
PAT1, but also to mRNAs, double-stranded RNA, rRNA,
the antiviral protein kinase R (PKR) and PACT (PKR-
activating protein), and proteins involved in cell growth
arrest [35,58,60].
Secretory vesicles containing viral membrane proteins
or even complete virions must also recruit plus-end-
directed motors for transport to the plasma membrane.
An example for this might be the binding of the C terminusof this arm. Each globular head of p150Glued has a MT-binding site, whereas the
Arp1 filament has been implicated in cargo binding. Kinesin-1 (w80 nm length) has
a rod-like structure with two heads with a diameter of 10 nm, a stalk, and a fan-like
end. Kinesin-1 is a heterotetramer of two kinesin heavy chains (KHCs; dark blue) and
two kinesin light chains (KLCs; light blue). Kinesin-2 (w54 nm length) is a
heterotrimer of two KIF3 chains (dark blue) that form globular heads with a
diameter of 10 nm, and one kinesin-associated protein (KAP; light blue). Kinesin-4
(w116 nm) is a dimer of two KIF4 chains with two globular heads of 12 nm
diameter, a central a-helical coiled-coil stalk and a globular tail [9]. Herpes simplex
virus (HSV) has a diameter of w225 nm. It contains an icosahedral capsid (dark
green) of 125 nm diameter enclosing the DNA genome, a tegument with w20
proteins (light green) and an envelope that anchors the viral spikes (black).
Adenoviruses (Ad) have a diameter of 70–100 nm. They consist of an icosahedral
capsid (green) that encloses the genome and DNA-associated proteins. 12 fibres
project from the vertices of the capsid and terminate in knobs (black). Human
immunodeficiency virus type 1 (HIV-1) has a diameter of 145 nm. The two single-
stranded RNA genomes and associated proteins are surrounded by a cone-shaped
capsid (dark green). The matrix (light green) is localized underneath the envelope
that contains viral glycoproteins (black). Canine parvovirus is an icosahedral capsid
(green) with a diameter of 26 nm. The intracellular mature virus (IMV) of vaccinia
virus (VV) is roughly brick shaped and measures w300–310!240–250!
110–140 nm. The intracellular enveloped virus (IEV) shown here contains two
additional membranes. For comparison, all structures were drawn approximately
to scale.
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Box 4. Future questions
† Do viral and cellular microtubule (MT) motor receptors have
homologous domains?
† Do viral and cellular MT motor receptors bind to the same motor
subunits?
† Do viral cargos bind to multiple MT motors simultaneously or
sequentially?
† How is net transport to MT minus- or plus-ends regulated during
viral entry or egress?
† What viral or cellular signals trigger changes in transport
direction?
† Do viruses use and regulate MT motors in the same way in
different cell types (e.g. viral infection of epithelial cells versus
infection of neurons)?
† Do viruses interfere with apoptosis and stress responses through
dynein light chain?
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Rof HSV-UL56 to the kinesin-3 family member KIF1A [61].
Moreover, the matrix protein present in the cytosolic Gag
polyprotein of many retroviruses binds to kinesin-4 [62],
and this interaction might convey subviral particles to the
plasma membrane for virus budding.
Bidirectional transport along microtubules
The great surprise from live cell imaging is that viruses
like cellular organelles often stop and restart runs, switch
between different MTs, and even change directions on a
single MT resulting in saltatory movements and pauses
for long periods with no apparent translocation. Many
cargoes show plus-end- and minus-end-directed MT
transport: mitochondria, intermediate filaments, ribonu-
cleoprotein complexes, endosomes, phagosomes, lipid
droplets and secretory vesicles [11,12,63,64]. This list is
likely to grow because the ability to record bidirectional
transport increases with improved temporal and spatial
resolution [11,12]. Individual particles cannot be tracked
unambiguously and short changes in direction might be
missed if there are undocumented periods between
consecutive frames.
Bidirectional transport has also been observed for PRV
[15,21], HSV [23,42], Ad [16,65], HIV-1 [22] and influenza
virus [24]. Whereas the latter is an endocytic voyager, the
others probably represent direct interactions between
viral structures andMTmotors. Inhibition of dynein leads
to more plus-end-directed transport of HSV, Ad andHIV to
the cell periphery [16,22,42]. Dynamitin overexpression
reduces the extent and frequency of minus-end-directed
Ad transport, whereas plus-end-directed motion is
detected more often [16].
Bidirectional MT transport can be used (1) to set up a
homogenous or polarized distribution of a given cargo that
could then be anchored to its subcellular destination, (2) to
adjust quickly the net transport in response to an internal
or external signal, (3) to step back to circumvent obstacles
on the MT track, (4) to explore different regions of the cell,
or (5) for error correction [12]. To achieve these goals,
different motors on different cargos must be carefully
regulated: dynein might be inactive on one cargo, and at
the same time active on another [11,12,63]. This implies
that viruses must ‘know’ how to activate MT motors to
ensure net transport to their desired destination. Acti-
vation of protein kinase A and p38 mitogen-activated
protein kinase (MAPK) during Ad entry stimulates the
frequency and velocity of minus-end-directedmotility [65].
On the basis of the experimental systems studied so far,
threemodels have been developed to describe the potential
regulation of bidirectional MT transport [11,12,63].
The first is a model of ‘exclusive motor presence’. If
there would be only a unique binding site on a particular
cargo, binding of a plus-end- or a minus-end-directed
motor could alternate but not occur simultaneously. To
change direction, a bound motor would have to detach and
another motor be recruited.
According to the second, ‘tug-of-war’, model, net
transport is achieved when one type of motor is more
active or makes larger steps than the other present on this
cargo. In this scenario, interference for example with
dynein activity would improve plus-end-directedwww.sciencedirect.com
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also abolish plus-end transport in some systems.
These results lead to the third model of ‘coordinated
regulation’, in which motors with opposite polarity attach
to a cargo, and their activities are coordinated by a
common upstream mechanism. For example, PRV tagged
with GFP-VP26 moves in both directions in axons, and
coordinated regulation seems to be responsible for the
dominance of the plus-end-directed transport late in
infection [15,21].
The coordination of opposite-polarity motors could be
mediated by dynactin, other adaptor proteins, or specific
motor regulation by kinases or phosphatases [63]. The
dynactin subunit p150Glued interacts with both DIC of
dynein and kinesin-associated protein (KAP) of kinesin-2,
overexpression of dynamitin can inhibit dynein and
kinesin-2 transport, and dynein and kinesin-1 can
physically interact with each other through DIC and
KLC [66,67]. Moreover, dynein and kinesin-1 compete for
an overlapping MT-binding site [68], and motor domains
bound to MT might therefore prevent binding of other
motors.
Live microscopy of defined viral particles analysed at
high spatial and temporal resolution will reveal how and
why so many cargoes including viruses use bidirectional
transport (Box 4).Microtubules in antiviral host responses?
Dynein also transports large protein aggregates to the
MTOC where they are packaged into aggresomes [69].
Such aggresomes either recruit chaperones for refolding,
proteasomes to clear this ‘garbage’ from the cytosol or are
eliminated by autophagy that terminates in lysosomal
degradation [70,71]. Could a cell treat an incoming viral
particle as a large protein aggregate that should be
degraded [44]? In this scenario, bidirectional MT trans-
port might increase the chance of a viral particle to avoid
degradation, and to get further from the MTOC to the
nucleus. Moreover, it will be interesting to determine how
dynein is recognizing a protein aggregate as garbage
destined for degradation.
In a healthy cell, dynein LC8 has been proposed to
inactivate Bim, a pro-apoptotic Bcl-2 member protein, but
upon specific signals, LC8-Bim can bind to its receptor Bcl-2
on cellular membranes, and apoptosis is induced [72].p-and-go along microtubules: taking a ride with dynein and kinesins, p. 320-327
mission from Elsevier
Review TRENDS in Microbiology Vol.13 No.7 July 2005326
RApoptosis is initiated by a defined proteolytic cascade and
ultimately results in cell death. During apoptosis, most
minus-end-directed MT transport is also inhibited
because DIC and the dynactin subunit p150Glued are
cleaved by caspases [73]. Many viruses induce apoptosis;
however, they also encode proteins that block apoptosis
[74]. Several viral proteins interact with LC8 (Table 1),
and might therefore modulate Bim activity. The LC8-
binding protein p54 of ASFV induces apoptosis after
transient transfection, as does the infection with ASFV,
possibly by p54 binding to LC8 and thus releasing Bim
[48,75]. LC8 also interacts with IkB, which forms a
heterodimer with NF-kB, which is involved in stress
responses during virus infection and regulates the
expression of many anti-apoptotic proteins [7,76].
Concluding remarks and future perspectives
MTs have important roles for most if not all viruses during
entry, assembly or egress. Dynein is the motor for
transport to the MTOC during virus entry and assembly.
The interaction of viral proteins with kinesins emerges as
a common feature during assembly and egress, and might
also catalyse transport from the MTOC to the nucleus
during entry. Many viral particles show bidirectional
motility, but nevertheless achieve net transport to the
minus- or plus-ends of MTs in different phases of their life
cycle. With the emerging technologies in digital time-lapse
microscopy, further analysis will dissect the underlying
virus–host interactions. A major challenge will be to
elucidate how viruses adjust the regulation of motor
activity to fulfil their transport needs (Box 4).
This knowledge will aid in the development of viral
vectors to express therapeutic proteins because viruses
have perfected the art of protecting genetic material and
transporting it to and within specific cells. Moreover, the
viral binding sites on MT motors might provide new
targets for the development of antiviral therapy. Although
the host also depends on the motors, viruses might
interact with them through unique sites. Finally, viral
particles provide excellent tools to elucidate the regulation
of bidirectional MT transport in animals, cells and in vitro.
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